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Foreword
This report results from the eighth national survey of HIV/
AIDS in Correctional Facilities, sponsored jointly by the
National Institute of Justice and the Centers for Disease
Control and Prevention. The survey was carried out between
May and December 1994, and had several new features this
year.  First, it covered the prevalence and prevention of
sexually transmitted diseases among inmates and, second,
a validation study permitted comparison of responses on key
policy issues from State correctional systems’ central offices
with those from selected individual facilities.  This revealed
a number of interesting discrepancies between central office
policies and facility practices.
The 1994 survey found that over 4,500 inmates have died of
AIDS since the beginning of the epidemic and that there
were over 5,000 inmates diagnosed with AIDS currently
incarcerated in responding correctional systems.  Despite
the continued growth of the epidemic among inmates,
however, the 1994 survey indicated a continued decline in
the number of correctional systems providing face-to-face
inmate HIV education.  Results also suggest that there are
continuing needs for improvement in HIV prevention coun-
seling, medical care and supportive services for inmates
with HIV, and drug treatment capacity for inmates.
Meeting the difficult challenges posed by HIV/AIDS in
correctional facilities, as well as exploiting the significant
opportunities for providing education, prevention, and in-
tervention to a previously underserved population, requires
collaboration among correctional and public health au-
thorities.  The National Institute of Justice and Centers for
Disease Control and Prevention have committed them-
selves to promoting such collaborations.  The agencies’
continued joint sponsorship of the Updates on HIV/AIDS in
Correctional Facilities represents one important method of
keeping the lines of communication open and encouraging
operational partnerships to address HIV/AIDS and other
health issues in correctional and criminal justice settings.
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Director
National Institute of Justice
Helene D. Gayle, M.D., M.P.H.
Director
National Center for HIV, STD, TB Prevention
Centers for Disease Control and Prevention
iv 1994 Update:  HIV/AIDS and STDs in Correctional Facilities
Acknowledgments v
Acknowledgments
It is a pleasure to acknowledge the assistance of a number
of people and organizations in the preparation of this report.
At Abt Associates Inc., my co-authors Michael Gross, Joel
Epstein, Santiago Sifre, Rebecca Widom and Tammy Enos
all contributed key portions of the report. Terry Dunworth
conducted several site visits. David Deal of Abt Associates’
Survey Research Group managed the challenging data
collection effort with guidance from Lynne Harrold, a
veteran of managing the previous survey. Wendy Sanderson
and Karen Minich provided administrative support, Mary-
Ellen Perry and Winn Sinclair handled word processing
with great skill, and Jackie Curtis produced the camera
ready copy.
Cheri Crawford of the National Institute of Justice was the
project monitor and offered numerous useful comments on
drafts of the report, as did several anonymous NIJ reviewers.
At the Centers for Disease Control and Prevention, Sandy
Kerr and several other staff also provided helpful feedback
on the draft report.
Finally, I am grateful to all of the correctional administra-
tors and health care staff who took the time to respond to the
questionnaire and to followup telephone inquiries. For this
update, site visits were conducted at facilities of the Federal
Bureau of Prisons and the state correctional systems of
Texas, Vermont, and Oregon. I wish to thank the staffs of
all these organizations for their gracious cooperation with
the site visits, which yielded a great deal of valuable
information for this report.
Theodore M. Hammett, Ph.D.
October 1995





Executive Summary ........................................................................................................................................................ xiii
Introduction...................................................................................................................................................................... xv
Chapter 1:  Epidemiology of HIV/AIDS and STDs in Correctional Facilities and the Population at Large .......... 1
Patterns of HIV/AIDS in the U.S. Population .................................................................................................................... 1
Reported AIDS Cases and the Revised Case Definition ...................................................................................... 1
HIV/AIDS by Racial/Ethnic Groups .................................................................................................................... 2
Women and HIV/AIDS......................................................................................................................................... 2
HIV/AIDS by Exposure Categories ...................................................................................................................... 2
Estimates of HIV Infection in the U.S. Population .............................................................................................. 4
HIV/AIDS in Correctional Facilities .................................................................................................................................. 4
No Job-Related Cases of HIV/AIDS Among U.S. Correctional Officers ............................................................ 4
AIDS Cases Among Correctional Inmates ........................................................................................................... 4
Inmate HIV/AIDS Deaths..................................................................................................................................... 4
Current Inmate AIDS Cases ................................................................................................................................. 5
AIDS Incidence Rates ........................................................................................................................................... 8
HIV Seroprevalence Among Correctional Inmates .............................................................................................. 9
Characteristics of Inmates With HIV/AIDS....................................................................................................... 11
HIV Transmission Among Correctional Inmates .............................................................................................. 14
STD Testing Results ........................................................................................................................................... 15
Endnotes ............................................................................................................................................................................ 19
Chapter 2:  HIV and STD Education and Behavioral Interventions ......................................................................... 23
The Importance of Comprehensive Correctional HIV/STD Prevention Programs.......................................................... 23
The State of Knowledge Among Inmates ......................................................................................................................... 24
Types of HIV Education and Prevention Programs Provided .......................................................................................... 24
Instructor-Led Education .................................................................................................................................... 26
Inmate Peer Programs ......................................................................................................................................... 30
HIV Prevention Counseling ................................................................................................................................ 33
Audiovisual and Written Materials .................................................................................................................... 33
STD Education .................................................................................................................................................... 33
Endnotes ............................................................................................................................................................................ 34
Page
Chapter 3:  HIV Precautionary and Preventive Measures ......................................................................................... 37
Infection Control Based on Universal Precautions ........................................................................................................... 37
Availability of Barrier Protection ..................................................................................................................................... 38
The Debate Over Condom Availability ............................................................................................................................ 38
Bleach and Needle Availability ........................................................................................................................................ 39
Endnotes ............................................................................................................................................................................ 39
Chapter 4:  HIV and STD Testing, Counseling, Confidentiality, and Disclosure Policies ...................................... 41
HIV Antibody Testing Policies ......................................................................................................................................... 41
Mandatory Screening .......................................................................................................................................... 41
Voluntary/On-Request Testing ........................................................................................................................... 41
Confidentiality and Disclosure of HIV Status .................................................................................................................. 43
HIV Pretest/Posttest Counseling ....................................................................................................................................... 45
Testing for Sexually Transmitted Diseases ...................................................................................................................... 46
STD Notification ................................................................................................................................................. 48
Pregnancy Testing ............................................................................................................................................................. 49
Endnotes ............................................................................................................................................................................ 49
Chapter 5:  Housing and Correctional Management of Inmates with HIV/AIDS ................................................... 51
Housing Policies ................................................................................................................................................................ 51
Work Assignments and Other Programming ................................................................................................................... 54
Conjugal Visits .................................................................................................................................................................. 54
Early and Compassionate Release .................................................................................................................................... 54
Discharge Planning ........................................................................................................................................................... 55
Rhode Island ....................................................................................................................................................... 56
Maryland ............................................................................................................................................................. 56
Connecticut ......................................................................................................................................................... 57
Federal Bureau of Prisons ................................................................................................................................... 57
Cook County (Chicago), Illinois ......................................................................................................................... 57
San Francisco ...................................................................................................................................................... 57
Self-Help Materials ............................................................................................................................................. 57
Endnotes ............................................................................................................................................................................ 58
Page
Chapter 6:  Medical Care and Psychosocial Services ................................................................................................. 59
Availability of Prophylactic and Therapeutic Drugs for Inmates with HIV Disease ....................................................... 59
Access to Experimental Therapies and Clinical Trials .................................................................................................... 60
Psychosocial and Supportive Services .............................................................................................................................. 61
Drug Treatment ................................................................................................................................................................. 63
Massachusetts:  A New Approach to Drug Treatment in Prison ....................................................................... 64
Endnotes ............................................................................................................................................................................ 64
Chapter 7:  Legal Issues ................................................................................................................................................. 67
Issues Raised by Inmates ................................................................................................................................................... 67
Protection From Harm by Fellow Inmates ......................................................................................................... 67
Challenges to Mandatory Testing ...................................................................................................................... 68
Other Testing Policies ........................................................................................................................................ 68
Confidentiality .................................................................................................................................................... 69
Segregation and Housing Assignments .............................................................................................................. 70
Access to Programs ............................................................................................................................................. 73
Adequacy of Medical Care.................................................................................................................................. 75
Criminal Indictment and Sentencing of Persons With HIV Infection ............................................................................. 75
Sentencing of Persons With HIV/AIDS ............................................................................................................. 75
Spitting and Biting ............................................................................................................................................. 76
Civil Cases Involving Potential Exposure to HIV ............................................................................................................ 76
Industrial Accident Claims ............................................................................................................................................... 77
Cases Involving Hepatitis and Sexually Transmitted Diseases ........................................................................................ 77
Endnotes ............................................................................................................................................................................ 77
Appendix:  Biomedical and Epidemiologic Research Developments ......................................................................... 81
Uncertainties About “Early Intervention” ........................................................................................................................ 81
Resistance to Anti-HIV Drugs and Therapeutic Choices ................................................................................................. 82
Zidovudine and Vertical (Mother-to-Infant) Transmission of HIV ................................................................................. 83
New Anti-HIV Drugs in Development ............................................................................................................................. 83
Preventive Vaccines .......................................................................................................................................................... 84




Table 1: Cumulative Total of Adult/Adolescent AIDS Cases in the United States
by Exposure Category, Through December 1993 .................................................................................. 3
Table 2: Cumulative Total AIDS Deaths Among Correctional Inmates and the
Population at Large, U.S., 1985–1994 ................................................................................................... 5
Table 3: Distribution of Cumulative Total Inmate AIDS Deaths, U.S., 1994 .................................................... 6
Table 4: Regional Distribution of Cumulative Total Inmate AIDS Deaths, U.S. ............................................... 7
Table 5: Distribution of Current Inmate AIDS Cases, U.S., 1994 ...................................................................... 8
Table 6: HIV Seroprevalence Data From Mandatory Mass Screening of Inmates ........................................... 10
Table 7: HIV Seroprevalence Data From Blinded Epidemiologic Studies of Inmates...................................... 12
Table 8: HIV Seroprevalence Data Based on Other Testing Criteria ................................................................ 16
Table 9: Syphilis Testing Data, 1993–1994 ....................................................................................................... 18
Table 10: Gonorrhea Testing Data, 1993–1994................................................................................................... 20
Table 11: Chlamydia Testing Data, 1993–1994 .................................................................................................. 21
Table 12: HIV/AIDS Education and Prevention for Inmates, November 1992–March 1993 and 1994 ............ 25
Table 13: Coverage of Inmate HIV Education/Prevention Programs Within State/Federal
Correctional Systems (N=51), 1994 ..................................................................................................... 26
Table 14: HIV/AIDS Education and Prevention Programs for Inmates .............................................................. 27
Table 15: Topics Covered in HIV/AIDS Education for Inmates, 1994 ............................................................... 28
Table 16: Topics Covered in HIV/AIDS Education for Inmates:  Results of the Validation Study ................... 29
Table 17: Summary of Correctional Policies on HIV Antibody Testing of Inmates, 1994 ................................. 42
Table 18: HIV Antibody Testing of Inmates, Hierarchical Categorization, 1994 .............................................. 43
Table 19: HIV Antibody Testing Policies, Hierarchical Categorization: Results of the Validation Study ........ 44
Table 20: Correctional Systems Conducting Mandatory Screening of Inmates, June–December 1994 ............. 45
Table 21: Policies Regarding Disclosure/Notification of Inmates’ HIV Antibody Test Results, 1994 .............. 46
Table 22: Notification of HIV Status .................................................................................................................... 47
Table 23: Summary of Correctional Policies on Inmate Testing for STDs, 1994 ............................................... 48
Table 24: Decline in Segregation Policies in State/Federal Systems (N=51), 1985–1994 ................................. 51
Table 25: Housing Policies for Inmates With AIDS, Symptomatic Non-AIDS, and Asymptomatic
HIV Infection, 1994.............................................................................................................................. 53
Page
Table 26: Discharge Planning Services, 1994 ..................................................................................................... 55
Table 27: Provision of Zidovudine for Inmates, 1994 ......................................................................................... 60
Table 28: Provision of Selected Drugs for Inmates, 1994 ................................................................................... 61
Table 29: Supportive Services for Inmates With HIV/AIDS, 1994 ..................................................................... 62





The 1994 NIJ/CDC survey reveals a cumulative total of
4,588 inmate AIDS deaths since the start of the epidemic.
At the time of their responses to the survey, correctional
systems reported 5,279 current cases of AIDS among in-
mates.  Cases continue to be unevenly distributed across
systems and regions, with the highest number of cases in the
Middle Atlantic region.  Blacks and Hispanics are overrep-
resented among correctional AIDS cases, as they are among
cases in the total population.  AIDS incidence rates are
substantially higher among inmates (518 cases per 100,000
State/Federal inmates and 706 per 100,000 city/county
inmates in 1994–1995) than in the total U.S. population (41
per 100,000 in 1993).  HIV seroprevalence rates are also
generally higher in prison and jail populations than in the
population at large, with a few systems having rates as high
as 20–26 percent.  However, most correctional systems
continue to have inmate seroprevalence rates below 2
percent, and seroprevalence rates appear to be either stable
or declining in most systems.  Seroprevalence is often
higher among female inmates than among male inmates.
STD testing reveals varying rates of infection, with higher
rates generally found in the East and South, and among
women.
As in previous years, there have been no documented cases
of occupational HIV transmission from inmates to correc-
tional staff.  Studies have shown that inmate-to-inmate HIV
transmission occurs, but at quite low rates.
HIV/STD Education
and Behavioral Interventions
There are some alarming policy trends to report, particu-
larly with regard to HIV/AIDS education and prevention.
Correctional systems have an important public health op-
portunity to address HIV and STDs through comprehensive
prevention programs involving education and ongoing
behavioral interventions.  However, this opportunity has
not yet been fully used.  HIV knowledge among inmates is
probably higher now than it was in the middle and late
1980’s, but some areas of uncertainty and misinformation
remain about transmission mechanisms and prevention
measures.  In this context, it is troubling that fewer correc-
tional systems are offering instructor-led HIV education
sessions for inmates in 1994 than in 1992–1993 (75 percent
of State/Federal systems).  Moreover, only about one-third
of State/Federal systems offer inmate peer-based education
and support programs, and this number has remained flat,
even though such approaches represent a promising and
cost-effective way to provide services.  There is a continuing
eed for more educational programs and materials in Span-
ish and more culturally appropriate materials.
Validation study results suggest that most facilities are
providing the modes of education required in their systems’
policies but may be expanding upon specified topics to
include more controversial subjects, such as safer drug
injection practices.
Ongoing HIV prevention counseling (beyond pretest and
posttest counseling) does not appear to be widely offered in
prisons and jails, representing a continuing weakness in the
correctional response to HIV/AIDS.
Precautionary
and Prevention Measures
No additional systems have instituted condom availability
since the 1992–1993 survey.  Six systems make condoms
available to inmates.  As in past years, no systems have
official policies making bleach available to inmates for
cleaning injection material.  Universal precautions for
infection control are generally the policy in correctional
systems, but they are not always well implemented.
Testing, Counseling, Confidentiality,
and Disclosure Policies
Trends in HIV antibody testing policies and notification of
test results remain stable.  The list of 17 State and Federal
systems with mandatory testing is identical to that in 1992–
1993.  Most systems offer HIV testing on request.  About 90
percent of correctional systems conduct routine STD testing
of inmates.
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Few correctional systems notify correctional officers of
inmates’ HIV status as a matter of official policy, and
validation study results indicate that facility policies gener-
ally comply in this regard.  However, actual practice may
differ from official directives, and unauthorized disclosure
to officers and others remains a problem.  Staff and resource
shortages have prevented many systems from providing
adequate pretest and posttest counseling.
Housing and
Correctional Management
In the housing of inmates with HIV and AIDS, there has
been a steady decline in segregation policies.  Case-by-case
decisions and presumptive general population assignments
remain most common.  Validation study results reveal some
of the real complexity in implementing housing policies in
institutions with different security levels and different popu-
lation characteristics.  Only two State systems—those in
Alabama and Mississippi—continue to segregate all known
HIV-infected inmates.
In most systems, inmates with HIV/AIDS are eligible for all
program and work assignments.  However, several systems
exclude such inmates from kitchen work, and this remains




Medical care for inmates with HIV/AIDS continues to be
uneven in quality.  Although the best-known therapeutic
drugs for HIV/AIDS are in widespread use, access to
experimental drugs and clinical trials remains quite rare in
correctional systems.  Support groups and other supportive
services are not offered as widely as they might be, and
validation study results suggest that such services are even
less available than central office responses would suggest.
Similarly, drug treatment services appear to be reaching a
far smaller proportion of inmates than could probably
benefit from them, judging from estimates of the percentage
of inmates with histories of drug use.
Sixty-one percent of State/Federal systems and 38 percent
of city/county systems report policies for the early or com-
passionate release of inmates with AIDS.  These numbers
have not increased significantly since the 1992–1993 sur-
vey, although changes to the New York State law have
resulted in many more releases from that system in the last
year.  Discharge planning and continuity of care for inmates
leaving correctional facilities remain areas in need of
significant improvement.  In particular, validation study
results indicate that a significant percentage (38 percent) of
facilities in systems with policies calling for discharge
planning were not actually providing such services.
Legal Issues
In legal developments, courts generally continue to uphold
correctional systems’ policies, irrespective of their direc-
tion, on the ground that correctional officials can best
determine what approaches serve “legitimate penological
interests.”  Perhaps the most significant caselaw develop-
ment was a Federal Circuit Court of Appeals decision
upholding the California Department of Corrections’ policy
of excluding HIV-infected inmates from food service as-
signments.  The correctional system claimed that such
assignments, although in reality posing little or no risk of
HIV transmission, might lead to inmate riots.
♦   ♦   ♦
An appendix to this report summarizes recent biomedical
and epidemiologic research developments.
In 1994, for the first time, State juvenile systems and city/
county juvenile detention facilities were included in the NIJ/




The health problems that increasingly affect correctional
inmate populations—including HIV/AIDS, tuberculosis,
and sexually transmitted diseases—pose difficult program-
matic and fiscal challenges for the administrators and staff
of prison and jail systems.  But these problems—which are
significantly associated with substance abuse, high-risk
sexual activity, poverty, homelessness, and poor access to
preventive and primary health care in the community—also
offer opportunities for correctional systems to address and
help improve the health of a particularly  underserved and
vulnerable segment of the population.  Better HIV, TB, and
STD prevention programs and medical care in prisons and
jails will also benefit the larger society, since the vast
majority of inmates return to the community.  To date,
providers of correctional health care and prevention ser-
vices have not fully taken advantage of the “public health
opportunity” available to them.  However, it remains a
significant opportunity that can be addressed by carefully
designed programs and dedicated staff.1
There is increasing recognition that addressing the chal-
lenges and opportunities of health care and disease preven-
tion in prisons and jails requires an active collaboration
between correctional and public health officials.  Attorney
General Janet Reno and Secretary of Health and Human
Services Donna Shalala have committed their departments
to foster a broader understanding of the relationships among
health and justice issues as reflected in responses to vio-
lence, substance abuse, and infectious diseases.  As part of
the effort to facilitate cooperation among health and justice
agencies, the National Institute of Justice (NIJ) has estab-
lished a working group of professionals representing law
enforcement, public health, institutional and community
corrections, medical and mental health services, the courts,
and victim services.2
At the level of correctional systems and facilities, mutual
understanding and cooperation can be encouraged through
active dialogue among correctional staff, community groups,
and inmates.  Such a dialogue has begun in Canada and has
helped to encourage the view that “the promotion of health
in prisons does not necessarily entail lessening of the safety
and security of prisons. . . .  Indeed, promotion of health in
the prison population and the education of both prisoners
and staff may be the best ways to create safety and security.”3
Another component of the DOJ/HHS strategy in the United
States is the collaborative sponsorship of research like the
national surveys and updates on HIV/AIDS in correctional
acilities, which have been jointly supported for the past few
years by the Centers for Disease Control and Prevention and
NIJ.  This 1994 Update reports on the eighth national
survey, conducted between May and December 1994.  As in
previous years, responses were received from all fifty State
correctional systems and the Federal Bureau of Prisons.
Twenty-nine large city and county jail systems also re-
sponded to the 1994 NIJ/CDC survey.  In an effort to assess
the extent to which individual facilities comply with or
depart from policies established by systems’ central offices,
the 1994 survey for the first time included a validation study
in which an abbreviated version of the instrument (covering
only key policy areas) was sent to a sample of 50 facilities
in 14 State systems and the Federal Bureau of Prisons.
Overall, the survey covered HIV/AIDS and STDs in adult
corrections (reported in this Update) as well as tuberculosis
(reported in a separate Research in Brief).  The survey was
supplemented with site visits to the State correctional
systems of Texas, Vermont, and Massachusetts and to three
facilities of the Federal Bureau of Prisons.
Endnotes
1. See, e.g., S. Polonsky, S. Kerr, B. Harris, J. Gaiter, R.
Fichtner, and M. Kennedy.  “HIV Prevention in Prisons
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Report 109 (September-October 1994): 615–625;  J. B.
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Chapter 1
Epidemiology of HIV/AIDS and STDs
 in Correctional Facilities
and the Population at Large
Patterns of HIV/AIDS
in the U.S. Population
Reported AIDS Cases
and the Revised Case Definition
In 1994, AIDS was the leading cause of death among all
Americans 25–44 years old, outstripping homicide, suicide,
heart disease, and cancer.1  Reported AIDS cases in the
United States increased very sharply—from 46,791 to
105,990, or 127 percent—between 1992 and 1993.  How-
ever, this probably represents the one-time effect of the
reporting of individuals who had been previously diagnosed
with the conditions added to the AIDS case definition in
1993.2  Under the revised definition of cases to be reported
to the Centers for Disease Control and Prevention (CDC),
HIV-infected persons with CD4 counts of less than 200 (but
no current symptoms), pulmonary tuberculosis, recurrent
pneumonia, and invasive cervical cancer are reportable as
AIDS cases.3
Virtually the same number of AIDS cases was reported to
CDC between July 1992 and June 1993, six months of which
were covered by the new definition and six months by the
old, as between July 1993 and June 1994, a period entirely
covered by the new definition (85,944 cases versus 85,260
cases).  If anything, this suggests a slowing of the overall
rate of cases being reported nationally.  Indeed, the CDC has
found that the rate of increase in overall AIDS incidence
began to slow during the middle of 1987.4
Through June 1994, almost 356,000 AIDS cases had been
reported among adults and adolescents in the United States,
and over 5,200 cases among children under 13 years.  These
figures include over 12,500 adult/adolescent cases and
almost 300 pediatric cases reported from Puerto Rico, where
the annual incidence rate for July 1993–June 1994 (74 cases
per 100,000) was higher than all States except New York
(85).
All States and cities and many rural areas have been affected
by the HIV/AIDS epidemic, but a small number of States
continue to account for the majority of reported cases of
AIDS in the nation.  Sixty percent of cumulative adult/
adolescent cases have been reported from five States:  New
York (19 percent); California (18 percent); Florida (10
percent); Texas (7 percent); and New Jersey (6 percent).
Three States account for more than half of the pediatric
AIDS cases—New York (27 percent), Florida (15 percent),
and New Jersey (9 percent)—suggesting that  the epidemic
of AIDS among children is even more geographically
concentrated.  Indeed, while the epidemic of HIV/AIDS has
affected all parts of the country to some degree, it may be best
understood as a pattern of “multiple localized epidemics”
with disproportionately severe impacts in certain types of
geographic areas, including those with high rates of poverty
and poor access to health care.5
As of the end of 1993, there had been 217,917 deaths from
AIDS reported in the U.S.  This represents 54 percent of all
diagnosed cases.  The cumulative case-fatality rate declined
by about 6 percent from 1992 to 1993.  This reflects in large
part the changing case definition, which increases the
denominator of diagnosed cases on which the case-fatality
rate is based.  Real and significant declines in case-fatality
rates are not likely in the near future, given discouraging
fi dings (summarized in the appendix) that available
antiretroviral therapies do not prolong survival with AIDS.
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HIV/AIDS by Racial/Ethnic Groups
Blacks and Hispanics continue to be sharply overrepre-
sented among U.S. AIDS cases.  Through 1987, 60 percent
of cumulative total cases were among whites, 25 percent
among blacks, and 14 percent among Hispanics.  By the end
of 1993, the respective percentages of cumulative total cases
had become 50, 32, and 17.  The 10 percent shift from whites
to blacks and Hispanics in six years reflects a much more
rapidly growing epidemic in communities of color.  Of new
cases reported during 1993, 45 percent were among whites,
36 percent among blacks, and 18 percent among Hispanics.
AIDS cases reported in 1993 among Hispanics revealed
some interesting differences in terms of exposure catego-
ries.  The majority of cases in individuals born in Central/
South America, Cuba, and Mexico were among men who
have sex with men, while the majority of cases in persons
born in Puerto Rico were associated with injection drug use.
Women and HIV/AIDS
The CDC has reported that the HIV/AIDS epidemic is
increasing more rapidly among women than among men.
Between 1992 and 1993, the percentage of total adult/
adolescent AIDS cases represented by women increased
from 13 percent to 16 percent.  On the other hand, the
absolute number of AIDS cases reported among male adults
and adolescents actually declined by 4 percent between the
periods July 1992–June 1993 and July 1993–June 1994,
while female cases increased by 14 percent.  This suggests
that in fact the epidemic may be continuing to worsen
among women while it is leveling off among men.
Women of color are disproportionately affected by HIV/
AIDS.  About 20 percent of women in the U.S. are black or
Hispanic, but almost three-fourths (73 percent) of all female
adult/adolescent AIDS cases have occurred in these groups
(53 percent among blacks and 20 percent among Hispan-
ics).
Recent research shows that the HIV/AIDS epidemic has hit
particularly hard among young black and Hispanic women
who regularly smoke crack cocaine.  Because of higher rates
of risky sexual practices (often associated with exchanging
sex for money or drugs) and higher rates of sexually
transmitted diseases, these women are at substantially
elevated risk for HIV infection.6
The disproportionate effect of HIV/AIDS on women of color
results in an equivalent disproportionality in the epidemic
of pediatric AIDS.  Eighty percent of pediatric cases have
occurred among blacks (55 percent) and Hispanics (24
percent).
HIV/AIDS by Exposure Categories
Table 1 shows the distribution of cumulative total AIDS
cases reported to CDC through 1993, by exposure categories
and sex.  Although the overall growth of the HIV/AIDS
epidemic may be slowing, it continues to grow in some
sectors—women, blacks, and Hispanics, and injection and
other drug users.
At the end of 1992, CDC estimated that AIDS diagnoses in
men who have sex with men and in injection drug users
would plateau in the next two years, while cases attributed
to heterosexual contact would continue to increase through
the period.7  Indeed, the percentage of AIDS cases attributed
to heterosexual contact increased from 2 percent during
1985 to 9 percent during 1993.  Heterosexually acquired
AIDS cases jumped by 130 percent from 1992 to 1993, as
opposed to an increase of 109 percent in cases in all other
exposure categories combined.  Although heterosexual
contact accounts for only 9 percent of AIDS cases reported
during 1993, this exposure category represented fully 25
percent of HIV positive tests reported to CDC by publicly
funded HIV testing and counseling sites in 1993.8  Persons
most at risk for heterosexual acquisition of HIV/AIDS
include adults and adolescents with multiple sexual part-
ners and with STDs, and sexually active persons living in
areas with high prevalence of HIV infection among injec-
tion drug users.9
The percentage of total AIDS cases that occurred among
men who have sex with men dropped from 65 percent in
1987 to 54 percent in 1993, while the percentage attribut-
able to injection drug use rose from 17 to 24 percent.  In New
York City, almost one-half (46 percent) of AIDS cases
reported through March 1994 were attributed to injection
drug use, as opposed to 37 percent among men who have sex
with men.10
There has been concern about relapse to high-risk sexual
behavior among gay men.11  Recently, Dr. Harold Jaffe,
director of CDC’s Division of HIV/AIDS, predicted “a
second wave” of AIDS among young gay men.12  However,
this pattern of new infections may not be reflected in
changing AIDS case rates for 5 to 10 years.  In the
meantime, the number of AIDS cases reported among men
who have sex with men has continued to decline nation-
ally—by 10 percent between the periods July 1992–June
1993 and July 1993–June 1994—while the number of cases
attributed to injection drug use increased by 3 percent, those
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Table 1
CUMULATIVE TOTAL OF ADULT/ADOLESCENT AIDS CASES IN THE UNITED STATES
BY EXPOSURE CATEGORY,a THROUGH DECEMBER 1993
Males Females Total
Exposure Category Number % Number % Number %
Men Who Have Sex With Men 193,652 62% — — 193,652 54%
Injection Drug Use 65,512 21 21,746 49% 87,259 d 24
Men Who Have Sex With Men
     and Inject Drugs 23,360 7 — — 23,360 7
Hemophilia/Coagulation Disorder 3,058 1 75 0 3,133 1
Heterosexual Contact 7,679 3 15,487 35 23,166 7
Receipt of Transfusion 3,660 01 2,521 6 6,181 2
Otherb/Risk Not Reported
     or Identifiedc 14,657 5 4,528 10 19,185 5
Total 311,578 100 44,357 100 355,936 100
aThis table lists AIDS cases by exposure category, that is, by the behavior or circumstance to which HIV transmission is
attributed.
b“Other” refers to 12 health care workers who developed AIDS after documented occupational exposure to HIV; to 4 patients
who developed AIDS after exposure to HIV in the health care setting; to 3 persons who acquired HIV perinatally and were
diagnosed with AIDS after age 13; and to 1 person with intentional self-inoculation of blood from an HIV-infected person.
c“Risk not reported or identified” refers to persons under investigation; persons who died, who were lost to follow-up, or
who declined interview; and persons who did not report one of the exposures listed above after interview.
dIncludes one person whose sex is unknown.
Source: Centers for Disease Control and Prevention (CDC), HIV/AIDS Surveillance Report 5, no. 4, (February 1994)
(cases reported through 1993).
attributable to heterosexual contact increased by 13 percent,
and perinatal cases increased by 17 percent during the same
period.  Heterosexual and perinatal transmission have been
closely associated with injection and other drug use—for
example, infection through sexual intercourse with a drug
user and vertical transmission from a mother whose infec-
tion is associated with injection or other drug use.  Pediatric
AIDS is most prevalent where the overall epidemic is most
associated with injection and other drug use and hetero-
sexual transmission of HIV.
The above discussion has been broadened to refer to “injec-
tion and other drug use” because of accumulating evidence
that regular crack use is associated with HIV infection.  A
recent study of young women and men in poor minority
communities of New York (Eastern and Central Harlem),
Miami (Liberty City and Overtown), and San Francisco
(Bayview-Hunter’s Point) revealed that regular crack smok-
ers were 2.4 times more likely to be HIV infected than those
who had never smoked crack.  The non–crack smokers were
in many respects as socially and economically disadvan-
aged as the crack smokers.  Four categories of sexual
practice accounted for the higher rates of HIV infection
among the crack smokers in the study:  commercial sex
work; recent, unprotected commercial sex work; anal sex
between men; and homosexual anal intercourse with 50 or
more male partners.  In short, regular crack use leads to
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higher rates of unsafe sexual practices, often in exchange for
drugs or money, and in turn to higher rates of STDs and HIV
infection.13
Estimates of HIV
Infection in the U.S. Population
The precise level of HIV infection in the U.S. population as
a whole is not known.  A planned household seroprevalence
survey was canceled in 1991 for methodological and politi-
cal reasons.  Composite estimates by the Public Health
Service from serosurveys in “sentinel” populations suggest
that about 800,000 Americans are infected with HIV, and
most are probably unaware of being infected.14
HIV/AIDS in Correctional Facilities
No Job-Related Cases of HIV/AIDS
Among U.S. Correctional Officers
As in all previous NIJ surveys, no job-related cases of HIV
infection were reported among correctional officers in
1994.  The CDC monitors occupational exposure and
seroconversion to HIV among health care and emergency
workers.  As of the end of 1993, there had been 40
documented cases of HIV transmission to health care work-
ers, and an additional 83 possible cases of occupational
transmission.  Thirty-three of the 40 confirmed cases were
among clinical laboratory technicians (15), nurses (13), and
nonsurgical physicians (5).  No confirmed cases of occupa-
tionally acquired HIV infection have occurred among emer-
gency medical technicians (EMT’s) or paramedics, the
category with exposure risks closest to those of correctional
officers.15
For several years, CDC funded seven health departments to
monitor potential HIV exposure and transmission incidents
involving correctional officers, police officers, EMT’s, and
other first responders.  These seven health departments
reported no confirmed occupational HIV transmissions.
One of the CDC-funded health departments monitored a
correctional facility.  It identified 166 potential exposure
incidents involving 149 staff members—61 correctional
officers and 88 medical or dental staff.  No HIV transmis-
sions occurred as a result of these incidents, however.  A
newly initiated CDC study is examining levels of compli-
ance with universal precautions by health care workers
employed in correctional settings.16
AIDS Cases Among Correctional Inmates
Previous reports in this series have included figures for
cumulative total AIDS cases in the reporting correctional
systems.  However, beginning with this report, the cumula-
tive total figure will no longer be presented because of
increasing levels of missing data.  As noted in the 1992
Update, it has been necessary to estimate for some correc-
tional systems at least one of the components necessary to
calculate cumulative total inmate AIDS cases.  The required
data components are current cases, deaths in custody, and
inmates released with HIV/AIDS.  Estimation was based on
previous years’ data and was always very conservative.
Because of this estimation, the cumulative total figures were
subject to increasing uncertainty.  In the 1994 survey, over
half of the correctional systems were unable to provide
figures for inmates released with HIV/AIDS, always the
most problematic component to obtain.  This seemed an
unacceptably high level of missing data.  By contrast,
almost all systems were able to provide figures for current
cases and deaths.  It was therefore decided to discontinue the
cumulative total calculation and present only current cases
and deaths.
Inmate HIV/AIDS Deaths
While it is unfortunate to break the time series based on
cumulative total AIDS cases, a time series on inmate deaths
is being substituted.  This time series for inmates can be
compared to the equivalent time series in the total U.S.
population, as was previously done with the cumulative
totals.  This comparison is presented in table 2.  Between
1992–1993 and 1994, cumulative inmate AIDS deaths
increased by 32 percent, while cumulative deaths in the total
population increased by 42 percent.  Since 1985, inmate
AIDS deaths have increased by 1,311 percent, while AIDS
deaths in the U.S. population increased by 2,904 percent,
more than twice as large an increase.
Table 2 shows that 4,588 inmates in the reporting correc-
tional systems had died of HIV/AIDS as of May–December
1994, when the survey was conducted.  This should not be
considered an absolutely accurate count, since the survey
was not exhaustive of all correctional systems and under-
reporting may have occurred in participating systems.
However, the figure represents 2 percent of the cumulative
total HIV/AIDS deaths reported in the United States through
June 1994 (240,323).  Twenty-one percent of reported
inmate HIV/AIDS deaths occurred since the 1992–1993
NIJ/CDC survey.
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Table 2
CUMULATIVE TOTAL AIDS DEATHS
AMONG CORRECTIONAL INMATES AND THE POPULATION AT LARGE,
U.S., 1985–1994
Cumulative Cumulative Deaths
Correctional Deathsa in Total U.S. Populationb
Number % Increase from Number % Increase from
of Deaths Preceding Report of Deaths Preceding Report
November 1985 325 N/A 8,000 N/A
October 1986 533 64% 16,500 106%
October 1987 865 62 24,412 48
October 1988 1,306 51 42,142 73
October 1989 1,423 9 65,467 55
October 1990 2,504 76 94,375 44
November 1992–March 1993 3,474 39 169,623 80
May–December 1994 4,588 32 240,323 42
aThe figures in this table represent inmate AIDS deaths in the Federal prison system, all 50 State prison systems, and
a sample of 28–37 large city and county jail systems (depending on the year of the survey).
bAdult/adolescent cases only. Pediatric cases excluded.
N/A:  Not available.
Sources: CDC, AIDS Weekly Surveillance Reports—U.S., November 4, 1985, October 5, 1986, October 5, 1987,
October 3, 1988; CDC, HIV/AIDS Surveillance Report, November 1989, November 1990, February 1993
(cases reported through 1992), 1994 mid-year edition (cases reported through June 1994); NIJ/CDC Question-
naire Responses.
Table 3 shows that the distribution of cumulative total HIV/
AIDS deaths across correctional systems is quite uneven.
Forty-three State/Federal systems reported 3,870 total deaths.
Six State/Federal systems reported more than 100 inmate
HIV/AIDS deaths, and seven systems reported more than 50
deaths.
The NIJ/CDC survey captures data from all State correc-
tional systems and the Federal Bureau of Prisons but
includes only a relatively small number of city/county jail
systems—in 1994, 29 jail systems submitted responses.
The sample includes the largest U.S. jail systems but omits
many others of substantial size.  In 1994, 17 city/county jail
systems in the NIJ/CDC survey reported a total of 718
inmate HIV/AIDS deaths.  Only 1 of the jail systems
reported more than 100 inmate deaths from HIV/AIDS, 1
reported 26–50 deaths, and 5 reported 11–25 deaths.
Additional data on HIV/AIDS deaths in jails come from the
Annual Survey of Jails conducted by the Bureau of Justice
Statistics.  The most recently available statistics, for 1992,
cover 503 jurisdictions with inmate populations in excess of
100.  Thirty-seven of these jurisdictions with “large jail
populations” reported 107 inmate AIDS deaths during
1992.  This represents 24 percent of the 445 total inmate
deaths reported by these jurisdictions to the BJS jail survey
in 1992.17
Table 4 reveals that the regional distribution of total inmate
HIV/AIDS deaths is also uneven, with the highest number
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State/Federal Prison Systems
(N=51)
Range of Number Number of
Total AIDS Deaths of Systems % AIDS Deaths %
0 8 16% 0 0%
1–3 9 18 17 0.5
4–10 10 20 60 2
11–25 7 12 136 4
26–50 4 8 174 4
51–100 7 14 557 14
> 100 6 12 2,926 76.5
Total 51 100 3,870 101b
City/County Jail Systems
(N=29)
Range of Number of Number of
Total AIDS Deaths Systems % AIDS Deaths %
0 12 41% 0 0%
1–3 6 21 8 1
4–10 4 14 20 3
11–25 5 17 78 11
26–50 1 3 0 0
51–100 0 – 49 7
> 100 1 3 563 78
Total 29 99b 718 100
aThe figures in this table represent the minimum number of correctional AIDS deaths to date, since the
NIJ survey does not include every U.S. county jail system.
bDue to rounding.
Source:  NIJ/CDC Questionnaire Responses.
Table 3
DISTRIBUTION OF CUMULATIVE TOTAL INMATE AIDS DEATHS, U.S., 1994a










REGIONAL DISTRIBUTION OF CUMULATIVE TOTAL INMATE AIDS DEATHS, U.S.
(Federal Prison System Excluded)a
Region
New Englandb 132 4%
Middle Atlanticc 1,850 50
E.N. Centrald 151 4
W.N. Centrale 18 1
S. Atlanticf 851 20
E.S. Centralg 85 2














aThe regional divisions used in this table are standard geographic divisions and are not based on numbers of AIDS cases.
The figures in this table represent the minimum number of correctional AIDS deaths to date, since the NIJ survey does not
include every U.S. jail system.
bMaine, New Hampshire, Vermont, Massachusetts, Rhode Island, Connecticut.
cNew York, New Jersey, Pennsylvania.
dOhio, Indiana, Illinois, Michigan, Wisconsin.
eMinnesota, Iowa, Missouri, North Dakota, South Dakota, Nebraska, Kansas.
f Delaware, Maryland, District of Columbia, Virginia, West Virginia, North Carolina, South Carolina, Georgia, Florida.
gKentucky, Tennessee, Alabama, Mississippi.
hArkansas, Louisiana, Oklahoma, Texas.
i Montana, Idaho, Wyoming, Colorado, New Mexico, Arizona, Utah, Nevada.
j Washington, Oregon, California, Alaska, Hawaii.
k Due to rounding.
Source:  NIJ/CDC Questionnaire Responses.
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of deaths in the Middle Atlantic region (principally New
York and New Jersey).
Current Inmate AIDS Cases
Table 5 shows the distribution of current inmate AIDS cases
across the reporting correctional systems.  Forty-seven State
and Federal prison systems reported 4,827 current cases, an
increase of 59 percent over the 1992–1993 survey.  This
increase is less steep than might be expected given the
change in the AIDS case definition that went into effect at
the start of 1993.  This may result from less aggressive
testing and diagnostic services and less complete reporting
of cases in correctional facilities than in the outside commu-
nity.  State and Federal prison systems reported a range of
0 to 2.4 percent of inmates having AIDS diagnoses.  Jail
systems reported 0 percent to 1.4 percent of inmates with
AIDS.
Twenty-three city/county jail systems reported 452 current
cases, an increase of 14 percent from 1992–1993.  The
distribution is quite uneven among State/Federal systems,
with 22 percent of the systems reporting 83 percent of
current cases.  Fourteen percent of city/county systems
reported 44 percent of current cases, a somewhat more even
distribution.
AIDS Incidence Rates
The annual AIDS incidence rate in the U.S. in 1993 was 41
cases per 100,000 population.  This was up sharply from 18
in 1992 due to the revised AIDS case definition.  State
incidence rates ranged from 2 cases per 100,000 in North
Dakota to 96 cases per 100,000 in New York.  Rates in
metropolitan areas with populations in excess of 500,000






Percentages may not add up to 100 percent due to rounding.
Source:  NIJ/CDC Questionnaire Responses.
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Number of of AIDS
Systems % Cases %
4 8% 0 0%
7 14 11 0
12 24 68 1
7 14 127 3
4 8 122 3
6 12 466 10
11 22 4,033 83
51 102 4,827 100
Number
Number of of AIDS
Systems % Cases %
6 21% 0 0%
5 17 10 2
2 7 14 3
12 41 230 51
2 7 62 14
2 7 136 30
0 0 0 0
29 100 452 100
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Not surprisingly, AIDS incidence rates are higher among
correctional inmates than in the total population.  This is
because of the high concentrations in correctional popula-
tions of persons with risk factors for HIV infection.  Inci-
dence rates in correctional systems vary widely, reflecting
the uneven distribution of actual cases, as well as divergent
diagnostic and reporting practices across systems.
In State/Federal systems, the aggregate AIDS incidence rate
(i.e., based on the total number of cases and the total inmate
populations across all systems) was 518 cases per 100,000,
up from 362 cases in 1992–1993.19  The median incidence
rate for State/Federal prison systems was 186 AIDS cases
per 100,000 inmates, with a range of 0 to 2,375 cases.
The aggregate incidence rate for reporting city/county jail
systems was 706 cases per 100,000 inmates.  The median
incidence rate was 289 cases, with a range of 0 to 1,416
cases.  However, the high turnover rates of jail inmates make
these incidence rates difficult to interpret.
HIV Seroprevalence
Among Correctional Inmates
Mandatory HIV screening (mandatory, identity-linked test-
ing of all incoming, current, or about-to-be-released in-
mates) and blinded epidemiologic studies both capture
populations uninfluenced by selection biases.  Therefore,
statistics based on these two methods are probably the most
reliable estimates of HIV seroprevalence among correc-
tional inmates.
The Bureau of Justice Statistics (BJS) develops national
estimates of HIV seropositivity rates among inmates based
on reports from systems with varying testing policies.  The
BJS estimate for 1993 is 2.4 percent.20  As noted in previous
updates, composite estimates based on data drawn from
systems with different policies may be of suspect accuracy.
Tables 6 and 7 present available HIV seroprevalence data
from mandatory testing and blinded studies.  Table 8
provides data based on voluntary/on-request and other
categories of testing.  In general, these figures show that, as
in previous Updates, HIV seroprevalence rates vary widely
from system to system.  Most systems continue to have rates
of 1 percent or below, and a few systems have rates as high
as 20–26 percent (females in New York State and New York
City).21  Jurisdictions with rates of inmate HIV seropositivity
of over 5 percent based on mandatory screening or blinded
studies include New Jersey, Massachusetts, Florida, Cook
County (Chicago), and Illinois (females only).  Systems
with rates between 2 and 5 percent include California,
Texas, Georgia, North Carolina, and King County (Seattle).
In most systems with data available for more than one
period, HIV seroprevalence rates are most often stable or, in
a few cases, declining.  There do not appear to be any
geographic patterns.  The following jurisdictions reveal
stable inmate HIV seroprevalence rates:  Texas, Illinois,
Georgia, Michigan, Missouri, Oregon, Alabama, Colorado,
T nnessee, Nebraska, Oklahoma, Arkansas, Hawaii, and
Rhode Island.
Declines in HIV seroprevalence based on blinded studies
occurred in New York State (among males from 17 percent
in 1987–1988 to 15 percent in 1990 [p=.01] to 11.5 percent
in 1992 [p=.01]) and Florida (among females from 24
percent in 1992 to 11 percent in 1993).  Based on mandatory
testing programs, HIV seroprevalence dropped from 2.4
percent to 1.4 from 1990–1992 to 1994 in Nevada, and
among females in New Hampshire from 7 percent in 1989–
1990 to 3 percent in 1992 to 2 percent in 1993.  Based on
voluntary testing in Massachusetts, seropositivity among
females dropped from 23 percent in 1987–1989 to 9 percent
in 1991 to 5 percent in 1993, and among males from 10
percent to 6 percent to 2 percent over the same intervals.
There were a few increases in HIV seroprevalence.  Rates
among incoming male inmates in New Hampshire in-
creased from 0.5 percent in 1989–1990 to 1.3 percent in
1992 to 2.2 percent in 1993.  In Louisiana, based on blinded
studies, HIV seroprevalence among males rose from 0.3
percent in 1990–1991 to 1.9 percent in 1992–1994.
Comparisons of HIV seropositivity rates from mandatory
screening or blinded studies on the one hand and voluntary
testing on the other are mixed.  In New York State, blinded
studies of incoming male and female inmates found higher
rates of HIV seropositivity than did on-request testing (15
percent versus 7.5 percent for males, 20 percent versus 13.4
percent for females).22  Similarly, in Massachusetts, HIV
seroprevalence rates from a blinded study (7 percent for
males and 13 percent for females) were higher than
seropositivity rates from voluntary testing (2 percent for
males and 5 percent for females).  These discrepancies may
reflect reluctance on the part of persons who know they are
at risk to “get the bad news” and/or fear that HIV status
would be disclosed and lead to discrimination or mistreat-
ment of persons with HIV.
Conversely, HIV seropositivity rates were higher based on
voluntary testing than on blinded studies in Rhode Island
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Table 6





Correctional System Dates Tested Seropositive Seropositive
Alabama 10/89–10/90 7,306 M+F 88 M+F 1.2% M+F
8/85–1994 67,666 M+F 581 M 0.9 M+F
54 F
Colorado 10/89–10/90 3093 M 20 M 0.6 M
358 F 1 F 0.3 F
1/92–12/94 17,434 M 85 M 0.5 M
1,484 F 6 F 0.4 F
Georgia 7/89–5/90 20,435 M+F 561 M+F 2.7 M+F
1/93–12/93 17,045 M+F 413 M 2.8 M+F
71 F
Idaho 1986–1992 13,010 M 43 M 0.3 M
1,440 F 5 F 0.3 F
7/93–6/94 1,380 M 5 M 0.3 M
120 F 0 F 0.0 F
Iowa 11/87–10/90 13,434 M+F 26 M+F 0.2 M+F
7/93–5/94 3,882 M+F 1 M+F 0.03 M+F
Michigan 4/90–2/91 22,669 Ma 378 M 1.7 M
4/90–2/91 5,510 Mb 18 M 0.3 M
4/90–2/91 1,895 F 42 F 2.2 F
10/93–9/94 12,505 M 143 M 1.1 M
877 F 14 F 1.6 F
Missouri 1985–10/90 24,284 M+F 127 M+F 0.5 M+F
1/87–4/94 59,736 M+F 293 M+F 0.5 M+F
Nebraska 3/87–10/90 6,426 M+F 21 M+F 0.3 M+F
3/87–12/92 10,756 M 35 M 0.3 M
448 F 8 F 1.8 F
3/87–5/94 15,024 M+F 57 M+F 0.4 M+F
Nevada 1990–1992 7,100 M+F 167 M+F 2.4 M+F
1/94–3/94 838 M 8 M 1.0 M
66 F 5 F 7.6 F
New Hampshire 1/87–9/89 1,760 M 9 M 0.5 M
10/89–10/90 92 F 6 F 6.5 F
1/92–9/92 838 M 11 M 1.3 M
382 F 12 F 3.1 F
1/93–11/93 911 M 20 M 2.2 M
500 F 10 F 2.0 F
North Dakota 1/92–12/92 408 M 0 M 0.0 M
20 F 1 F 5.0 F
Oklahoma 6/87–11/90 19,120 M 51 M 0.3 M
2,346 F 3 F 0.1 F
4/87–12/92 31,221 M 184 M 0.6 M
4,103 F 12 F 0.3 F
4/87–5/94 40,422 M 243 M 0.6 M
5,355 F 17 F 0.3 F
11Epidemiology of HIV/AIDS and STDs
Number Number %
Correctional System Dates Tested Seropositive Seropositive
Rhode Island 11/91–12/92 8,225 M 227 M 2.8% M
775 F 62 F 8.0 F
?–1994 38,135 M+F 1,351 M+F 3.5 M+F
Utah 7/89–11/90 4,000 M 33 M 0.8 M
231 F 6 F 2.6 F
1/92–12/92 3,000 M 15 M 0.5 M
500 F 0 F 0.0 F
Wyoming 1/90–10/90 181 M 1 M 0.6 M
46 F 0 F 0.0 F
Mississippi 7/89–10/89 7,743 M 78 M 1.0 M
310 F 7 F 2.3 F
Alabama 1987–1989 25,321 M+F 2 M 0.008M+F
0 F
?–1994 48,654 M+F 4 M 0.01 M+F
1 F
Missouri 1985–10/90 16,435 M+F 33 M+F 0.2 M+F
1/87–4/94 40,264 M+F 13 M 0.03 M+F
0 F
Nevada 1/90–12/92 6,265 M+F 9 M 0.1 M+F
0 F
1/94–3/94 589 M 0 M 0.0 M
27 F 0 F 0.0 F
Wyoming 7/90 34 M 0 M 0.0 M
Inmates Tested
Table 6 (continued)
HIV SEROPREVALENCE DATA FROM MANDATORY MASS SCREENING OF INMATES
aMales 24 or more years old.
bMales 18–24 years old.
Source:  NIJ/CDC Questionnaire Responses.
All Inmates
  at Release
All Current
  Inmates
(both males and females), Florida (females only, male rates
were similar), Rhode Island, and Washington (males only,
female rates were similar).  In these jurisdictions, inmates
who believed they were at elevated risk were, for whatever
reason, more willing to come forward for testing.
As in previous reports, HIV seroprevalence is often higher
among female inmates than among male inmates.  This
pattern seems most common in the Northeast, where New
York City, New York State, New Jersey, Massachusetts,
Connecticut, and Rhode Island all report higher rates for
females than males.  As discussed below, this may be due to
the high prevalence of injection drug and crack use among
female inmates in these States.  Elsewhere, HIV
seroprevalence is higher among females than among males
(Florida, Illinois, Cook County [Chicago], Nevada, Califor-
nia, and Washington State).
Characteristics of Inmates with HIV/AIDS
Gender.  The vast majority of inmate AIDS deaths and
current AIDS cases continues to be among men.  Ninety-six
percent of cumulative AIDS deaths and 91 percent of
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Table 7
HIV SEROPREVALENCE DATA FROM
BLINDED EPIDEMIOLOGIC STUDIES OF INMATESa
Number Number %
Correctional System     Dates Tested Seropositive Seropositive
Arkansas 7/90 698 M 6 M 0.9% M
23 F 0 F 0.0 F
2/92–11/92 1,500 M 8 M 0.5 M
300 F 3 F 1.0 F
California 1/88–5/88b 5,372 M 137 M 2.6 M
(All incoming) 807 F 25 F 3.1 F
Florida 1/88–1/89 900 M 53 M 5.9 M
281 F 22 F 7.8 F
Hawaii 1/88–10/90 2,327 M 22 M 0.9 M
142 F 0 F 0.0 F
3/88–3/92 3,010 M 33 M 1.1 M
273 F 0 F 0.0 F
1/88–6/93 3,586 M 45 M 1.3 M
314 F 1 F 0.3 F
Illinoisc 1988 808 M 27 M 3.3 M
4/89–6/89 501 M 20 M 4.0 M
1/91–12/91 989 M 41 M 4.1 M
880 F 50 F 5.7 F
Louisiana 1/90–12/91 2,000 M 6 M 0.3 M
6/92–8/94 1,000 M 19 M 1.9 M
Massachusetts 1/92–6/92 1,890 M 137 M 7.2 M
306 F 40 F 13.1 F
New Jersey 9/91–10/91 1,100 M 99 M 9.0 M
100 F 15 F 15.0 F
New York (State) 12/87–1/88d 494 M 84 M 17.0 M
1990 563 M 84 M 15.0 M
1992e 2,532 M 292 M 11.5 M
9/88–12/88 480 F 90 F 18.8 F
1992–93e 872 F 177 F 20.3 F
North Carolina 11/89–4/90 7,942 M 238 M 3.0 M
784 F 36 F 4.6 F
Oregon 9/90–10/90 437 M 4 M 0.9 M
 76 F 0 F 0.0 F
9/90–6/92 2,035 M 23 M 1.1 M
853 F 6 F 0.7 F
?–1994 3,176 M 27 M 0.9 M
1,421 F 18 F 1.3 F
South Carolinaf 4/88–6/88 457 M 8 M 1.7 M
3 F 0 F 0.0 F
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Number Number %
Correctional System    Dates Tested Seropositive Seropositive
Tennessee 7/88–8/90 4,461 M 52 M 1.2% M
448 F 1 F 0.2 F
7/88–1/92 9,810 M+F 126 M+F 1.3 M+F
Texas 9/89–10/89 1,226 M+F 30 M+F 2.4 M+F
10/90–12/90 986 M 26 M 2.6 M
279 F 11 F 3.9 F
?–? 1,441 M 45 M 3.1 M
502 F 19 F 3.8 F
Virginiag 6/89–8/89 1,287 M 30 M 2.3 M
Washington 8/87–1/88 796 M 5 M 0.6 M
3/91–5/91 500 M 1 M 0.2 M
3/87–12/91 1,296 M 1 M 0.08 M
236 F 6 F 2.5 F
Los Angeles County, 10/90 400 M 11 M 2.8 M
California 100 F 1 F 1.0 F
Quebec, Canada 12/87–10/90 520 M 44 M 8.5 M
248 F 19 F 7.7 F
Cook County, 11/89–12/89 372 M 23 M 6.2 M
Illinois 100 F 8 F 8.0 F
New York City, 9/89 1,690 M 272 M 16.1 M
New York 546 F 140 F 25.6 F
1/91–2/91 2,061 M 262 M 12.7 M
519 F 116 F 22.4 F
King County 9/90–12/91 214 M 9 M 4.2 M
(Seattle), Washington 24 F 1 F 4.2 F
Table 7 (continued)
HIV SEROPREVALENCE DATA FROM
BLINDED EPIDEMIOLOGIC STUDIES OF INMATES
aThese studies were anonymous (not identity-linked) and conducted to determine seroprevalence rates in a population.
Several systems did not specify the inmate category (for example, all incoming) tested in their study.
bJ. A. Singleton et al., “HIV Seroprevalence Among Prisoners Entering the California Correctional System,” California
Department of Health Services, January 1989.
c Illinois Department of Corrections and Abt Associates Inc., unpublished data.
dB. I. Truman et al., “HIV Seroprevalence and Risk Factors Among Prison Inmates Entering New York State Prisons,”
presented at the Fourth International AIDS Conference, Stockholm, June 1988.
eJ. Mikl, P. F. Smith, and R. B. Greifinger, “HIV Seroprevalence Among New York State Prison Inmates Entering the
Bedford Hills, Downstate, and Ulster Correctional Facilities, August 1992–February 1993,” presented at the Ninth
International Conference on AIDS, Berlin, June 1993.
f M. C. Monroe et al., “Studies of HIV Seroprevalence and AIDS Knowledge, Attitudes and Risk Behaviors in Inmates
in the South Carolina Department of Corrections, 1988,” December 1988.
gCommonwealth of Virginia, Department of Corrections, “HIV Seropositivity Study,” October 1989.
Source (unless otherwise noted):  NIJ/CDC Questionnaire Responses.
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current inmate AIDS cases in 1993 have been among males.
Aggregate AIDS incidence rates in State/Federal systems
were 464 cases per 100,000 among men and 705 cases
among women.  In responding city/county jail systems, the
rates were 342 cases per 100,000 among men and 201 cases
among women.  As discussed above, HIV seroprevalence is
very often higher among female than among male inmates.
Incarceration rates are rising faster among women than
among men, and women in prisons and jails are more likely
to be drug users than are male inmates.  Economic depen-
dency, injection drug use, crack use, and associated in-
creases in unsafe sexual practices (e.g., exchanging sex for
drugs and/or money) have placed many women at elevated
risk for HIV/AIDS.  Recent studies of incarcerated women
in New York and Massachusetts confirm the correlates of
high rates of HIV infection.  In New York, a study of 216
women who agreed to voluntary testing (29, or 13 percent,
of whom were HIV seropositive) found that injection drug
use was the most significant predictor of HIV seropositivity,
with drug injection in a shooting gallery further increasing
the likelihood of being HIV seropositive.23
A study of 87 women recruited through the infectious
disease clinic at Massachusetts Correctional Institution,
Framingham, (70 percent of whom were HIV seropositive)
explored a broader range of potential correlates than did the
New York study.  The Massachusetts study found that
injection drug use, commercial sex work, a history of
childhood sexual abuse, and a history of genital or anal
warts were all predictive of HIV seropositivity.  Perhaps the
most important finding of this study is the strong associa-
tion between sexual abuse and risk-taking behaviors related
to HIV.24  These findings indicate the importance of incor-
porating counseling for survivors of sexual abuse in HIV
prevention programs for women.  (This is discussed further
in chapter 2.)
Racial/Ethnic Groups.  Different correctional systems
supplied various combinations of AIDS case statistics to the
1994 NIJ/CDC survey, including cases among current
inmates, released inmates, and inmates who died of AIDS
while incarcerated.  Combining these statistics reveals the
following median racial/ethnic breakdowns of AIDS cases
in responding State/Federal systems:  43 percent black, 38
percent white, and 13 percent Hispanic.  This compares
with the following distribution among total cumulative
AIDS cases in the U.S. population:  50 percent white, 32
percent black, and 17 percent Hispanic.  The
disproportionality in the total U.S. population is thus prima-
rily between whites and blacks.  The difference is even more
striking in city/county systems where the median distribu-
tions are 58 percent black, 15 percent white, and 14 percent
Hispanic.
Data from some systems independent of the NIJ/CDC
survey also reveal disproportional distributions of cases by
racial and ethnic groups, but with some differences.  Of
cases reported in the total New York State population
through March 1994, 32 percent were among whites, 39
percent among blacks, and 28 percent among Hispanics.
Among New York State inmate cases, 12 percent were
among whites, 40 percent among blacks, and 47 percent
among Hispanics.25  The most striking difference in these
New York State figures is the overrepresentation of Hispan-
ics among inmates with AIDS.  This overrepresentation of
Hispanics among New York inmate cases may reflect the
large Puerto Rican component of the Hispanic inmate
population.  This population has particularly high rates of
HIV infection due to the movement of injection drug users
back and forth between Puerto Rico and New York City
communities, reinforcing the already high levels of HIV
infection in these communities.
Exposure Categories.  The NIJ/CDC survey does not seek
breakdowns of AIDS cases by exposure categories.  Efforts
to obtain this information in previous years’ surveys have
been largely unsuccessful.  However, data from some other
sources indicate that injection drug use may be the predomi-
nant exposure category in inmate AIDS cases.  Among New
York State inmate cases reported through March 1994, 93
percent were attributed to injection drug use.26  Studies in
New York City and Maryland have also shown injection
drug use to be the primary inmate exposure category.27
Nationwide HIV testing data suggest increasing rates of
infections due to heterosexual contact and other unpro-
tected sex, especially among women.  These patterns may
begin to be reflected in correctional populations.
HIV Transmission Among Correctional Inmates
HIV transmission among correctional inmates remains a
matter of serious concern.  Indisputably, sex, injection drug
use, and tattooing are occurring in prisons and jails regard-
less of prohibitions against all of these activities.
Condoms are not officially available to inmates in most
correctional systems.  In the absence of condoms, inmates
may use and reuse expedients such as fingers cut from latex
surgical gloves.28
Rape and other forms of nonconsensual sex are particularly
serious issues demanding serious responses from correc-
tional systems, independent of the issue of HIV transmis-
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sion.  While there is little systematic data on the incidence
of rape behind bars, one advocate has asserted that 131,000
adult males are sexually victimized in correctional facilities
each year.29  In the spring of 1994, a series of investigative
articles on rape in Massachusetts prisons prompted the
State’s Department of Correction to institute new proce-
dures for identifying and investigating alleged rape inci-
dents.  This included training for all correctional officers,
counselors, and medical staff.30
Some members of the Massachusetts State legislature and
others have called for mandatory HIV testing as a response
to the revelations regarding prison rape.  In reality, how-
ever, rape and HIV are separate issues requiring indepen-
dent responses.31
Research from Britain suggests that injection drug use is
less common in prisons than on the outside but considerably
more risky, because the very shortage of needles that
reduces prevalence of use also increases sharing.  Moreover,
risk is exacerbated by inmates’ often limited understanding
of “sharing.”  In reality, sharing includes not only passing
needles among people, but also using needles and syringes
that have been used by persons not present, and perhaps not
properly cleaned; sharing injection solutions (as in
“backloading” and “frontloading”); and sharing contain-
ers, cotton, and other paraphernalia.32  When needles are not
available, pieces of pens and light bulbs are sometimes used
by inmates to inject drugs.33
Tattooing is a common practice in prisons and jails, and it
is often done with guitar strings and other expedient mate-
rials given the shortage of sterile needles.  In tattooing,
sharing of the needle or needle substitute, ink, and string
used to transmit the ink may pose risks for HIV transmis-
sion.34
The only controlled study to date of HIV transmission in
correctional facilities was carried out among male inmates
in the Illinois Department of Corrections between 1988 and
1990.  Of almost 2,400 inmates HIV seronegative on entry
to the system (in an attempt to exclude “window period”
infections, only inmates who had spent at least three months
in a county jail prior to entering the State system were
eligible for the study), seven had documented HIV
seroconversions after one year of incarceration.  This repre-
sents an annual incidence rate of 0.3 percent.35  Several
other U.S. studies with varying methodologies involving
baseline and follow-up testing have found annual
seroconversion rates of less than 1 percent.36  While these
are low rates, they nevertheless demonstrate that transmis-
sion has occurred and, when applied to total inmate popu-
lations, result in nontrivial numbers of in-prison HIV
infections.  Based on a model developed by researchers in
Australia, annual HIV seroconversion rates among injec-
tion drug users in prison may range from 1.7 percent to 3.3
percent, depending on the assumed frequency of shared
injections.37
Several other studies in the United States and Australia have
identified cases of HIV infection by testing inmates continu-
ously incarcerated since before the supposed appearance of
HIV in the population.38  The American study comes from
the Florida State correctional system, where 87 of 556
inmates continuously incarcerated since 1977 had been
voluntarily tested for HIV antibody and 18 were positive.
This represents a seropositivity rate of 21 percent on the
basis of the number tested.39  This is quite a high rate.
However, it is important to note that it may represent a self-
selected sample of those who sought testing because they felt
at risk for HIV infection due to their behaviors in prison.  In
any case, only 16 percent of those continuously incarcerated
since 1977 were tested.  Annual HIV seroconversion rates
based on total numbers of inmates susceptible (that is,
entering seronegative) and years of potential exposure
would no doubt be much lower.  The article does not present
the data necessary to calculate annual seroconversion rates
for the entire Florida inmate population.  In general, it is
equally important to avoid understating and, as the Florida
article seems to do, overstating the problem of HIV trans-
mission in correctional facilities.
A Scottish study found evidence of HIV acquisition among
prisoners who admitted to injecting drugs while in prison.40
STD Testing Results
This year, for the first time, the NIJ/CDC survey sought
statistics on STD testing results.  As discussed above, STDs
have often been found to be correlates of HIV infection,
since HIV and other STDs share many risk factors.  Statis-
tics for syphilis, gonorrhea, and chlamydia testing are
presented in tables 9–11.  The statistics are divided into
those based on routine testing (routine testing generally
means that everyone is tested unless they specifically refuse)
and those based on other testing policies, as specified.
However, some of the high positivity percentages provided
under routine testing indicate that in these instances, more
selective populations were tested, such as individuals with
symptoms or those convicted of sexual offenses.  Results
based on routine testing should be more reflective of the
total inmate population, if they in fact reflect real “routine”
testing of the entire inmate population.
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Table 8
HIV SEROPREVALENCE DATA BASED ON
OTHER TESTING CRITERIA
Number Number %
Correctional System Dates  Tested Seropositive Seropositive
Arkansas 1/92 125 M 1 M 0.8% M
10 F 0 F 0.0 F
Colorado 1/92–11/92 1,580 M 1 M 0.0 M
122 F 0 F 0.0 F
Connecticut 1/93–12/93 3,942 M 204 M 5.2 M
616 F 53 F 8.6 F
Florida 7/92–9/92 3,491 M 236 M 6.8 M
257 F 61 F 23.7 F
1/93–12/93 1,102 F 119 F 10.8 F
Indiana 10/93–12/93 2,000 M+F 15 M+F 0.8 M+F
Kansas 7/93–5/94 843 M+F 6 M+F 0.7 M+F
Massachusetts 10/87–10/89 2,401 M 231 M 9.6 M
(State prisons) 429 F 98 F 22.8 F
1/91–12/91 2,425 M 141 M 5.8 M
337 F 29 F 8.6 F
1/93–12/93 2,355 M 43 M 1.8 M
735 F 33 F 4.5 F
Minnesota 11/87–12/92 7,500 M 60 M 0.8 M
200 F 2 F 1.0 F
Montana 11/91–10/92 229 M 2 M 0.9 M
50 F 0 F 0.0 F
New Mexico 10/88–10/89 1,818 M 9 M 0.5 M
145 F 0 F 0.0 F
1/90–9/92 3,980 M 6 M 0.2 M
150 F 1 F 0.7 F
7/93–6/94 2,453 M 9 M 0.4 M
272 F 3 F 1.1 F
Ohio 1/90–12/90b 4,409 M 68 M 1.5 M
198 F 2 F 1.0 F
1/93–12/93 17,253 M 201 M 1.2 M
1,484 F 20 F 1.3 F
Oregon 11/88–10/89 354 M 3 M 0.8 M
76 F 2 F 2.6 F
Rhode IslandC 10/89–3/90 4,110 M 160 M 3.9 M
264 F 32 F 12.1 F
Texas 1/91–12/91 5,684 M 418 M 7.4 M
1,712 F 67 F 3.9 F
?–4/94 50,746 M 2,825 M 5.6 M
12,423 F 420 F 3.4 F
Washington 10/85–4/94 7,152 M 125 M 1.7 M
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Wisconsin 1/93–12/93 5,634 M 25 M 0.4% M
380 F 1 F 0.3 F
West Virginia 10/89–10/90 257 M 0 M 0.0 M
0 F 0 F 0.0 F
Alameda County, ?–9/94 191 M 42 M 22.0 M
California 265 F 8 F 3.0 F
San Francisco, 4/93–5/94 413 M 43 M 10.4 M
California 137 F 22 F 16.1 F
Orange County, 6/93–6/94 922 M 13 M 1.4 M
California 1,103 F 15 F 1.4 F
Fulton County, 1/94–3/94 1,010 M 72 M 7.1 M
(Atlanta), Georgia 114 F 4 F 3.5 F
Cook County 1/92–12/93 4,562 M 384 M 8.4 M
(Chicago), Illinois 805 F 48 F 6.0 F
Suffolk County 11/88–11/89 364 M 59 M 16.2 M
(Boston), Massachusetts 1/92–11/92 149 M 7 M 4.7 M
14 F 2 F 14.3 F
Hennepin 5/93–4/94 88 M 2 M 2.2 M
(Minneapolis), Minnesota 11 F 1 F 9.1 F
11/93–6/94 64 M 1 M 1.6M
5 F 0 F 0.0 F
Philadelphia, 1/93–12/93 1,164 M 96 M 8.2 M
Pennsylvania 87 F 3 F 3.4 F
Harris County 7/87–10/89 1,048 M 163 M 15.6 M
(Houston), Texas 1,070 F 48 F 4.5 F
1/92–9/92 1,941 M 187 M 9.6 M
1,118 F 71 F 6.4 F
Maine 1/93–6/94 1,067 M 4 M 0.4 M
20 F 0 F 0.0 F
South Carolina 1994 3,217 M+F 204 M+F 6.3 M+F
Sacramento County, 5/94 45 M 0 M 0.0 M
California 18 F 0 F 0.0 F
Baltimore City, 6/94 35 M 17 M 48.6 M
Maryland 1 F 1 F 100.0 F
Marion County 1/92–12/92 63 M 5 M 7.9 M
Inmates Tested
Table 8 (continued)
HIV SEROPREVALENCE DATA BASED ON





Correctional System Dates Tested Seropositive Seropositive
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Arizona 9,690 M+F 204 M+F 2.1% M+F
Connecticut 11,781 M 943 M 8.0 M
3,412 F 580 F 17.0 F
Georgia 23,512 M+F 1,187 M+F 5.0 M+F
Iowa 4,162 M+F 15 M+F 0.4 M+F
Kentucky 4,941 M 6 M 0.1 M
Maryland 8,942 M 102 M 1.1 M
1,003 F 53 F 5.3 F
Massachusetts 1,020 F 68 F 6.7 F
Mississippi 4,001 M 116 M 2.9 M
370 F 5 F 1.4 F
Missouri 10,846 M 185 M 1.7 M
1,189 F 122 F 10.3 F
Montana 1,004 M 0 M 0.0 M
New Hampshire 911 M 8 M 0.9 M
500 F 11 F 2.2 F
New Mexico 3,347 M 52 M 1.6 M
Oregon 5,421 M 137 M 2.5 M
512 F 3 F 0.6 F
South Carolina 13,620 M+F 1,064 M+F 7.8 M+F
South Dakota 695 M 8 M 1.1 M
84 F 0 F 0.0 F
Texas 30,363 M 584 M 1.9 M
2,001 F 123 F 6.1 F
West Virginia 372 M 1 M 0.3 M
20 F 0 F 0.0 F
Wisconsin 527 F 9 F 1.7 F
Wyoming 240 M 2 M 0.8 M
Fulton County 750 M 54 M 7.2 M
(Atlanta), Georgia 248 F 24 F 9.7 F
Cook County 61,079 M 1,676 M 2.7 M
(Chicago), Illinois 8,416 F 872 F 10.4 F
Philadelphia, 15,647 M 523 M 3.3 M
Pennsylvania 2,110 F 220 F 10.4 F




Correctional System Tested Positive Positive
Routine
Table 9
SYPHILIS TESTING DATA, 1993–1994a
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Alameda County 367 M 10 M 2.7% M
(Oakland), California 68 F 2 F 2.9 F
Orange County, 650 M 7 M 1.1 M
California 1,103 F 71 F 6.4 F
Marion County 243 M 4 M 1.6 M
(Indianapolis), Indiana
Suffolk County 2,157 M 121 M 5.6 M
(Boston), Massachusetts 266 F 34 F 12.8 F
Testing Policy
Number Number %




SYPHILIS TESTING DATA, 1993–1994
aStatistics were requested for the 12 months prior to the survey.
Source:  NIJ/CDC Questionnaire Responses.
As with HIV, these figures reveal a wide range of positivity
rates for STDs among inmates.  For syphilis, rates range
from 0 percent to 17 percent (females in Connecticut).
Rates tend to be higher in the Northeast, Middle Atlantic,
and South and are often higher in women than in men.
Gonorrhea positivity rates based on routine testing range
from 0 percent to 32.5 percent (Broward County, Florida).
Rates are highest in the South.  Fewer statistics are available
for chlamydia.  Positivity rates based on routine testing
range from less than 1 percent to 4 percent (Massachusetts).
Only a few systems reported the results of testing for pelvic
inflammatory disease (PID).  The contrast between the
Northeast and the Midwest was manifest here again, as the
PID positivity rate was 8 percent in Massachusetts and 0
percent in South Dakota.
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Chapter 2
HIV and STD Education
and Behavioral Interventions
ability to act in a certain way) with sensitivity to how broader
gender and sociocultural factors (e.g., the values and his-
torical experiences of variously defined groups from couples
to social networks to cultural and other communities to the
society as a whole) influence individual behavior choices.1
Drawing on their perception that the epidemiology of HIV/
AIDS in the United States represents “multiple localized
epidemics,” three leading researchers have recently called
for a two-level prevention program composed of universal
and targeted elements.  The universal components should
include dissemination of basic information on HIV/AIDS
and risk reduction methods, efforts to reduce discrimination
based on HIV status, and removal of restrictions on access
to condoms, sterile needles, and other materials needed to
implement guidelines for safer behavior.  In addition,
communities with high prevalence and/or risk of HIV/
AIDS (which surely include correctional facilities, although
they are not specifically enumerated by the authors) should
be targeted with intensive interventions.  These interven-
tions should address the “physiologic, emotional, interper-
sonal and cultural contexts” of behavior and emphasize
the following strategies:  “communicating face to face in
understandable language, . . . changing peers’ attitudes
toward sex and drug use, teaching new technical and social
skills . . . , providing the means for safer behavior . . . [and
continuously assisting persons] to avoid relapses into un-
safe behavior.”2
Correctional HIV prevention efforts have thus far empha-
sized education or provision of information.  The other
necessary elements of a comprehensive HIV prevention
program have been largely missing.  Too little attention has
been paid to the very serious social, cultural, economic, and
psychological barriers to HIV-related behavior change.3
Harm reduction and risk reduction strategies have been




It has become a commonplace that prisons and jails are
important settings for HIV/STD education and prevention
efforts, because of the high concentrations among inmates
of persons with histories of injection and other drug use,
high-risk sexual practices, and other behaviors that may
place them at elevated risk for HIV infection.  In addition,
inmate populations are “captive audiences” available for
education and intervention programs for the length of their
stays in correctional facilities.  Finally, virtually all prison-
ers return to the community, so helping them to reduce their
risk-taking behavior benefits not only them but also others
they may encounter in the outside world.
The importance of seizing the opportunity to implement
comprehensive, high-quality HIV/STD education and pre-
vention programs in prisons and jails is, or should be, well
known.  To date, however, as the data presented in this
chapter make clear, correctional systems have not taken full
advantage of this opportunity.  Moreover, few individuals
being released from prisons and jails are able to have access
to long-term support systems in the community to help them
sustain difficult behavioral changes.
An abundance of research makes clear that information
alone is insufficient to induce permanent changes in the
often deeply ingrained or addictive behaviors that place
people at risk for HIV infection.  Instead, effective HIV
prevention requires comprehensive approaches that ad-
dress the complex contexts in which high-risk behaviors
occur and persist.  A recent report of the Institute of
Medicine calls for integration of individual concepts such as
“self-efficacy” (i.e., the individual’s belief in his or her
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grams, often because authorities are reluctant to teach about
proscribed behaviors, such as sex and drug use, and to
provide the means to render these activities safer.
The challenge of providing effective HIV education and
prevention for correctional inmates is thus heightened by a
central tension:  the best programs seem to be those that are
most explicit about particular precautionary and preventive
measures, yet correctional regulations often prohibit such
explicit messages and, in any case, almost universally
prohibit the distribution of condoms, bleach, and other
materials needed to implement them.
This chapter summarizes findings on HIV education and
behavioral intervention programs from the 1994 NIJ/CDC
survey and site visits and offers examples of efforts to move
from largely informational strategies to more comprehen-
sive prevention programs, even in the face of institutional
proscriptions and obstacles.  While staff education was not
covered in the 1994 survey, this also represents a critical




Knowledge is a first step in HIV prevention.  However, in
correctional facilities, as in the world outside, simply know-
ing what behaviors place one at risk for HIV usually does not
translate into avoidance of these behaviors.  There also
continues to be discrimination against HIV-infected per-
sons that may be based on misinformation or occur in spite
of generally accurate understanding of transmission routes.
A survey of Virginia inmates, for example, revealed that
most were reluctant to be around persons with HIV even
though they had a good understanding of how the virus is
transmitted.4
Inmates are probably better informed about HIV now than
they were in the middle and late 1980’s, when irrational
fear, sometimes approaching hysteria, about AIDS gripped
many correctional facilities.  A number of surveys document
that most inmates and correctional staff understand the
major means of HIV transmission.  Still, areas of uncer-
tainty and misinformation remain.  In the Virginia survey
cited above, most respondents knew that HIV is transmitted
through sex and needle use, but many were uncertain how
transmission actually occurred during these activities.  Al-
most one-fourth of both male and female inmates in Vir-
ginia thought HIV could be transmitted during homosexual
contact but not during heterosexual contact.  At the same
time, over 90 percent of both males and females said it was
unsafe to have a blood transfusion, nearly half thought HIV
could be transmitted through saliva, and one-fourth be-
lieved transmission could occur through sharing dishes or
utensils.  Misinformation about transmission through other
forms of casual contact also persists among Virginia in-
mates.5  Only about half of Oregon inmates attending HIV
education workshops gave correct answers to pretest ques-
tions regarding the body fluids through which HIV may be
transmitted, the most risky practices for HIV transmission,
and the length of the “window period” between infection
and development of detectable antibodies.6
Another issue that must be taken seriously in the planning
and execution of HIV education programs is the extent to
which certain groups, especially blacks, believe that HIV
was deliberately introduced for genocidal purposes.  This
belief is apparently widespread among black inmates in
New York State prisons.7  This makes it even more impor-
tant to have HIV education and prevention programs of-
fered by persons with credibility among inmates and to
institute peer-based programs.
Types of HIV Education and
Prevention Programs Provided
Table 12 summarizes the types of HIV education and
prevention programs provided by correctional systems ac-
cording to the 1994 NIJ/CDC survey.  It shows a continuing
decline from 1992–1993 to 1994 in the percentage of State
and Federal prison systems that provide instructor-led HIV
education for inmates—that is, face-to-face educational
sessions led by trained instructors at which inmates have the
opportunity to ask questions.  In 1994, 75 percent of prison
systems reported providing instructor-led education in any
of their facilities.  Sixty-two percent of city and county jail
systems, about the same as in 1992–1993, reported instruc-
tor-led inmate education in 1994.
Peer-based HIV education programs were reportedly of-
fered in 35 percent of State and Federal prison systems and
in only 7 percent of city/county jail systems.  The small
percentage of jail systems offering peer programs is, no
doubt, partly explained by the high turnover and short
average length of stay in these facilities.  There has been
little change in these percentages since 1992–1993.
HIV prevention counseling is reportedly provided by larger
percentages of correctional systems than is instructor-led
HIV education—86 percent of State/Federal systems and 69
percent of city/county systems.  However, it is likely that at
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Table 12
HIV/AIDS EDUCATION AND PREVENTION FOR INMATES,
NOVEMBER 1992–MARCH 1993 AND 1994
U.S. State/Federal Prison Systems U.S. City/County Jail Systems
November 1992– November 1992–
March 1993 1994 March 1993 1994
(N=51) (N=51) (N=31) (N=29)
Number of Number of Number of Number of
Systems % Systems % Systems % Systems %
Instructor-Led 44 86%1 38 75% 18 58% 18 62%
Educationa,b
Peer Education 17 33 18 35 3 10 2 7
Programsb
HIV Prevention N/A —1 44 86 N/A — 20 69
Counselingb
Videos/Audiovisualsb 49 96 45 88 28 90 19 66
Written Materialsb 49 96 48 94 22 71 21 72
aInstructor-led education involves the participation of a trained leader in some substantial part of a session.
bPrograms provided in at least one facility in the reporting correctional system.
N/A:  Not available.
Source: NIJ/CDC Questionnaire Responses.
least some respondents mistook this question to refer to
pretest and posttest counseling rather than to ongoing
prevention counseling, as it was intended.
Audiovisual and written materials on HIV/AIDS are used in
the majority of systems, but the percentages of systems
reporting their use declined since 1992–1993.
The reasons for the continuing decline in attention to HIV/
AIDS education and prevention in correctional facilities are
unclear but may include dissipation of the earlier crisis
atmosphere regarding AIDS, lack of attention to HIV issues
in the outside community surrounding the facilities, and
resource constraints.  In any case, the trend is troubling.  As
already emphasized, correctional facilities are prime set-
tings for ongoing HIV prevention work, but clearly many
systems are not taking full advantage of this opportunity.
Table 13 provides further evidence of the missed opportu-
nities to provide HIV/AIDS prevention and education pro-
grams for inmates.  This shows that less than one-third (29
percent) of State/Federal prison systems provided instruc-
tor-led HIV education in all of their facilities, and 12 percent
did not know how many facilities provided such programs.
Only one State prison system reported offering HIV peer
education in all of its facilities.  Almost half of the State/
Federal systems reported that HIV prevention counseling
was offered and audiovisual materials on HIV/AIDS were
used in all their facilities, while almost two-thirds said
written materials on HIV/AIDS were distributed in all their
institutions.  There were no significant differences in cov-
erage of men’s and women’s facilities by these education
methods.
Table 13 is based on the responses of correctional systems’
central offices regarding coverage of their facilities by
different HIV education and prevention methods.  Over the
years since the NIJ/CDC survey series began, there have
been concerns raised about the accuracy of information
provided by systems’ central offices.  Therefore, in 1994,
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Table 13
COVERAGE OF INMATE HIV EDUCATION/PREVENTION PROGRAMS
WITHIN STATE/FEDERAL CORRECTIONAL SYSTEMS (N=51), 1994
Number of Number of Number of Number of
Type of Program Systems % Systems % Systems % Systems %
Instructor-Led 7 14%1 23 45% 15 29% 6 12%
Educationa
Peer Education 30 59 17 33 1 2 3 6
Programs
HIV Prevention 3 61 20 39 24 47 4 8
Counseling
Videos/Audiovisuals 3 6 22 43 23 45 3 6
Written Materials 0 — 16 31 32 63 3 6
aInstructor-led education involves the participation of a trained leader in some substantial part of a session.
Source: NIJ/CDC Questionnaire Responses.
In No
Facilities







Where Provided Within System
abbreviated questionnaires focusing on policies were sent to
samples of individual facilities in selected State and Federal
correctional systems so that their responses could be com-
pared with those submitted by central offices.  (City/county
systems were not included in the validation study, since they
tend to have far fewer individual facilities.)  The results of
this “validation study” are presented throughout the report.
Table 14 displays validation study results for aspects of HIV
education and prevention programs.  It shows varying levels
of agreement between central office and facility responses.
For example, in three systems whose central offices reported
that all of their facilities provided instructor-led HIV edu-
cation, 80 percent of the individual facilities reported that
they, in fact, offered instructor-led education.  Analogous
rates of agreement for HIV prevention counseling, use of
audiovisuals, and distribution of written materials were 100
percent, 87 percent, and 91 percent, respectively.  Further
discussion of each of the major methods of HIV education
and programming is provided below.
Instructor-Led Education
Instructor-led education is a basic means of providing
information on HIV/AIDS, risk factors for HIV transmis-
sion, and methods of reducing inmates’ risk of acquiring
and transmitting HIV.  Intake and ongoing education and
prevention programs offer the chance to educate inmates
about the particular risks they may encounter in a correc-
tional facility and help them to reduce their high-risk
behaviors, while prerelease programs afford an important
opportunity to reinforce risk reduction messages and strat-
egies as individuals are returning to the community.
In addition to the issues raised above regarding the extent
to which facilities within a system are covered by particular
programs, it is important to know the extent to which
inmates in facilities providing education programs are
actually attending them.  An indication is provided by
learning whether attendance is mandatory.  Seventy-one
percent of State/Federal systems report that HIV education
sessions are mandatory for all incoming inmates, while 24
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Table 14
HIV/AIDS EDUCATION AND PREVENTION PROGRAMS FOR INMATES:
Results of the Validation Study (VS)
 Systems in VS
With This Policy Facilities in VS % in Agreement
Instructor-Led Education (I-LE) 3 5 80 %
Provided in All Facilities
I-LE Mandatory 10 27 82
for All Incoming Inmates
I-LE Mandatory 4 15 47
for All Releasees
HIV Prevention Counseling 5 12 100
Provided in All Facilities
Videos/Audiovisual Materials 9 22 87
Used in All Facilities
Written Materials 9 22 91
Provided in All Facilities
Source: NIJ/CDC Questionnaire Responses.
fewer systems include topics such as negotiation skills for
safer sex, identifying barriers to behavioral change, triggers
for relapse, and coping skills that are best covered in
ongoing prevention programs rather than in “AIDS 101” or
similar introductory education sessions.  Indeed, these
lower percentages suggest that few systems are actually
providing ongoing HIV prevention programs.
Validation study results on topics covered in HIV education
(table 16) suggest some interesting patterns.  In general, the
percentages of facilities in agreement on topics supposed to
be covered based on central office responses (on the left side
of the table) are higher than the percentages of agreement
regarding topics not supposed to be covered.  That is, for
example, in 12 systems where safer sex practices were
supposed to be covered in HIV education, 88 percent of the
facilities in the validation study reported that this topic was
indeed included.  On the other hand, in 5 systems where
safer injection practices were not supposed to be covered in
HIV education, two-thirds of the facilities reported covering
this topic anyway.  Thus, at least some individual facilities
seem inclined and able to expand their educational pro-
percent report mandatory sessions for current inmates, and
25 percent for inmates about to be released.  Validation
study results (table 14) show a fairly high level of agreement
regarding mandatory HIV education for incoming inmates
(82 percent of facilities in agreement), but a lower rate
regarding mandatory prerelease education (47 percent of
facilities in agreement).  This suggests that over half of the
facilities in these systems are not abiding by a policy that
HIV education be mandatory for inmates about to be re-
leased.
Table 15 shows the topics that correctional systems report
are covered in their HIV/AIDS education programs.  Topics
such as basic HIV information, alcohol and drug risks, and
safer sex practices are widely covered.  However, smaller
percentages of systems include practical prevention skill
such as proper condom use, safer injection practices, and
pregnancy choices.   These topics may be more controvers al
(e.g., pregnancy termination) or difficult to address because
the means to implement the messages (condoms, bleach,
sterile injection material) are largely prohibited to inmates
as a matter of correctional policy and/or law.  In addition,
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Table 15
TOPICS COVERED IN HIV/AIDS EDUCATION FOR INMATES, 1994
U.S. State/Federal U.S. City/County
Prison Systems Jail Systems
(N=51) (N=29)
Number of Number of
Topics Systems % Systems %
Basic HIV information 48 94%1 23 79%
Meaning of HIV test results 43 84 22 76
Safer sex practices 44 86 22 76
Negotiation skills for safer sex 20 39 17 59
Proper condom use 30 59 19 66
Safer injection practices 28 55 16 55
Tattooing risks 45 88 17 59
Alcohol/drug risks 46 90 22 76
Self-perception of risk 32 63 18 62
Identifying barriers to behavioral change 28 55 19 66
Triggers for behavior relapse 19 37 18 62
Coping skills 24 47 15 52
Referral to other services 37 73 18 62
Vertical transmission of HIV 40 78 19 66
Pregnancy choices 29 57 14 48
        Covered in Education Sessions
Source: NIJ/CDC Questionnaire Responses.
grams beyond the topics specified or authorized by their
systems’ central offices.  This should not be completely
surprising, since, in most systems, wardens, superinten-
dents, and health services staff retain substantial influence
over how programs and policies are implemented in indi-
vidual facilities.  Thus, at least some facilities appear able
to circumvent the limits placed by systems on the content of
HIV education and prevention programs.
As noted, one of the key features of a targeted HIV preven-
tion program is “communicating in understandable lan-
guage.”  Since many inmates are not native English speak-
ers, this should include offering education in non-English
languages.  Survey responses indicate that only 39 percent
of State/Federal prison systems and 41 percent of city/
county jail systems provide HIV education in Spanish.
Beyond simple linguistic understandability there is the
question of credibility.  In general, there is likely to be
substantial inmate mistrust of information provided by
correctional staff, particularly on controversial topics such
as HIV/AIDS.  Therefore, correctional systems should
seriously consider having inmate peers or outside groups,
such as public health departments or AIDS service organi-
zations, provide HIV education in their facilities.  Survey
results indicate that correctional systems are already mak-
ing fairly widespread use of outside resources for HIV
education.  While 98 percent of State/Federal prison sys-
tems use their own medical staffs to provide HIV education,
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80 percent also report using public health departments, 56
percent report using AIDS service organizations, and 31
percent say they use inmate peer educators.  Among re-
sponding city/county jail systems, two-thirds report relying
on their own medical staffs, but two-thirds also report using
public health departments, 52 percent use AIDS service
organizations, and only 10 percent report use of inmate peer
educators.
New York State mounted an ambitious public health depart-
ment–based HIV education effort for inmates.  In 1990, the
State health department’s AIDS Institute was funded to
provide basic HIV education sessions for inmates and staff,
as well as testing and counseling services to the entire State
prison system.8  However, an inmate who has been active in
efforts to establish inmate peer education programs on HIV
in New York stated that the AIDS Institute’s Criminal
Justice Initiative had serious weaknesses.  It did employ
presenters who were more “street-wise” than most correc-
tional or health department officials, but these presenters
sometimes failed to address the very specific risk practices
and myths about prevention that are common in prisons.
Also, many sessions became diverted by lengthy and often
fruitless discussions of prisoners’ prevalent concerns that
the HIV epidemic was deliberately created by the govern-
ment.  This New York inmate is very skeptical about the
value of one-time sessions without follow-up.  He reported
that the anonymous testing provided by the State health
department was very much welcomed by many inmates, but
that anonymous testing was never again available at his
facility after one opportunity in 1990.  The peer education
that was supposed to be the next phase of the AIDS
Institute’s program never materialized at the facility.9
An assessment based on focus groups with inmates in New
York City jails and former New York State prisoners found
a range of experience with HIV educational programs in
correctional facilities.  Generally, women reported more
exposure to HIV education while incarcerated.  By contrast,
some men said they had been in facilities with no HIV
education or prevention programs.10
In the Oregon State prison system, HIV education and
pretest/posttest counseling have been provided since 1987
by Correctional Treatment Services (CTS), which is staffed
and housed by the State’s Mental Health Division but
funded by the Department of Corrections.  This arrange-
ment has generally worked well to dissociate the provision
of education and counseling from the correctional system.
CTS educators and counselors appear to have developed
excellent credibility with both inmates and correctional
staff.  Site visits conducted as part of this NIJ/CDC study
included attendance at HIV education sessions presented at
men’s and women’s facilities in Oregon.  The CTS educator
was extremely knowledgeable and effective in developing
rapport with the inmates.  She spoke in frank and under-
standable terms of situations and issues that were relevant
to the experiences of this population, encouraged and
licited substantial inmate participation, and offered clear,
practical guidelines for risk reduction.11
Achieving consistency of program quality, topic coverage,
and factual information provided in HIV education become
particularly complex and challenging issues in large correc-
tional systems with multiple facilities.  An innovative
approach has been taken by the Florida system, which
employed video teleconferencing to present HIV education
sessions for inmates simultaneously at 10 men’s prisons.
With funding from Burroughs-Wellcome, the program was
led by two HIV-positive educators and covered prevention,
testing, drug therapies for HIV disease, and support and
treatment following release.  Inmates at all 10 prisons were
able to ask questions using telephone hookups.  A similar
program was presented for female inmates in Florida.12
Inmate Peer Programs
As suggested above, noninmates can certainly provide
effective HIV education programs if they are carefully
chosen for the ability to develop rapport with, and win the
trust of, the audience.  However, peer-based programs do
offer a number of advantages.  They can be implemented at
little cost to the correctional system, since inmates provide
most of the labor.  Moreover, provided they are carefully
selected and thoroughly trained, peer educators may be
more credible with inmates and more likely to speak in
terms relevant and understandable to inmates.  Peer educa-
tors are able to do substantial informal one-on-one outreach
and support in the yard and other areas of the facility, as well
as conducting formal education, counseling, and support
groups, and can be available on a 24-hour basis.
Despite these advantages, inmate peer education programs
on HIV are offered in only 35 percent of State/Federal prison
systems and only 7 percent of responding city/county jail
systems.  These percentages, based on central office re-
sponses, showed little change since the 1992–1993 NIJ/
CDC survey.  There was insufficient validation study data
on peer programs to assess the extent to which individual
facilities in these systems are actually offering peer pro-
grams.  However, in large systems, HIV education and other
types of programs can vary considerably from facility to
facility, depending on the receptivity of the warden and the
inmates themselves.
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A New York inmate who has worked to establish peer
education programs in four different State prisons noted
that it is really a “two-front” effort.  The inmates themselves
are often seriously divided along ethnic and racial lines, and
some are hostile to persons with HIV and to all efforts to
address the problem of HIV, whether offered by persons
with HIV or not.  At the same time, the prison administra-
tion must be convinced of the value and importance of peer
education programs.  This is complicated by the often
inherent suspicion of and opposition to inmate organization
and inmate-initiated programs.13  This New York inmate
reported meeting significant resistance from facility admin-
istrators.  On several occasions, he was transferred to
another facility just as he was beginning to get a peer
program under way.14  (Correctional officials indicate that
these transfers were routine, based on his high escape risk,
and had nothing to do with his efforts to organize peer
programs.)  Currently, there are peer programs of varying
levels of activity at about 8 of 68 New York State prisons.15
These include the well-known and exemplary ACE pro-
gram at the Bedford Hills women’s facility and the PACE
program at Eastern men’s facility.  The success and visibil-
ity of the ACE program spawned programs in other facili-
ties and encouraged some correctional administrators to
support peer programs.  There is also a community-based
component of ACE (called ACE-OUT) that provides sup-
portive services, including a “buddy” program, for former
inmates with HIV.
 Inmates and staff have both raised issues of confidentiality
in opposition to peer programs.  Concerns have been
expressed that inmates’ HIV status may be compromised
through contact with peer educators or peer counselors.
This could occur by the peer educators, directly divulging
the information or, indirectly, by other inmates, observing
interactions between peer educators and HIV-infected in-
mates.  The medical director at the Federal Penitentiary in
Atlanta asserted that peer HIV counseling would result in
“putting a bullseye” on inmates seen associating with the
counselors.  Staff at the Federal Bureau of Prisons’ Metro-
politan Correctional Center in Miami have not permitted
peer programs for similar reasons.16
Inmate peer educators in Oregon and elsewhere acknowl-
edge that confidentiality is a serious issue—as a result,
Oregon inmates cannot do pretest and posttest counsel-
ing—but are firmly committed to maintaining confidential-
ity and to ending discrimination against persons with
HIV.17  All peer programs must address this issue with
sensitivity and care.  The recently initiated inmate HIV peer
education programs described below illustrate approaches
that have worked well in a variety of correctional systems.
As revealed in these examples, key ingredients of an effec-
tive HIV peer education program appear to be the active
support and collaboration of facility administrators, use of
a variety of formats and vehicles for education and preven-
tion messages, and availability of ad hoc, one-on-one con-
tact, as well as more formal and structured sessions.
Oregon State Penitentiary:  Project O.A.S.I.S. (Oregon
AIDS Support [Inmate] Services).  Project O.A.S.I.S. was
founded in 1994 by an inmate who became concerned after
hearing many inaccurate statements about HIV from other
inmates in the facility.  With the support and close collabo-
ration of a counselor from Correctional Treatment Services,
O.A.S.I.S. initiated a number of programs and services
including HIV workshops, one-on-one education and sup-
port, and referrals.  Plans for the future include a “buddy”
program for inmates with HIV/AIDS, a display of panels
from the AIDS Quilt with associated educational programs,
and development of HIV education videos.  Currently, four
highly dedicated and committed inmates are involved in the
O.A.S.I.S. program, and the group has applied for official
recognition as a “Special Interest Inmate Group.”18
A series of three one-hour sessions is offered each quarter as
part of the regular school program in the prison.  Topics
include basic facts on HIV and its transmission and treat-
ment, as well as practical guidance on condom use and
cleaning of injection equipment.  Four series were held
during 1994, with an average attendance of 12.  A training
manual and participant’s workbook are being prepared.
One-on-one outreach, education, and support occur in the
yard and other parts of the prison.  According to members
of O.A.S.I.S., they provide support to a number of HIV-
infected inmates who are too mistrustful to have access to
the correctional system’s health services.  The peer team
provides counseling, referrals to services both within and
outside the facility (for those about to be released), and other
services that help to free Correctional Treatment Services
providers to do more pretest and posttest counseling.
California Medical Facility, Vacaville:  HIV Peer Edu-
cation Program.  California Medical Facility, Vacaville, is
one of the largest correctional facilities in the United States
and houses most of the system’s known male HIV-infected
inmates.  Several different peer education programs have
existed at Vacaville over the years, but the current program
seems the most solid.  It is an official program of the facility,
with detailed policies and procedures.  A psychiatric social
worker, a paid staff member of the prison, supervises the six
inmate peer educators.  These positions are paid inmate
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jobs.  Peer educators must receive at least four hours of
training each month.  The educators reflect the diversity of
the inmate population—three are black, three Hispanic, and
three white.  The threefold mission of the peer program is
to work toward eliminating HIV transmission and reinfec-
tion within the facility, increase understanding of HIV/
AIDS and compassion for inmates living with HIV, and
create a “norm devaluing high-risk behaviors.”19
To achieve these goals, the program has adopted a multime-
dia strategy, involving live presentations, guest speakers,
videos, slides, audiocassettes, role-playing, storytelling,
drama, posters, and a resource library.  Because of the
program’s conviction that “learning takes place over time,”
sessions are presented on an ongoing basis every month.
Topics covered in monthly sessions include psychosocial
issues in living with HIV, self-esteem and taking responsi-
bility for one’s behaviors, proper condom use, proper pro-
cedures for cleaning needles and injection material, relapse
prevention, and maintaining behavior change.  Although
sessions include information on safer sex and safer injection
practices, each must be preceded by a statement that drug
use, tattooing, condoms, and sexual activity are prohibited
in prison and that the education is not intended to encourage
any prohibited practices.20
In addition to the monthly education sessions, the peer
program at Vacaville offers on-call initial education for all
new arrivals at the facility and counseling for HIV-infected
inmates and those concerned about high-risk behavior or
HIV antibody testing.  The program emphasizes the facts
about HIV and the importance of treating HIV-infected
persons with respect and compassion.  The texts of two
posters developed by the program reflect these themes:
Public Notice:  As of 1993, there have been 194,334
AIDS-related deaths in the United States.  As of
1993, there has been no documented case of a
person contracting the disease by eating food
prepared or served by a[n] HIV positive person.
[Ironically, as discussed later in this Update, a
recent court decision allowed the California De-
partment of Corrections to exclude HIV-infected
inmates from food service jobs on the ground that
their presence in such jobs might cause a riot.  This
suggests the persistence of some aspects of HIV-
related misinformation in correctional facilities.]
Don’t condemn those with HIV or AIDS.  Con-
demn those who would turn their backs on those
with HIV or AIDS.21
Louisiana State Penitentiary, Angola:  HIV/AIDS Peer
Education Program.  This program was founded in Octo-
ber 1993 and has a staff of four inmate volunteers who
received training from the State health department.  All of
these inmate peer educators have other prison jobs.  Peer
educators at Angola conduct weekly HIV education sessions
for incoming inmates.  One serious, but perhaps not uncom-
mon, limitation is placed on this education by the prison
administration:  it is not allowed to cover specific safer sex
techniques.22
In addition to the weekly sessions, the program has devel-
oped some innovative features including presenting almost
weekly interviews and discussions on HIV issues on the
facility’s FM radio station (the only inmate-run station
licensed by the FCC in the Nation); working with the
Angola Drama Club (whose members have been trained as
peer educators) to produce “The Enemy Within,” a play on
HIV written by one of the inmates; writing numerous
articles for outside publications; speaking at other correc-
tional facilities and other organizations in the community;
and holding an all-day conference on HIV/AIDS at Angola
in October 1994, attended by about 300 persons from inside
and outside the prison.23
The conference included welcoming remarks by the war-
den; sessions led by facility professional staff on HIV peer
education programs, the epidemiology of HIV/AIDS at
Angola, and medical treatment of inmates with HIV/AIDS;
sessions led by peer educators entitled “The Impact of Life
Sentences on HIV/AIDS in Prison,” “The Pros and Cons of
Segregating HIV-Infected Inmates,” “HIV/AIDS:  Double
Impact—Workable Solutions,” “Living with HIV in Prison,”
and “Leaving the Penitentiary with HIV Infection”; and a
presentation of the Drama Club’s play on HIV in prisons.
Peer educator Andrew Joseph told of how a life sentence and
other pressures of prison life can engender carelessness
about high-risk behavior.  According to Joseph, some
“lifers” “figure they will not get out of prison, so why should
they care how they die?  They begin to figure that it is better
to die doing something that brings enjoyment to them than
to waste away in prison and die of old age without family and
friends.”  As a way of attempting to create a semblance of
“normalcy in an abnormal place,” Joseph and the peer
education team strongly favor initiation of conjugal visits
for inmates.24  In “HIV/AIDS: Double Impact—Workable
Solutions,” peer educator G. Ashanti Witherspoon cogently
described the impact of HIV/AIDS within the prison and
outside, as inmates return to the community, and the
generally inadequate correctional response in terms of
medical care, education, and peer counseling.  Witherspoon
proposed a solution consisting of comprehensive peer edu-
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cation for inmates, education for correctional staff and
administrators, and cooperation among correctional staff,
health departments, and community-based organizations to
develop effective HIV services for inmates that are also
sensitive to the security concerns of correctional officials.
Witherspoon described some of the programs at Angola,
including incorporation of HIV issues into the inmate-run
CPR training program.25  Theortic “Bojack” Givens out-
lined a discharge planning program under development by
the peer educators at Angola that they hope will be imple-
mented at all Louisiana prisons. This is part of the peer
education team’s overall effort to close the gaps among
“those who make things happen; those who watch things
happen; and those who ask what happened.”26  With the
inspiration and encouragement of the Angola program,
inmates at Avoyelles Correctional Center, another men’s
prison in Louisiana, recently began an HIV peer education
program.
HIV Prevention Counseling
As already discussed, the survey questions on HIV preven-
tion counseling may have been misinterpreted to refer to
pretest/posttest counseling rather than ongoing prevention
counseling as they were intended.  Pretest and posttest
counseling can be occasions for providing useful prevention
information and guidance, but they often occur at moments
of extremely high stress and preoccupation with test results.
Therefore, ongoing prevention counseling and other work
designed to encourage and maintain difficult behavior
change is an extremely important part of a comprehensive
HIV prevention program.
Bearing in mind the possible misunderstanding of the
question, 86 percent of State/Federal prison systems re-
ported offering prevention counseling, as did 69 percent of
participating city/county jail systems.  Validation study
results for State/Federal systems reveal 100 percent agree-
ment on the provision of prevention counseling within
individual facilities in systems reporting that such counsel-
ing was available in all their facilities.
Virtually all of the responding correctional systems (96
percent of State/Federal systems and 86 percent of city/
county systems) reported providing HIV prevention coun-
seling to all inmates who requested it.  Ninety percent of
State/Federal prison systems and 59 percent of responding
city/county jail systems said they provided counseling for all
HIV-infected inmates.
As to the format of the counseling, 98 percent of State/
Federal systems and 86 percent of city/county systems
reported that it was individual, while 67 percent of State/
Federal systems and 55 percent of city/county systems
reported also offering group counseling services.
Audiovisual and Written Materials
Eighty-eight percent of State/Federal systems and 66 per-
cent of city/county systems reported employing videos and
other audiovisual materials in HIV education programs.
Ninety-four percent of prison systems and 72 percent of
responding jail systems said they distributed written mate-
rials on HIV.  Validation study results in State/Federal
ystems revealed quite high levels of agreement for indi-
vidual facilities in systems whose central policies called for
use of audiovisuals and written materials in all facilities.
Materials used in HIV education and prevention programs
must be understandable and accessible to the target popula-
tions and sensitive to diverse cultures and gender groups.
The reported mean reading level for HIV materials used in
prison and jail systems was seventh grade, which seems
appropriate.  Seventy-one percent of State/Federal systems
reported using written materials on HIV specifically ad-
dressed to women, while 61 percent of prison systems said
they had materials specifically prepared for Hispanics, 31
percent for blacks, and 18 percent for Asian Americans.
The respective figures for city/county jail systems were 66
percent, 66 percent, 55 percent, and 24 percent.
STD Education
In 1994, for the first time, the NIJ/CDC survey included
separate questions on STD education.  The results indicate
that STD education is not widely provided in correctional
facilities. Less than half (49 percent) of State/Federal prison
systems reported any instructor-led STD education, while
one-third said that it was offered in all women’s facilities,
and only 16 percent reported such education in all their
facilities.  Use of written materials on STDs was more
widely reported in State/Federal prison systems:  three-
quarters said such materials were provided in at least some
facilities, while one-third said they were distributed in all of
their facilities.  About the same percentage of responding
city/county jail systems (48 percent) reported instructor-led
STD education in at least some facilities, while a slightly
lower percentage of these systems (69 percent) reported
distribution of STD written materials.
Given the often-identified relationship between STDs and
HIV infection—both in terms of common risk behaviors
and STDs as potential cofactors in the transmission of
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HIV—education and prevention programs for inmates should
more systematically incorporate information and guidance
on STDs.  Failure to address STDs in HIV prevention
programs may compromise the effectiveness of the pro-
grams.
As noted earlier with regard to HIV prevention, correctional
systems have not yet taken full advantage of opportunities
to use discharge planning to engage inmates being released
in longer-term STD prevention and related services in the
community.  These include family planning and prenatal
care services.
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37HIV Precautionary and Preventive Measures
Responding effectively to HIV/AIDS within correctional
facilities requires instituting reasonable procedures for the
protection of inmates and staff from HIV infection.  Imple-
menting constructive policies often involves balancing con-
flicting demands.  A key principle in this effort is that
precautionary and preventive measures instituted be consis-
tent with educational messages provided to inmates and
staff about HIV/AIDS.  Policies or procedures that conflict
with or go beyond educational messages may cause unnec-
essary fear and increased mistrust of correctional authori-
ties.  This chapter discusses HIV preventive measures and




As detailed in chapter 4, few correctional systems reported
a policy of notifying correctional officers of inmates’ HIV
status.  However, these policies are still debated.  Some
correctional officers and unions believe that they need, and
should have access to, this information in order to protect
themselves on the job.
Opponents of disclosure policies generally point to two
problems.  The first is that no practicable testing program
could ever ensure that all HIV-infected inmates are known.1
However, programs of mandatory testing and notification
might create the illusion that all infected people had been
identified, which, in turn, could foster a false sense of
security.  Second, particularly in systems with many HIV-
infected persons, it would be easy to forget or confuse who
is HIV positive.
The best alternative to a disclosure policy is the principle of
“universal precautions.”  Universal precautions treat all
people as if they are infected.  This means avoiding unpro-
tected contact with body fluids that are considered poten-
tially infective, especially blood and semen.  Revised guide-
lines from CDC state that universal precautions are not
necessary for contact with saliva, tears, sweat, vomitus,
urine, or feces unless they contain visible blood.2
Universal precautions have long been recommended by the
CDC for health care settings and apply equally well to
correctional and law enforcement settings.  Universal pre-
cautions should be applied by both staff and inmates in
correctional facilities, as a sound approach to preventing all
blood-borne infectious diseases including hepatitis B.  CDC
issued extensive guidelines regarding HIV transmission
and prevention for health care and emergency workers in
1989.  These include recommendations for the use of
protective equipment, such as gloves and CPR masks, and
for the disposal of needles and other “sharps,” body and cell
searches, handling of infectious materials, and cleaning up
spills.  Procedures to follow once an exposure has occurred
are also specified; these include medical protocols and
procedures for documenting incidents.3
However, there is evidence that despite strong recommen-
dations and their embodiment in written policy, universal
precautions are not well implemented in at least some
corrections settings.  A CDC-funded surveillance of pos-
sible occupational exposures to HIV in a State correctional
system identified 166 incidents, including needlesticks,
nonintact skin exposures, and mucous membrane expo-
sures.  Although no HIV infections occurred as a result of
these incidents, CDC concluded that over half of the expo-
sures could have been prevented had personal protective
equipment been used.4
Regulations issued by the Occupational Safety and Health
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force to universal precautions in health care, correctional,
and other work settings.  Under these regulations, employ-
ers are required to establish written exposure control plans,
identify and train workers with potential for exposure to
blood-borne pathogens and tuberculosis, provide necessary
infection control equipment, offer free hepatitis B vaccina-
tions and PPD skin testing for TB infection, and provide
evaluation and follow-up services to any employees who
have had potential exposures.5
Detailed infection control policies and procedures, many of
which are based on CDC’s guidelines and universal precau-
tions, have been adopted by many correctional systems.
Systems must ensure that their policies and procedures
comport with the OSHA regulations as well.
Although CDC guidelines and OSHA regulations call for
the implementation of universal precautions, no set of
written policies or procedures can cover all contingencies,
particularly in unpredictable environments such as prisons
and jails.  Situations faced by law enforcement and correc-
tional personnel often require an immediate response.  In
exigent situations, officers and other staff must use their
judgment in the application of universal precautions.  How-
ever, infection control policies can provide general guid-
ance and inform decisions made by correctional staff.
Training is also essential, so staff have a clear understand-
ing of high-risk incidents and the opportunity to discuss
possible situations and appropriate responses.
Availability of Barrier Protection
As noted in chapter 2, many correctional systems now
include discussions of safer sex practices in their HIV
educational programs.  In the vast majority of correctional
systems, however, the means to put these messages into
practice are not officially available.
The number of systems that make condoms available to
inmates has remained stable for several years.  Mississippi6
and Vermont are the only State systems that distribute
condoms.  No systems have begun distributing condoms
since the 1992 NIJ/CDC survey.  The San Francisco,
Philadelphia, New York City, and Washington, D.C., jail
systems also distribute condoms.  Further, one other jail
system reported making condoms available to inmates in
practice, although the official policy is not to distribute
condoms.  The medical director of this jail system reported
that he was motivated by clear public health needs, although
disclosure of the practice would likely provoke public
disapproval.  Condom availability has also been instituted
in all Canadian Federal prisons and some Provincial pris-
ons in Canada.7  Six State correctional systems in the United
States, including the New York State system, make condoms
available for conjugal visits.
Distribution of condoms varies by correctional system.
Inmates at the Mississippi State Penitentiary in Parchman
can buy unlimited supplies of condoms at the canteen for 25
cents each.  Most systems tie condom distribution to health
services or HIV education.  In New York City, inmates are
limited to one condom per medical visit and are supposed to
be counseled by medical staff before receiving a condom.  In
Vermont, condoms are available through health services
with counseling in most instances, but they are sometimes
also made available in health services offices without coun-
seling.  In at least one Vermont institution, lubricant is
provided with condoms.  Condoms are available at HIV/
AIDS educational programs in San Francisco and at HIV
antibody test counseling sessions or during sick call in
Philadelphia.  Condoms are available in the infirmary and
at counseling and education sessions in District of Colum-
bia jails.8  The number of condoms distributed to inmates
annually varies widely by correctional system and is no
doubt related to the method of distribution.  In New York
City, where condoms are available only after counseling,
about 1,200 condoms are distributed annually.  By contrast,
in San Francisco, condoms are available to all who attend
HIV education services, and about 10,000 condoms are
distributed each year.9
In the San Francisco and District of Columbia jail systems,
HIV prevention for women is specifically addressed by
making dental dams available.  These are squares of latex




Correctional medical staff often advocate condom availabil-
ity whereas correctional administrators and security staff
oppose it.  This ideological divide reflects different perspec-
tives.  Health care workers view corrections from the public
health model, which acknowledges that sex takes place in
prison and stresses the need to prevent HIV transmission,
while correctional officials tend to emphasize security and
adherence to regulations.  They worry that condom distribu-
tion would signal their acceptance of sex, which is pro-
scribed within the institution, and that condoms might be
used as weapons or to conceal drugs or other contraband.
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Some correctional medical staff have implemented what
they consider appropriate public health measures, such as,
the distribution of condoms, even when this was prohibited
by the correctional system.10
In Vermont, the condom availability policy was actually
championed at first by a deputy superintendent of one of the
facilities.  He believed at the time, and continues to believe,
that “good public health policy is good correctional policy.”
According to this correctional administrator, sex happens
in prisons, and it would be irresponsible not to make
protection available.11
In the systems with condom availability, few if any prob-
lems have occurred with condoms being used as weapons or
for smuggling contraband, despite suggestions by oppo-
nents that this would occur.  A hospital administrator at the
Mississippi State prison in Parchman recalled only one
incident when a condom was used for smuggling contra-
band.12  In Vermont, after an initial period of some height-
ened interest and controversy, condom distribution became
routine and was no longer an issue.  Vermont officials report
few if any problems with the misuse of condoms for smug-
gling contraband or for weapons, and they suggest that there
is no evidence of increasing sexual activity or undesirable
behavior since the condom policy was instituted.  In a survey
of over 400 officers in Canada’s Federal prison system, 82
percent reported that condom availability had created no
problems in their facilities.13
Bleach and Needle Availability
Many correctional systems include information on safer
injection practices in their education and counseling.  How-
ever, only two systems have policies for the provision of
bleach, and no systems distribute needles.  Since injection
drug use is illegal in prison and in the outside community,
correctional officials conclude that distributing bleach or
needles would condone illegal activity.  Moreover, needles
and bleach do pose serious security and safety risks in
correctional facilities.   Still, needles are present in many
facilities, and their scarcity tends to foster sharing and other
risky practices.  A British study found that although needle
use was rarer in prisons than on the street, it tended to be
riskier when it did occur.14  A Scottish study provides further
indication of high risk with injection drug use in prisons.  Of
43 inmates in Glenochil prison who admitted to injection
drug use at some time in their lives but not while in prison,
34 were tested for HIV antibody and none were positive.  By
contrast, 12 of 25 (44 percent) of inmates who admitted to
injecting drugs in the prison tested HIV seropositive.15
In the United States, only the San Francisco and Harris
County (Houston) jail systems officially make bleach avail-
able for cleaning drug-injection material.  A pilot program
of bleach distribution is being implemented in Canada, and
the Canadian Expert Committee on AIDS and Prisons
recommends making small quantities of full-strength bleach
“easily and discreetly accessible” to inmates.16  However,
bleach is available for general cleaning purposes in many
systems, and some inmates may have de facto access to
bleach for needle cleaning even in the absence of policies
explicitly permitting this.
Recent research has shown that bleach may not be fully
effective for disinfecting injection equipment unless its use
carefully follows correct procedure.  The CDC’s revised
procedure calls for rinsing with clean water, then with full-
strength bleach, then with clean water again at least three
times, shaking the syringe for 30 seconds during each
rinsing.17  Although proper cleaning with bleach does
significantly reduce the risk of HIV transmission, the only
way to be certain that there is no infected blood in a needle
or syringe is to use new sterile equipment every time.  Bleach
is recommended only “when no other safer options are
available.”18
Although there are no needle exchange programs in prisons
in the United States, a Swiss prison has started a pilot needle
exchange program.  In addition to counseling and educa-
tion, inmates at the Hindelbank Institution for Women can
exchange used needles and syringes for sterile ones at
automatic dispensers throughout the institution.19  Some
argue that providing needles to inmates condones illegal
activity and would create safety risks within an institution.
However, Martin Lachat, interim director of the Hindelbank
Institution for Women, commented:
The transmission of HIV or any other serious
disease cannot be tolerated.  Given that all we can
do is restrict, not suppress, the entry of drugs, we
feel it is our responsibility to at least provide sterile
syringes to inmates.  The ambiguity of our man-
date leads to a contradiction that we have to live
with.20
The Canadian Expert Committee recommended further
research, including scientifically valid pilot studies on
needle exchange in prisons.21
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Chapter 4
HIV and STD Testing, Counseling,
Confidentiality, and Disclosure Policies
A fairly stable set of correctional systems continue to have
policies for mandatory HIV antibody testing of inmates.  In
some instances, however, the justification for this policy has
shifted from one based on the prevention of transmission
(even, oddly, in the absence of an associated segregation
policy) to one more grounded in medical intervention.
Although mandatory testing could, in theory, increase
access to diagnosis and treatment, most systems have found
it preferable to pursue the goals of medical intervention and
treatment in the context of voluntary or on-request testing
policies.  The CDC continues to support confidential HIV
counseling and testing services in numerous correctional
facilities through its cooperative agreements with public
health departments.
This chapter discusses HIV and STD testing, counseling,
and notification policies based on the results of the 1994
NIJ/CDC survey.
HIV Antibody Testing Policies
Tables 17 and 18 show that mandatory HIV testing contin-
ues to be the policy of a minority of State/Federal prison
systems, but it is an apparently stable minority.
For the first time, the 1994 survey included pregnant
females as a separate category for mandatory HIV testing.
Thirteen State systems (26 percent) reported mandatory
testing for pregnant women.  None of the responding city/
county systems reported mandatory testing of pregnant
inmates.  This will be an important policy to monitor in view
of recent evidence that treating pregnant women with
zidovudine (ZDV) reduces the risk of HIV transmission
from mother to infant.
The above statistics on testing policies are based on central
office responses to the survey.  The validation study discov-
red high agreement rates in systems with mandatory mass
screening and voluntary/on-request testing policies but a
total absence of agreement in systems with policies calling
for mandatory testing of pregnant females.  Table 19 shows
that of four women’s facilities in systems with policies for
testing all pregnant women, none reported carrying out this
policy.
The following sections provide further discussion of man-
datory and voluntary/on-request testing policies.
Mandatory Screening
Table 20 lists the State/Federal prison systems—16 State
systems and the Federal Bureau of Prisons—that report
mandatory mass HIV screening of inmates at intake or
release.  Six of the 17 systems test at both times, whereas the
Federal Bureau of Prisons reports mandatory testing only at
release.  Due to the rapid turnover in jail systems, it is not
surprising that none of the responding city/county jail
systems report mandatory mass screening policies.  High
turnover rates make the logistics of mass screening very
difficult.  There has been no change in the number of
systems reporting mandatory screening since the 1992
update.
Although 16 prison systems report HIV screening at intake,
the Alabama and Mississippi State systems remain the only
2 systems to segregate all known HIV-infected inmates.
Housing policies are discussed in chapter 5.
Voluntary/On-Request Testing
As shown in tables 17 and 18, a large percentage of prison
and jail systems offer HIV testing to inmates on request.  In
f ct, among city/county systems, voluntary or on-request
testing is the most frequently reported basis of testing.  Dr.
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U.S State/Federal U.S. City/County
Prison Systems Jail Systems
(N=51) (N=29)
Number of Number of
Systems % Systems %Testing Policies
Mandatory Testing of:
All Incoming/New Inmates 16 31% 0 0%
All Releasees 4 8 0 0
Pregnant Females 13 26 0 0
Voluntary/Inmate Request Testing 40 78 28 97
Available to All Inmates
Testing if Clinical Indicationsb 49 96 25 86
Other Testingc 19 37 9 31
Table 17
SUMMARY OF CORRECTIONAL POLICIES ON HIV ANTIBODY TESTING OF INMATES, 1994a
aThis table includes actual and planned policies. The categorization is not mutually exclusive.
bClinical signs or symptoms of HIV infection or AIDS.
cExamples of other testing include court order, high-risk conduct, undiagnosed illness, etc.
Source: NIJ/CDC Questionnaire Responses.
Jan Diamond, a physician who formerly worked in the
California prison system, argues strongly for encourage-
ment of voluntary inmate HIV testing because it is “an
important way to reach a disenfranchised population . . .
who otherwise receive little HIV intervention or health
care.”1
Successful encouragement of voluntary inmate testing may
be challenging.  As noted in chapter 1, studies in New York
State prisons show higher rates of HIV seropositivity in
blinded epidemiologic studies representative of the entire
inmate population than among those who came forward for
voluntary testing.  The apparent reluctance of HIV-positive
individuals to be tested is at variance with the assumption
that individuals who are at high risk for HIV infection will
come forward for testing, particularly if they believe that
they can benefit from early medical intervention.  For both
medical and psychological reasons, this assumption may be
flawed.  First, recent research suggests that early interven-
tion with ZDV is probably ineffective in lengthening sur-
vival with AIDS.  Second, whether or not they have consid-
ered the benefits of early medical intervention, many indi-
viduals may feel that it is psychologically easier not to know
their HIV status:  put simply, “they do not want any bad
news.”  In a Maryland study of voluntary testing, about half
of the inmates chose to be tested; the most common reason
for declining testing was fear of a positive result.2  A nurse
at a Vermont prison confirmed this conclusion during an
interview conducted for this NIJ/CDC study.3
Despite the discouraging news about early treatment with
ZDV, there may be other early interventions useful for at
least some who learn their HIV status.  These include
prophylaxis for Pneumocystis carinii pneumonia (PCP) or
other opportunistic infections associated with HIV infec-
tion, immunizations, and counseling regarding diet and
food preparation to avoid food-borne pathogens.
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U.S. State/Federal U.S. City/County




Systems % Systems %
Table 18












17 33% 0 0%
30 59 28 97
4 8 1 3
51 100 29 100
aIncludes actual and planned policies. This is a hierarchical categorization: jurisdictions that do mass screening are placed
in the uppermost category, regardless of whether they also test for other purposes; jurisdictions that offer voluntary or
on-request screening but do no mass screening are placed in the voluntary category regardless of whether they also test when
clinically indicated.
bIn this table, clinical indications include lowered CD4 (T4) counts, opportunistic infections, and TB positivity or active TB.
Source: NIJ/CDC Questionnaire Responses.
A combination of mass HIV education and intensive coun-
seling focusing on individuals who self-identify as high
risk, may be a more effective means of getting inmates to
volunteer for HIV testing.4  Research done in the New York
City jail system provides support for this strategy.5
Dr. Jan Diamond recommended the following methods of
maximizing acceptance of voluntary testing:  using non-
correctional staff for counseling and testing; maintaining
confidentiality if at all possible; considering the use of
anonymous testing; and providing follow-up after testing
with high-quality counseling, education, and medical care.6
Confidentiality and
Disclosure of HIV Status
One of the best ways to maximize acceptance of testing by
those most at risk for HIV is to ensure that confidentiality
of results is protected.  In correctional settings, this poses
great challenges.  As shown in table 21, the majority of
prison and jail systems have policies against notifying
correctional staff, other than medical staff, of inmates’ HIV
status.  Policies permitting disclosure to nonmedical staff
usually limit this to central office or institutional manage-
ment staff.  Indeed, policies for disclosure to central office
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Table 19
HIV ANTIBODY TESTING POLICIES, HIERARCHICAL CATEGORIZATION:
Results of the Validation Study (VS)
 Systems in VS   Facilities in VS
With This policy in These Systems % in Agreement
Mandatory Mass Screeninga 4 11 82 %
Mandatory Testing of Pregnant Women 4 4b 0
Voluntary/On-Request Testing 8 21 95
Clinical Indications 1 1 0
a Screening of all incoming inmates or all releasees.
b Facilities with female inmates.
Source: NIJ/CDC Questionnaire Responses.
and institutional management staff declined among State/
Federal systems by 12 and 14 percent, respectively, since the
1992 survey.  In 1994, only four State systems (8 percent)
and four responding city/county systems (15 percent) re-
ported policies for notifying line correctional officers of
inmates’ HIV status.
Table 21 shows that the inmate, medical staff, and the public
health department are the most commonly notified parties,
as a matter of official policy. Next most common is sexual
partners. A partner notification policy might mean that the
inmate notifies the partner(s) directly, that correctional
officials notify the partner(s), or that public health authori-
ties are notified and follow up with the partner(s).  About 90
percent of the State/Federal systems and 75 percent of city/
county systems use two or more methods of notification.  In
such cases, notification of sexual partner(s) is not left
entirely up to the inmate.
Table 22 summarizes validation study results regarding
notification of HIV status.  The left-hand side of the table
shows the percentages of facilities reporting that they notify
various parties in compliance with central office policies.
Notably, facilities’ reported compliance with central office
policies against notification of correctional officers was
extremely high (97 percent).  Most other agreement rates
are fairly high except those regarding central office staff,
sexual and needle sharing partners, and assault victims.
This suggests that some facilities are not notifying central
offices of cases of HIV infection and that many facilities may
not be complying with partner and victim notification
policies established by their systems.  The right-hand side
of the table shows that unauthorized notifications are occur-
ring in some facilities as a matter of institutional procedure.
Such unauthorized notifications appear to be most common
with regard to other medical staff and public health depart-
ments.
Beyond officially stated policies at the system or facility
level, actually maintaining confidentiality of HIV-related
and other sensitive information is extremely difficult in a
correctional setting.  One State system, for example, uni-
formly “flags” with a prominent sticker the medical records
of inmates who are infected with blood-borne diseases.
Although official policy does not require or authorize
notification, medical staff practice may provide inmates or
correctional staff with opportunities to learn confidential
information.
Flagging or obvious coding of medical records has become
relatively uncommon, but other means of unofficial disclo-
sure of HIV status remain in the normal course of correc-
tional life.  Even without obvious flagging of records,
medical staff or inmates working in medical units have
access to the information and may disclose it.  Despite
official policies, many correctional officers and inmates
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U.S. State/Federal Prison Systems U.S. City/County Jail Systems
(N=51) (N=29)


















CORRECTIONAL SYSTEMS CONDUCTING MANDATORY SCREENING OF INMATES,
JUNE–DECEMBER 1994a
aDefined as mandatory HIV antibody testing, generally identity-linked, of all new inmates, all releasees, and/or all 
current inmates, regardless of whether they show clinical indications of HIV infection. In terms of correctional policy,
this type of testing differs in purpose and method from blinded epidemiological studies. Blinded studies are anony-
mous (not identity-linked) screenings intended to assess seroprevalence rates in a particular population.
Source: NIJ/CDC Questionnaire Responses.
believe they are entitled to know who is HIV infected.
Correctional officers have substantial power and can use it
to obtain information.  In short, official policies will only
protect confidentiality if they are enforced through vigilant
monitoring.
HIV Pretest/Posttest Counseling
Pretest and posttest counseling are critical components of
HIV programs in correctional facilities.  There may have
been uncertainty about the meaning of the 1994 survey
questions regarding HIV prevention counseling.  The ques-
tions were intended to refer to ongoing prevention counsel-
ing, but many systems probably answered in terms of pretest
and posttest counseling.  Over half of all correctional
systems reported providing HIV counseling in all of their
facilities.  Sixteen percent of State/Federal systems and 13
percent of city/county systems report that less than 50
percent of their facilities are providing counseling.  On
average, 78 percent of facilities in State/Federal and city/
county systems are reportedly providing counseling.
Pretest and posttest counseling should be provided on an
individual basis.  However, many correctional systems
simply do not have sufficient staff to offer individual pretest
counseling and therefore conduct this counseling in groups.
It is absolutely essential that posttest counseling be given
individually, and almost all correctional systems report this
to be their policy.  However, as with confidentiality, policy
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Table 21
POLICIES REGARDING DISCLOSURE/NOTIFICATION OF INMATES’
 HIV ANTIBODY TEST RESULTS, 1994a
aFigures include systems that specified the conditions under which disclosure/notification to certain parties could be made
(e.g., only with inmate consent and/or on a “need-to-know” basis) and systems that did not specify these conditions.
bMost systems view notification of residential or work placements as falling in the domain of parole agencies/divisions.
cThis category includes public agencies, courts, and other parties unspecified by responding systems.
Source: NIJ/CDC Questionnaire Responses.
Inmate/Patient 51 100 % 29 100 %
Attending Physician
or Health Care Worker 50 98 26 90
Other Medical Staff
(community or correctional) 36 74 19 66
Correctional Management—
Central Office 20 39 6 21
Correctional Management—
Institution 16 31 9 31
Correctional Officers (security) 4 8 4 15
Public Health Department 40 80 21 72
Spouse/Sexual Partner(s) 30 59 13 45
Needle-Sharing Partner(s) 19 37 7 24
Assault Victims of Inmate
(in community and/or in prison/jail) 17 35 10 38
Parole Agency 10 20 2 7
Residential Placementb 6 12 0 0
Work Placementb 0 0 0 0
Otherc 12 24 10 34
Parties To Be Notified During
Incarceration and/or at
Release According to Policya
U.S. State/Federal U.S. City/County
Prison Systems Jail Systems
(N=51) (N=29)
Number of Number of
Systems % Systems %
does not always translate into practice.  There are numerous
allegations regarding failure to conduct counseling with
inmates when tests are negative (thereby losing an impor-
tant education opportunity) and insensitive and inappropri-
ate methods of notifying seropositive inmates.
Testing for Sexually
Transmitted Diseases
Table 23 shows that the routine testing of inmates for STDs
is much more common than the screening of inmates for
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HIV.  (Routine testing means that individuals are tested
unless they specifically decline.)  Nearly 90 percent of State/
Federal systems routinely test inmates for syphilis, gonor-
rhea, and/or chlamydia.  Approximately one-third of city/
county systems conduct such testing.  Put another way, 42
of the responding State/Federal systems test all incoming
inmates for at least one of these three STDs, yet of those 42
systems, 67 percent do not screen incoming inmates for
HIV.  And while no city/county system screens for HIV
among incoming inmates, 36 percent do test for STDs.  The
wider use of routine STD testing probably results from the
faster availability of results and the greater certainty of
treatment effectiveness, as well as from the historically
lesser concern associated with making STD testing manda-
tory.  Probably because more systems conduct routine STD
testing, fewer offer STD testing on request.
Two State systems and one city/county system test males for
STDs but not females, and two State systems test females
only.  Again, this is most likely a matter of logistics.  One
of the State systems that reported testing only females
explained that inmates are usually discharged or sent to
U.S State/Federal U.S. City/County
Prison Systems Jail Systems
(N=51) (N=29)
Number of Number of
Systems % Systems %Testing Policies
Table 23
SUMMARY OF CORRECTIONAL POLICIES ON INMATE TESTING FOR STDs, 1994a
aThis table includes actual and planned policies. The categorization is not mutually exclusive.
bClinical signs or symptoms of HIV infection or AIDS.
Source: NIJ/CDC Questionnaire Responses.
Routine Screening of:
All Incoming Male Inmates 44 86% 11 38%
All Incoming Female Inmates 44 86 10 34
All Incoming Males and Females 42 82 10 34
All HIV-Positive Inmates 31 61 9 31
Voluntary/Inmate Request Testing 30 59 24 83
Available to All Inmates
Testing if Clinical Indicationsb 49 96 27 93
their housing assignments so quickly that medical staff do
not have enough time to take blood samples.  In this State
system, females are tested for syphilis because there is a
phlebotomist available who is able to draw blood on the day
female inmates arrive.
Unavoidable circumstances and logistical constraints some-
times limit the ability of correctional systems to provide
routine STD testing.  However, correctional health care
staff should recognize the public health value of providing
early detection and treatment services to incoming inmates
with histories of high-risk behavior.  At a minimum, formal
systems for referral to STD testing and treatment services in
the community should be incorporated into discharge plan-
ning.  Such measures would contribute to the protection of
public health in the larger community.
STD Notification
Eighty percent of all State/Federal systems have a policy for
notifying the sexual partners of inmates with a positive
syphilis test, 76 percent notify partners regarding gonor-
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rhea positivity, and 72 percent notify partners of positive
chlamydia tests.
City/county systems follow the same pattern of notification
for the different types of STDs.  Partners are notified most
frequently if an inmate has a positive test for syphilis (79
percent of systems), followed by gonorrhea with 75 percent
of systems reporting partner notification, and 68 percent of
city/county systems reporting partner notification for chlamy-
dia.
As with HIV notification policies, the NIJ/CDC survey
collected information on what constituted partner notifica-
tion.  Specifically included was notification by the inmate,
correctional officials, and/or public health authorities.  Of
the State systems that report STD partner notification
policies, only 2 percent leave the notification of syphilis
entirely up to the inmate.  Slightly more State/Federal
systems (8 percent) leave the notification of gonorrhea or
chlamydia up to the inmate.  Among the city/county systems
that have notification policies, 18 percent leave notification
of sexual partners up to the inmate.
The majority of systems report notification policies for
partners of inmates with STDs, yet there is still a sizable
minority of correctional systems that do not.  An inmate’s
sexual partner may be outside the correctional system and
therefore not the system’s “responsibility.”  However, noti-
fication of an STD can be an important opportunity for
education and prevention, as well as medical treatment of
partners who may be unknowingly transmitting STDs to
others in the community.  Moreover, the timely notification
of partners may result in substantial savings by avoiding
costly treatment of STD complications.
Pregnancy Testing
Forty-four percent of State/Federal systems report routine
pregnancy testing of incoming females.  This is double the
percentage of city/county systems that report pregnancy
testing.  The difference can probably be attributed to the
high turnover and short average length of stay in jails.
Pregnancy testing and HIV testing of women found to be
pregnant may become increasingly important in light of
research findings suggesting the efficacy of early interven-
tion with ZDV in preventing vertical transmission of HIV.
Moreover, STD testing and treatment of pregnant women
would result in significant reduction of adverse birth out-
comes, such as congenital syphilis.
 1. J. Diamond, “HIV Testing in Prison:  What’s the
Controversy?” (commentary), The Lancet 344 (Decem-
ber 17, 1994): 1605–1651.
 2. C. Behrendt et al., “Voluntary Testing for HIV in a
Prison Population With a High Prevalence of HIV,”
American Journal of Epidemiology 139 (1994): 918–
926.
 3. Interview with Lynn McMorrow, Northwest State Cor-
rectional Facility, Swanton, Vermont, November 8,
1994.
 4. M. L. Lachance-McCullough, J. M. Tesoriero, M.D.
Sorin, and A. Stern, “HIV Infection Among New York
State Female Inmates: Preliminary Results of a Volun-
tary Counseling and Testing Program,” The Prison
Journal 73, no. 2 (1994): 198–215.
 5. S. Florio et al., “HIV Infections in the New York City
Jails: A Voluntary Program,” Poster Abstract POC
4318, the Eighth International Conference on AIDS,
Amsterdam, July 1992.
 6. Diamond, “HIV Testing in Prison.”
Endnotes
50 1994 Update:  HIV/AIDS and STDs in Correctional Facilities
Housing and Correctional Management of Inmates with HIV/AIDS 51
Chapter 5
Housing and Correctional Management
of Inmates with HIV/AIDS
that responded to the survey segregate inmates with any type
of HIV disease.  While segregation policies have continued
to lose favor, there was some shift between the 1992–1993
and 1994 surveys from policies calling for general popula-
tion housing to those calling for case-by-case decisions.
Some of this apparent shift may be due to respondents’
uncertainty about the meaning of the categories—that is, a
policy for the presumptive general population housing of
inmates with HIV may be hard to distinguish from a policy
in which decisions are made on a case-by-case basis.  At the
same time, there may also have been some real increase in
a view that a case-by-case decision-making policy offers the
best way to address the medical and psychosocial needs of
inmates with HIV disease.
Differing interpretations of these two policy categories and/
or real discrepancies in policy between central offices and
individual facilities are apparent in the validation study
results.  In systems reporting policies for general population
housing of inmates with AIDS, symptomatic non-AIDS,
and asymptomatic HIV infection, rates of agreement for
individual facilities were 60 percent, 75 percent, and 64
percent, respectively.  Rates of agreement were even lower
for facilities in systems reporting case-by-case housing
decisions for these categories of inmates—33 percent, 24
percent, and 17 percent.
The real complexity of policies regarding housing and
programming for inmates with HIV—particularly in large
systems with HIV-infected inmates in multiple facilities—
is well illustrated by the situation in the California State
correctional system.1  A 1990 consent decree in the case of
Gates v. Deukmejian, which had challenged the State’s
policy of segregating all known male HIV-infected inmates
in a closed wing at California Medical Facility, Vacaville,
established a pilot program of partial integration for se-
lected inmates.2  These inmates continued to live in a
This chapter discusses issues regarding the managemen  of
inmates with HIV/AIDS, including housing policies, work
assignments, availability of conjugal visits, early and com-
passionate release, and discharge planning.
Housing Policies
Since the first NIJ survey was conducted in 1985, there has
been a marked trend away from policies calling for the
segregation of inmates with HIV infection and AIDS.  Table
24 shows the steady decline in the number of State/Federal
prison systems reporting the segregation of inmates with
AIDS and asymptomatic HIV infection.  In 1985, 38 (75
percent) of the prison systems reported segregating inmates
with AIDS, and 8 systems (16 percent) reported segregating
inmates with asymptomatic HIV (then called HTLV-III)
infection.  By 1994, the numbers had shrunk to 4 and 2
systems respectively.
This change resulted from a steady erosion of the view that
segregation represents an effective and prudent method of
preventing the transmission of HIV.  At the same time,
alleviation of the earlier levels of hostility and even hysteria
surrounding inmates with HIV disease has rendered it much
more feasible for them to be housed in the general popula-
tion of correctional facilities.
The same two State prison systems, those in Alabama and
Mississippi, that had reported segregating all known HIV-
infected inmates in 1992–1993 still reported such a policy
in 1994.  Alabama’s segregation policy is the subject of a
continuing lawsuit, as discussed in chapter 7.
Housing policies reported by prison and jail systems in 1994
for inmates with AIDS, symptomatic non-AIDS, and
asymptomatic HIV infection are summarized in Table 25.
This table shows that none of the city/county jail systems
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separate wing but could participate in educational and work
programs with the general population of the facility.  The
pilot program was to be monitored and expanded or adjusted
based on performance.
Over time, a dual system has been established at Vacaville
and San Quentin, with open units (separate housing and
integrated programming as in the original pilot program)
and closed units (continued separate housing and program-
ming).  Inmates with documented histories of high-risk
behavior (i.e., participation in anal intercourse, oral sex, or
assault involving potential blood exposure to another) within
the past year and those for whom there is “reasonable cause
to believe” they will engage in such behaviors are excluded
from assignment to an open unit.3  At Vacaville and San
Quentin there is no full integration of known HIV-infected
inmates into the general population, although there are
believed to be numerous inmates whose infection is not
known to the correctional department and who remain in
general population housing and programming.  The
plaintiff’s attorneys in the Gates case have not fought to end
segregated housing for HIV-infected inmates at Vacaville,
because the vast majority of the affected inmates wanted this
to continue.  The lead attorney asserted that this is because
the inmates with HIV feel safer being housed in the separate
wing and believe they benefit from a stronger internal
support system there.  They are satisfied with this arrange-
ment as long as they can have access to programs in the
general population.
At the men’s prison at San Luis Obispo, by contrast, known
HIV-infected inmates live in the general population, but
most are double-celled together.  The prison authorities will
not knowingly assign an HIV-infected and non-HIV-in-
fected inmate to be cellmates.
Finally, at the women’s prison at Frontera, all three condi-
tions exist—that is, closed unit, open unit, and general
Table 24
DECLINE OF SEGREGATION POLICIES IN STATE/FEDERAL SYSTEMS (N=51),
1985–1994
Years
1985 8 16 % 38 75 %
1986 8 16 30 59
1987 5 10 41 80
1988 6 12 20 39
1989 4 8 16 31
1990 4 8 9 18
1992/1993 2 4 5 10
1994 2 4 4 8
Source:  NIJ/CDC Questionnaire Responses
       Systems With Segregation Policies
HIV-Infected Inmates     Inmates With AIDS
Number of Number of
Systems % Systems %
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population housing.  In the California case, in other words,




In most instances, inmates with HIV who live in the general
population or have access to general population program-
ming are eligible for all work assignments and other pro-
grams.  However, some types of program assignments have
continued to be controversial.  In California, participation
of HIV-infected inmates in four types of programming—
work furloughs, medical services jobs, family visits, and
food service jobs—remained at issue at the time of the
agreement on housing units.  Subsequently, the correctional
department allowed HIV-infected inmates to participate in
work furloughs and work in medical services jobs but has
remained firm in its opposition to family visits and food
service work assignments.
Indeed, the assignment of inmates with HIV to food service
work has continued to provoke controversy in a number of
systems.  In Arizona, a Federal district court ruled out the
exclusion of HIV-infected inmates from food service as-
signments as a violation of the Federal Rehabilitation Act,
but this decision was subsequently overturned by the Circuit
Court of Appeals on technical grounds.4  In California, by
contrast, the correctional system’s exclusion of HIV-in-
fected inmates from food service jobs was upheld by the
Ninth Circuit Court of Appeals.  There was agreement
regarding the lack of evidence of HIV transmission through
food, but the court still accepted the correctional department’s
position that assigning HIV-infected inmates to food ser-
vice jobs might lead to prison riots and abuse of those
inmates.  The Circuit Court’s ruling overturned an earlier
district court opinion on the issue of food service work
assignments.5
Policies that exclude HIV-infected inmates from food ser-
vice jobs or force them to eat on disposable dishes contradict
and undermine educational messages.  If educational pro-
grams stress that HIV is not contracted through casual
contact, including food and utensils, then inmates will
question the necessity of excluding HIV-infected persons
from food service jobs.  Likewise, they may wonder why
disposable plates and utensils are used.  Such concerns may
lead to a mistrust of the correct educational messages and
breed fear about the casual transmission of HIV.  These
policies may also break the confidentiality of HIV-infected
inmates.  Inmates can quickly deduce that anyone refused a
food service job or forced to use disposable utensils is HIV
infected.6
Conjugal Visits
Conjugal visits are available to inmates in only eight State/
Federal prison systems (16 percent).  No city/county jail
systems reported making conjugal visits available to in-
mates.  In those with conjugal visit programs, five (10
percent of all State/Federal systems) make these visits
available to HIV-infected inmates.  In 1991, the New York
State correctional system, in a policy reversal, opened
conjugal visits to HIV-infected prisoners.  As noted above,
HIV-infected inmates in California continue to be excluded
from conjugal visits.  In Louisiana, inmate HIV peer
educators have argued that instituting conjugal visits would
reduce the sexual tension that leads to homosexual contact
in prisons and often to high-risk sexual activity among
inmates.7
Early and Compassionate Release
It has commonly been argued that since inmates in the
advanced stages of AIDS and other terminal illness pose
little threat to the community, they should be afforded early
release so that they can return to their families and commu-
nities and not be forced to die in prison.  The 1994 NIJ/CDC
survey reveals that 31 State/Federal prison systems (61
percent) and 11 responding city/county jail systems (38
percent) have policies for early or compassionate release,
and 19 State/Federal systems (37 percent) and seven city/
county systems (24 percent) have policies for medical
furlough of such inmates.  A total of 214 inmates in 22 State/
Federal systems and 131 inmates in nine city/county sys-
tems have been reportedly released under such policies.
The generally hard-line political climate regarding the
treatment of criminals and publicity surrounding crimes
committed by inmates who were released through various
programs have contributed to the difficulty of implementing
and taking full advantage of early release programs for
terminally ill inmates.  In Massachusetts, a medical parole
bill was vetoed by the Governor even though it included
strong requirements for certification that the inmate to be
released pose no threat to the community.
At the same time, revisions to the New York State medical
parole bill adopted in the spring of 1994 render that
provision more likely to be used.  The original legislation
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required a physician to make a judgment that the inmate was
unlikely to commit further crimes if released.  Very few
physicians were willing to make such a nonmedical judg-
ment.  Under the legislative revisions, the physician is asked
only to make a medical judgment that the prisoner’s illness
is terminal and results in severe restrictions on his or her
ability to self-ambulate.8  Over 50 New York State inmates
with AIDS or other terminal illnesses were released on
medical parole during 1994, as opposed to a total of only 6
through January 1993.  There is no evidence that any of
these individuals committed serious crimes following their
release.
In Maryland, as part of a comprehensive discharge planning
program (discussed below), inmates with HIV/AIDS are
identified for expedited medical parole, and their cases are
coordinated by a special staff of case managers and a nurse
consultant.  Under this program, the number of inmates
receiving medical parole increased from 8 in 1991 to 23 in
1993.  None of the inmates released on medical parole has
been reincarcerated for violent crimes.9
Discharge Planning
There may be a temptation on the part of correctional
authorities to reduce their medical services costs by seeking
the release of inmates with AIDS and other illnesses.
Regardless of how or when inmates with HIV/AIDS are
released from prisons and jails, however, it is essential that
comprehensive discharge planning be done so that inmates
are connected with services they need in the community.
Eighty-two percent of State/Federal systems and 55 percent
of responding city/county systems reported providing dis-
charge planning for inmates with HIV/AIDS.  Table 26
shows the services reportedly offered by correctional sys-
tems as part of the discharge planning process.  Between 49
Table 26
DISCHARGE PLANNING SERVICES, 1994
U.S. State/Federal Prison Systems U.S. City/County Jail Systems
(N=51) (N=29)
Appointment Appointment
Referral Made Made Referral Made Made
Number Number Number Number
Services of Systems % of Systems % of Systems % of Systems %
Medicaid/Related 36 71% 13 25% 13 45% 4 14%
Benefits
CD4 Monitoring 33 65 12 24 13 45 4 14
Therapeutic
Medications 35 69 12 24 14 48 6 21
Substance Abuse
Treatment 25 49 7 14 14 48 6 21
Ongoing HIV
Counseling 35 69 9 18 14 48 5 17
Psychosocial Support 32 63 8 16 14 48 4 14
Source: NIJ/CDC Questionnaire Responses.
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and 71 percent of State/Federal systems report making
referrals, depending on the category of service, whereas
only 16 to 25 percent of systems report making actual
appointments for releasees to obtain these services.  Per-
centages are lower for both discharge planning referrals and
arrangement of appointments in city/county systems.  Expe-
rience shows that the more extensive the prerelease plan-
ning and arrangements, the greater the likelihood of follow-
through by releasees.
Actual facility-level performance may have even more
shortcomings than indicated by reported system-level poli-
cies.  The validation study reveals that 62 percent of
facilities in systems with policies to provide discharge
planning reported actually providing such services.  More
than one-third of these facilities reported not providing
discharge planning despite their central office’s policy that
it be done.  A New York inmate interviewed for this study
stated that this discharge planning was not occurring in
some facilities despite a systemwide policy that facility
parole officers help inmates with HIV/AIDS secure their
benefits for medications (ADAP) and SSI prior to release.
However, the inmate reported significant recent progress in
discharge planning at his facility, especially for those
inmates involved in an HIV support group led by the
Catholic chaplain.10
A number of correctional systems have initiated special and,
in some cases, quite innovative programs to improve dis-
charge planning for inmates with HIV/AIDS.  The Health
Resources and Services Administration (HRSA) has funded
a number of these programs under the Special Projects of
National Significance (SPNS) component of the Ryan White
Care Act.  These programs seek not only to improve the
process of discharge planning before inmates are released,
but also to improve follow-through and continuity of care
once they return to the community.  Examples of these
programs are provided below.  A key to success in many of
these programs is collaboration among correctional sys-
tems, academic institutions, and medical centers in the
community.  The most successful programs also appear to
be those that do not limit their assistance to medical
treatment but attempt to address the full range of human and
social service program needs of the client.  These may
include housing, employment training and placement, drug
treatment, and other services.  In general, the more the
releasee can be helped to make the transition to life in the
community, the less chance he or she will commit further
crimes and return to prison.
Rhode Island
Rhode Island’s discharge planning program involves the
correctional department, Miriam Hospital, and Brown
University.11  The program is staffed by part-time nurses
who seek to provide full evaluation and discharge planning
services for all HIV-infected inmates beginning at least
three months prior to their discharge.  The program also
monitors and follows up on individuals’ status and progress
once they leave prison.  In its first year of operation, the
program provided services to 68 percent of HIV-infected
inmates at the Rhode Island Adult Correctional Institution.
Most of those inmates not reached had very short sentences.
The prerelease evaluation in Rhode Island includes needs
assessment and arrangements for medical care, substance
abuse treatment, finances, housing, family support, child
care, and employment.  The discharge planning staff have
established an extensive network of organizations in the
community willing to provide services to releasees.  Under
an arrangement with Miriam Hospital/Brown University, it
is often possible for these releasees to be cared for by the
same physicians who treated them in prison.  Housing and
substance abuse services have posed particular challenges,
but the program has established important linkages with a
range of residential and outpatient treatment agencies as
well as with housing services.  Sunrise House is a particu-
larly important linkage, providing long-term housing and
supportive services for releasees with HIV who have no
families or others with whom they could live.
An indication of the effectiveness of the Rhode Island
program comes from a comparison of short-term recidivism
rates for participants and nonparticipants.  Among women
with HIV infection, 12 percent who had received discharge
planning services returned to prison within six months,
whereas 27 percent of those who had not participated in the
program were back in prison within six months.
Maryland
In Maryland, medical case management is provided for
inmates with HIV/AIDS beginning three to six months
before their release.12  Through this process, inmates are
qualified for medicaid, SSI, and other benefits before they
r turn to the community.  The case management staff
prepare and submit necessary paperwork while the inmate
is still incarcerated.  Moreover, the Maryland program has
used the U.S. Department of Housing and Urban
Development’s Housing for People with AIDS (HPWA)
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program to locate subsidized housing for a number of
releasees.13  Housing is often a particularly difficult problem
for inmates with HIV/AIDS returning to the community,
many of whom do not have families willing to take them in.
Connecticut
In collaboration with Yale University Medical School, the
Connecticut correctional system has instituted a range of
new programs for inmates with HIV/AIDS.14  One program
seeks to improve discharge planning and follow-up for
female HIV-infected inmates at Niantic who are returning
to the New Haven area.
An investigation of barriers to follow-up on referrals re-
vealed problems with long waiting lists for methadone
maintenance and other substance abuse treatment and
delayed eligibility for medicaid and other benefits, as well
as releasees’ reluctance to contact agencies in the commu-
nity unless they had been personally introduced to them
prior to release.  The Interfaith AIDS Network received a
contract to conduct discharge planning and follow-up for
women inmates with HIV/AIDS about to be released to New
Haven.  A case manager from Interfaith AIDS Network
visits Niantic several times each week to meet with inmates
scheduled for release.  The case manager works with the
inmates to expedite the process of qualification for medicaid
and other benefits, to make appointments for medical
treatment on the outside, and to find resources for substance
abuse treatment, if appropriate.  The case manager then
follows up with inmates after they are released to ensure that
they make appointments.
Among women involved with the program, rates of keeping
appointments and following through on referrals have been
quite high.  Ninety-eight percent of the women kept initial
medical appointments, and 77 percent were still under
regular medical treatment six months after their release.
Rates of successfully obtaining methadone maintenance
and some other services were not as high, but the program
has clearly helped many HIV-infected women to obtain
better support and care in the community.
Federal Bureau of Prisons
At its Lexington, Kentucky, medical facility for women, the
Federal Bureau of Prisons has undertaken a broad collabo-
rative program with the University of Kentucky Medical
Center and the national network of AIDS Education and
Training Centers (AETC’s) funded by the U.S. Public
Health Service.15  Using this network, female inmates with
HIV/AIDS nearing release from Lexington are linked with
medical providers in the communities to which they will
return.  The AETC’s refer releasees to providers in these
communities.  The prison medical staff then communicate
with the providers to ensure continuity of treatment and
care.  In some instances, referral providers have been able
to enroll releasees in experimental treatment protocols.
Cook County (Chicago), Illinois
Discharge planning may be even more challenging in city/
county jails where lengths of stay are generally short and
turnover rates are high.16  However, several large jail
systems have undertaken efforts in this area.  In Cook
County, Illinois, case managers from Cermak Health Ser-
vices meet with inmates and make referrals.  Because of
caseload and short stays, referrals are often made after the
inmate is released.  Necessary medical records on the
inmate are then forwarded to the referral provider.  Case
managers also work to contact releasees who received HIV
antibody tests in jail but had not yet been informed of their
results prior to their release.
San Francisco
Each releasee from San Francisco jails receives a packet
containing condoms, bleach, alcohol swabs, and printed
HIV prevention and referral materials.17  But inmates are
“not just dumped onto the streets,” according to Ralle
Greenburg, director of the Forensic AIDS Project of the
city’s public health department.  The program also provides
extensive case management services for HIV-infected in-
mates in the city’s jails.  These services include community
linkages for inmates being released.  Placement and refer-
rals for medical and psychosocial services are offered, and
jail-based case managers often continue to work with the
inmates after they return to the community.
Self-Help Materials
Discharge planning for inmates with HIV/AIDS is lacking
or inadequate in many correctional facilities.  Moreover,
even where prerelease planning is adequate, there may be
insufficient support and follow-up once inmates return to
the community.  To address this need, the AIDS in Prison
Project of the Osborne Association in New York City has
provided some simple written guidance and offers ongoing
assistance and support for former inmates with HIV/AIDS.
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The written guidance suggests prerelease steps (e.g., ar-
ranging housing, obtaining necessary identification papers,
applying for medical and other benefits, and obtaining
support and case management services) and provides spe-
cific information on organizations and resources that can
help inmates make these arrangements.  The guidelines also
outline first steps for former inmates to take once they are
released: report to your parole officer; find a case manager;
maintain sobriety; and remain calm and be assured “that
things will work out with patience and persistence.”18
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Chapter 6
Medical Care and Psychosocial Services
The provision of medical care and psychosocial services for
inmates with HIV disease continues to pose challenges for
correctional systems as the numbers of inmates requiring
services increases and the pressure on budgets is height-
ened.  In the face of escalating costs and caseloads in HIV/
AIDS and other health problems, many correctional sys-
tems are turning to contracted services and managed care
approaches.1  Some argue that inmates with HIV disease
remain seriously underserved and are often treated with
cruelty and insensitivity.2  There continue to be allegations
of prisoners with AIDS being relegated to the “care” of
untrained, incompetent, and unconcerned staff and permit-
ted to die alone, without proper medical treatment or
supportive services.3  Others argue that many inmates are
getting more and better medical and psychosocial services
in prison than they ever got on the outside, and that although
the state of care for inmates with HIV disease still needs
improving, most correctional systems have come a long way
in the availability of medical and psychosocial services.4
There is clearly a mixed pattern, with some systems provid-
ing better levels of care than others.
Particularly challenging areas in the realm of medical and
psychosocial services, beyond escalating caseloads and
budgetary pressures already cited, include ongoing avail-
ability of therapeutic drugs, regular high-quality primary
and specialty care (and the proper mix of these services),
care for AIDS dementia and other neuropsychological
manifestations of HIV disease, case management, follow-
up and continuity of care, hospice care, access to clinical
trials and experimental therapies, and appropriate nutri-
tional supplements.  Important aspects of adjunctive and
psychosocial services include ongoing counseling and sup-
port, as well as substance abuse treatment.  The Correctional
Association of New York has offered a series of policy
proposals for improving medical care for inmates with HIV/
AIDS.  These include the following:
• Standardized medical care policies and protocols.
• Independent quality assurance.
• Delivery of care by departments of health or private
providers.
• A primary health care model.
• Expanded resources and support for correctional health
care.
• Minority, multilingual, and multicultural health staff.
• High quality of women’s health care.
• Access to AIDS-related clinical trials.
• Training in neuropsychological symptoms.5
Availability of
Prophylactic and Therapeutic
Drugs for Inmates with HIV Disease
The availability of zidovudine (ZDV) to inmates continues
to be widespread in correctional systems throughout the
United States.  The 1994 NIJ/CDC survey reveals that ZDV
is available in all responding correctional systems (table
27).  The Food and Drug Administration and the Public
Health Service have recently softened the recommendation
that ZDV be prescribed when the CD4 count is 500 or below
and suggested instead that ZDV be an option in cases where
the CD4 count is 200–500, with case-by-case determination
based on the CD4 count trend and other clinical indications.
Fifty-five percent of State/Federal systems and 31 percent of
responding city/county systems use a CD4 count of 500 or
below as their criterion for ZDV administration.  Thirty
percent of State/Federal and 34 percent of city/county
systems listed “other” criteria for ZDV administration,
including relying on physicians’ orders and offering the
drug to all patients with symptoms or all with HIV infection.
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U.S. State/Federal U.S. City/County
 Prison Systems  Jail Systems
(N=51) (N=29)
Number of Number of
Systems % Systems %
Table 27
PROVISION OF ZIDOVUDINE FOR INMATES, 1994a
51 100% 29 100%
28 55% 9 32%
0 0 0 0
0 0 0 0
1 2 3 10
3 6 2 7
4 8 5 17
15 30 10 34
Zidovudine Offered
Eligibility Criteria
CD4 (T-4) count < 500
CD4 (T-4) count < 400
CD4 (T-4) count < 300–250




aIncludes systems with policies under revision.
Source: NIJ/CDC Questionnaire Responses.
Although still less common in correctional care than ZDV,
other antiretroviral drugs have increased in availability to
inmates with HIV/AIDS.  Table 28 summarizes the avail-
ability of other drugs for inmates with HIV disease.  The
drug ddI is offered by 86 percent of State/Federal systems
and 96 percent of responding city/county systems.  It is most
commonly used when the patient is resistant or intolerant to
ZDV, or when ZDV produces no clinical improvement.
DDC is also most commonly used when the patient is
resistant or intolerant to ZDV, when the CD4 count is 500
or lower with symptoms, or simply at the recommendation
of the physician.  Although the 1994 survey reveals that
DDC is fairly widely available, 24 percent of State/Federal
systems and 18 percent of responding city/county systems
do not offer this therapy to inmates with HIV disease.
Bactrim/Septra, a now more commonly used prophylactic
than aerosolized pentamidine for Pneumocystis carinii
pneumonia, appears to be most often used when the patient’s
CD4 count is 200 or less (42 percent of State/Federal and 37
percent of city/county systems).  This prophylactic therapy
is available in 96 percent of State/Federal systems and in
all but one responding city/county system.
Access to Experimental
Therapies and Clinical Trials
Access to both clinical trials and experimental therapies is
still limited in prisons and jails.  Just over one-quarter of
State/Federal systems (28 percent) offer experimental
drugs to inmates with HIV disease (a 10 percent increase
over 1992–1993), and only three of the responding city/
county systems offer such access.  The low rate of access in
jail systems no doubt relates to the high turnover in these
facilities.  As in 1992–1993, only six State/Federal systems
(12 percent)—Maryland, New York, Texas, Ohio, Vir-
ginia, and the Federal Bureau of Prisons—reported having
inmates in clinical trials, most commonly Phase II and
Phase III efficacy trials.  While a number of other systems
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Table 28
PROVISION OF SELECTED DRUGS FOR INMATES, 1994
U.S. State/Federal U.S. City/County
 Prison Systems  Jail Systems
(N=51) (N=29)
Number of Number of
Systems % Systems %
51 100% 29 100%
49 96% 28 97%
39 76 22 82
44 86 26 96
14 28 3 12






Inmate Participation in Clinical Trials
Source: NIJ/CDC Questionnaire Responses.
permit inmate participation in trials, such participation
often poses logistical difficulties, and involves additional
cost.  Inmate subjects must sometimes adhere to compli-
cated regimens and must be transported to outside medical
centers for follow-up appointments.
Psychosocial and
Supportive Services
Some organizations working with prisoners with HIV cite
an ongoing lack of “regular, sympathetic and compassion-
ate treatment” in correctional facilities.6  These organiza-
tions also cite reductions in resources for psychosocial
services as widespread and detrimental, particularly to
inmates with HIV disease.  Budget cuts often hit psychosocial
and support services particularly hard.  The increasingly
common contracting out of medical care and related ser-
vices for inmates sometimes results in cutbacks in indi-
vidual counseling, support groups, and other psychosocial
services.
Eighty percent of State/Federal systems report that correc-
tional medical staff or public health personnel provide at
least some HIV counseling.  Nevertheless, the fact that so
few survey responses described in detail a well-organized
psychosocial support program is reason to be skeptical
about the adequacy of these services.  The number of
correctional systems with full-time specialized counselors
serving HIV-infected inmates is still low.
While the availability of specialized professional staff to
provide psychosocial and support services is low, the avail-
ability of peer counselors remains very low as well.  Table
29 shows that only 16 State/Federal systems (31 percent)
and 3 city/county systems (10 percent) reported having HIV
peer counselors.  While lack of professional credentials and
restrictions on inmate activities have been cited as obstacles
for peer counseling programs in prison, this area merits a
closer look.  It may represent a cost-effective method of
dealing with caseloads.  Moreover, a wealth of creativity,
resources, and commitment is often found in peer counse-
lors.  Research evidence suggests that peer counselors
working in community-based outpatient drug treatment
and HIV outreach programs, when given proper training
and supervision, have been effective not only at counseling,
but also at developing creative interventions, as well as
maintaining long-term participation.7
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Support groups represent another important part of
psychosocial services to inmates with HIV/AIDS.  HIV
support groups conducted by correctional staff are report-
edly offered in 67 percent of State/Federal systems and 22
percent of responding city/county systems; peer-led support
groups are reported by 39 percent of State/Federal systems
and 11 percent of responding city/county systems.  Finally,
56 percent of State/Federal systems and 43 percent of
responding city/county systems offer HIV support groups
led by outside organizations.
Validation study results suggest that many individual facili-
ties may fail to provide the support groups reported as policy
by the central offices of their systems.  One-half to two-
thirds of facilities in systems reportedly providing support
groups said that they did not in fact offer such groups (table
30).
An examination of requests for technical assistance adds
further weight to the perception that there is a need to
improve the availability, diversity, and quality of psychosocial
and supportive services for inmates with HIV disease.
About one-third of the systems responding to the survey
indicated an interest in technical assistance on HIV coun-
seling.
Ongoing supportive services are particularly important to
prisoners with HIV disease (and other serious illnesses)
who may be experiencing serious psychological difficulties
associated with their condition and high levels of stress
related to dealing with such illness in a correctional setting.
Stress can be particularly devastating for patients with HIV
disease.  A large body of research points to illness-related
stress as having a major negative impact on the immune
system.8  Arguably, strategies to help inmates with HIV
disease cope with their illness might be as important as
access to therapeutic and prophylactic drugs.  While
psychosocial and supportive services are proven tools for
helping people with stress, survey responses suggest they
are far from well established in prisons and jails.  Despite
the low cost and standardization of stress management
programs, very few correctional systems reported having
such programs.
“Buddy” programs have been developed by AIDS service
organizations in the outside community to provide support
for persons living with AIDS.  A similar approach holds
promise for inmates with AIDS.  Buddy programs for
inmates with AIDS are being developed in Massachusetts
prisons and by the inmate peer program in the Oregon State
Penitentiary.
If they cannot be released to die in the community, prisoners
in the terminal stages of AIDS or other diseases may benefit
from the availability of hospice care within correctional
facilities.  This is now offered in the Florida State system,
and others, including New York, are considering it.
16 31% 3 10%
20 39% 3 11%
34 67 6 22
28 56 12 43
Table 29
SUPPORTIVE SERVICES FOR INMATES WITH HIV/AIDS, 1994
U.S. State/Federal U.S. City/County
 Prison Systems  Jail Systems
(N=51) (N=29)
Number of Number of
Systems % Systems %Services Provided
HIV Peer Counselors Available
Inmate Peer-Led Support Groups
Staff-Led Support Groups
Support Groups Led by Outside
   Organizations
Source: NIJ/CDC Questionnaire Responses.
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Drug Treatment
The dramatic increase in correctional populations dur-
ing the past 12 years has been fueled by the mass
incarceration of drug users.  At least some incarcerated
drug users find ways to continue their drug use behind
bars.
Increasingly stringent mandatory sentencing provisions
and persistently serious levels of substance abuse in the
community will likely sustain the increase of the correc-
tional population in general and of the number of drug-
involved inmates in particular.9  In this context, the
provision of effective drug treatment remains both a
challenge and an opportunity for correctional systems.
As in the case of HIV education and prevention, correc-
tional systems have ongoing access to large numbers of
individuals in need of treatment and, by providing
effective treatment, could help reduce relapse and recidi-
vism rates.  As the drug-using population increases,
however, the resources needed for drug treatment, and
psychosocial and medical services will also continue to
increase.
Based on survey responses from 34 State/Federal sys-
tems, a median of 70 percent of male inmates were
estimated to have histories of drug use other than mari-
juana.  Based on responses from 32 State/Federal sys-
tems, a median of 71 percent of female inmates had
histories of drug use other than marijuana.  Among 17
city/county systems, a median of 80 percent of male and
female inmates were estimated to have used drugs other
than marijuana.
Although various drug treatment modalities may be found
in correctional settings, the 1994 survey requested informa-
tion on only two:  residential (separately housed within the
correctional institution) treatment and ambulatory counsel-
ing.  Responses to the 1994 NIJ/CDC survey reveal that
more than 48,000 inmates are participating in either resi-
dential treatment or ambulatory counseling in 37 State/
Federal systems.  This figure represents only 5 percent of the
total reported incarcerated populations of these systems,
very low given the estimated prevalence of pre-incarcera-
tion drug use among inmates.
About 5,800 city/county inmates in 16 systems were re-
ported to be in residential or ambulatory treatment.  This
represents 4 percent of the inmate populations of these
systems.  The low percentage in jail systems is partly a result
of short stays in such facilities.
These figures suggest a continuing serious shortfall in drug
treatment services in correctional facilities.  However, it is
clear that some correctional systems offer access to high-
quality drug treatment.  Information on the methods uti-
lized by these systems to provide quality drug treatment may
be useful so that they can be replicated elsewhere.  In
general, more systematic communication and sharing of
strategies and modalities of substance abuse treatment
would be useful.
 Systems in VS   Facilities in VS
With This Policy in These Systems % in Agreement
Inmate-Led Peer Counseling Support Groups 7 18 33 %
Staff-Led Support Groups 10 26 42
Support Groups Led by Outside Agency 7 15 53
Table 30
SUPPORTIVE SERVICES FOR
INMATES WITH  HIV/AIDS:
Results of the Validation Study (VS)
Source: 1994 NIJ/CDC Questionnaire Responses.
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Massachusetts:  A New
Approach to Drug Treatment in Prison
Massachusetts has established a stress management and
relaxation program for substance abusers in five of its
prisons.10  Admission to the program is based on a formal
application process.  This program is modeled after the
nationally recognized Stress Reduction Clinic at the Uni-
versity of Massachusetts (UMass) Medical Center.  The
program is administered by UMass medical center staff
trained under Dr. Jon Kabat-Zinn, founder of the Stress
Reduction Clinic and author of the best-selling book Full
Catastrophe Living.  The UMass Medical Center program
was profiled in the PBS documentary Healing and the Mind
with Bill Moyers, for its unique capacity to help people
control and even overcome chronic health problems for
which standard biomedical science has provided no an-
swers.
The program is conducted in a group setting.  Groups meet
twice a week for 1½ to 2 hours.  The average group consists
of 16 inmates.  Those in attendance are substance abusers,
and staff estimate that about 40 percent are also HIV
positive and that many more are at high risk for HIV
infection.
The correctional version of this program runs in ongoing
cycles of six months.  Each inmate-participant takes the
whole six-month cycle once and graduates with the tools to
deal with stress and achieve relaxation and “centering” for
the rest of his/her life.  Each cycle consists of three stages of
eight weeks’ duration.  There is a one-week “vacation”
between stages.  At the end of the whole cycle, participants
may be reclassified to lower security or join the general
population if they had been in segregated housing.
In the prison setting, the program strives to address some of
the same issues it tackles in the hospital setting:  to help
inmates work with their addiction, disease, and stress, as
well as to assist in developing healthy coping mechanisms
and control of specific and nonspecific pain.  This is done
by teaching inmates how to use meditation, breathing, and
specific yoga-type exercises to focus the mind.  The Stress
Reduction Clinic program is referred to as “mindfulness-
based stress reduction.”  In addition, it seeks to guide
inmates through the difficult and painful process of coming
into contact with feelings they have been avoiding most of
their lives.
According to George Mumford, project director for the
Prison Program at the Massachusetts Department of Cor-
rection, the intention is to provide inmates with the “oppor-
tunity to learn how to respond rather than react to, for
instance, anger.”  The concept of “mindfulness” is used as
the basis of this program, and that concept is defined as
“moment-to-moment awareness” and a process of recogniz-
ing “the consequences of our actions . . . by learning how to
pause and make [healthy] choices.”
The Department of Correction program has been in place
since 1992 and has graduated over 1,500 inmates.  It reports
changes that include “reductions in violence, relapse, an-
ger, antisocial behavior, and especially a sense of health.”
Mumford adds that “stillness and quietness [in meditative
practice] seems to improve [not only] the emotional life but
the immune system and reduce problems associated with
idle time in the prison setting.”
Meditation programs in prisons are not new, but this one
seems particularly effective.  The UMass Medical Center
has collected data suggesting that “the majority of people
[involved in this program] report lasting decreases in both
physical and psychological symptoms . . . pain levels also
improve and people learn to cope better. . . .  The majority
also report an increased ability to relax, greater energy and
enthusiasm for life, improved self-esteem and an increased
ability to cope more effectively with both short- and long-
term stressful situations.”  (Since they are not based on a
controlled study, these data should be considered suggestive
rather than conclusive evidence of program effectiveness.)
The cost-effectiveness of such programs is also appealing.
At the UMass Medical Center, the cost of this program for
the general public is over $600 for a three-month program
cycle.  In contrast, the correctional system’s relaxation and
stress management program is estimated to cost about $250
per inmate for a six-month program cycle.  The lower cost
in the correctional setting is attributed in part to an inter-
agency agreement providing a “bulk” price for large num-
bers of inmates.
The same program is also accessible to correctional manag-
ers and officers in Massachusetts.  According to Mumford,
it is important to make this type of program available to
correctional staff, because “if they understand and experi-
ence what we are doing they will be in a position to help us
improve the program for everyone.”
Endnotes
 1. Douglas C. McDonald, Managing Prison Health Care
and Costs (Washington, D.C.: National Institute of
Justice, May 1995).
65Medical Care and Psychosocial Services
 2. Interview with Anne Braudy, staff attorney, Massachu-
setts Correctional Legal Services, November 17, 1994.
 3. See, e.g., Judy Greenspan et al., “Struggle for Compas-
sion: The Fight for Quality Care for Women With AIDS
at Central California Women’s Facility,” Yale Journal
of Law and Feminism 6 (Summer 1994): 383–395.
 4. Interview with Tim Gagnon, contract manager for HIV/
AIDS Correctional Programs,  AIDS Bureau, Massa-
chusetts Department of Public Health, December 2,
1994.
 5. AIDS in Prison Project, Correctional Association of
New York, “National Policy Agenda Covering Prison-
ers and Former Prisoners Living With AIDS/HIV in the
U.S.,” draft, 1994, pp. 6–7.
 6. Interview, Amy Montgomery, SPAN, Inc., Prison to the
Community Programs, Boston, November 10, 1994.
 7. Abt Associates Inc., unpublished data, 1995.
 8. See, e.g., M. A. Chesney and S. Folkman, “Psychologi-
cal Impact of HIV Disease and Implications for Inter-
vention,” Psychiatric Clinics of North America 17
(March 1994): 163–182.
 9. See, e.g., U.S. General Accounting Office, “Drug Treat-
ment:  State Prisons Face Challenges in Providing
Services,” Report to the Committee on Government
Operations, U.S. House of Representatives, September
1991, GAO/HRD-91-128.
10. The following discussion is based on an interview with
George Mumford, director of the Prison Program, the
Stress Management Clinic, University of Massachu-
setts Medical Center, November 15, 1994; and (pro-
gram brochure), University of Massachusetts Medical
Center, Stress Reduction Clinic, Department of Medi-
cine, Division of Preventive and Behavioral Medicine.




Although courts continue to come to different conclusions
about the rights of inmates and policies for housing, correc-
tional management, and medical care for HIV-positive
inmates, several general principles are emerging.  While
segregation of asymptomatic HIV-infected inmates appears
to be on the decline, courts generally continue to uphold
correctional systems’ housing policies as well as prohibi-
tions against food service and other work assignments for
those found to be HIV positive or to have other infectious
diseases.  The courts have also sought to tackle the question
of the right of inmates to live free from the risk of contract-
ing HIV or other physical injury.  In Farmer v. Brennan, the
U.S. Supreme Court articulated the duty of prison officials
to protect prisoners from assault by other inmates.1
The following sections review recent legal developments
related to HIV/AIDS in correctional settings.
Issues Raised by Inmates
In 1993–1994, new cases brought by prisoners have chal-
lenged policies and practices regarding protection from
harm by fellow inmates, mandatory and other HIV antibody
testing, confidentiality, segregation and housing assign-
ments, access to programs, and medical care.
Protection From Harm by Fellow Inmates
What may turn out to be the first case arising from inmate-
to-inmate transmission of HIV involves Christopher
Clugston, a convicted murderer recently released from a
Florida prison after being granted clemency by Governor
Lawton Chiles.  Clugston, who spent 10½ years in prison,
claims he was infected with HIV during a gang rape while
incarcerated.2  However, Clugston has yet to file any formal
legal action embodying this allegation.
Prisoners at risk of sexual attack that could expose them to
HIV infection can turn to the courts for relief under the
Eighth Amendment by bringing suit under 42 U.S.C. §
1983 against the responsible officials or government enti-
ties.3  Perhaps the most significant case to come before the
courts in recent years with relevance to HIV/AIDS in
prisons is Farmer v. Brennan, 114 S. Ct. 1970 (1994),
mentioned above.  The U.S. Supreme Court’s ruling in
Farmer may help to define further the obligation of correc-
tions officials to protect prisoners from injury at the hands
of fellow prisoners.  On June 6, 1994, the high court ruled
that prison officials may be found liable for failing to protect
an inmate from violence at the hands of other prisoners if the
officials did not act when they knew of a “substantial risk of
physical harm.”4  The Court’s 9-0 ruling came in the case
of a transsexual Federal prisoner whose suit against prison
officials had been dismissed by two lower Federal courts in
Indiana.  The ruling gave the prisoner a chance to show at
trial that the beatings and rapes he suffered were the result
of prison officials’ “deliberate indifference” to his need for
special protection.  In a case three years ago, the court made
deliberate indifference the governing standard for lawsuits,
asserting that prison conditions were so far below accepted
standards as to amount to cruel and unusual punishment.5
The Farmer case, which clearly established the duty of
prison officials to protect inmates from fellow inmates as
well as from officers, still requires a showing by the prisoner
that the officials knew of the risk and failed to take reason-
able measures to prevent injury to the prisoner.  However,
an inmate can prevail without proving that he or she had
warned officials of a particular threat or that officials
believed that harm was about to befall a particular inmate.
Circumstantial evidence can suffice to demonstrate that
officials had the requisite knowledge, and the judge or jury
“may conclude that a prison official knew of a substantial
risk from the very fact that the risk was obvious.”6
The Farmer ruling, together with a 1993 Supreme Court
ruling that the involuntary exposure of prison inmates to
secondhand tobacco smoke can amount to cruel and unusual
punishment, is of potential importance to HIV-positive
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inmates who risk physical violence at the hands of fellow
inmates and to those who may be infected with HIV through
a rape in prison.  While the Farmer ruling does not make it
easier for prisoners to win such cases, it makes it more
difficult for the government to have the suits dismissed at an
early stage.7
Challenges to Mandatory Testing
Connor v. Foster, 833 F. Supp. 727 (N.D. Ill. 1993),
involved an arrestee who alleged that he was involuntarily
tested for HIV after his arrest, in part because one of the
arresting officers had been pricked during the arrest by a
hypodermic needle in the plaintiff’s pocket.  The court ruled
that there was no clearly established right to refuse an HIV
test under these circumstances, and Illinois statutes autho-
rized the test.
In considering the plaintiff’s claim, the court ruled that
State law explicitly sanctioned the testing of the arrestee.
Effective January 1, 1990, Illinois amended its statutes to
dispense with the need for written informed consent to
conduct an HIV test,
when a law enforcement officer is involved in the
line of duty in a direct skin or mucous membrane
contact with the blood or bodily fluids of an
individual which is of a nature that may transmit
HIV as determined by a physician in his medical
judgment.8
The arrestee had admitted being a drug user and that the
arresting officer stuck himself on the hypodermic needle the
arrestee had used shortly before he was arrested.  The court
ruled that because the puncture suffered in conducting the
search clearly contained the potential for transmission of
HIV, under Illinois law, no written consent was needed to
force the arrestee to undergo a blood test to determine the
presence of HIV antibodies.
Other Testing Policies
On April 19, 1994, the Federal Court of Appeals for the
Sixth Circuit ruled that the constitutional rights of a Ken-
tucky prisoner were not violated when he was refused HIV
antibody testing by correctional authorities for more than
two years because he did not meet the State’s testing criteria
for prisoners.9  In Doe v. Wigginton, 21 F. 3d 733 (6th Cir.
1994), the Court of Appeals for the Sixth Circuit upheld a
Federal district court decision denying the inmate plaintiff’s
request for an HIV antibody test on admission to prison.  The
prison’s policy restricted testing to persons presenting
clinical symptoms including a “presumptive history of
exposure” or pregnancy combined with a history of injec-
tion drug use, prostitution, or sexual activity with an
injection drug user.  Subsequently, the plaintiff asked for
and received a test based on his statement, later disavowed,
that he had “slept with” a number of drug-addicted prosti-
tutes.  The plaintiff then tested positive.  Later, an officer
opened the plaintiff’s medical file, which had been stamped
“confidential,” and discussed his HIV-positive status pub-
licly.
Considering the initial failure to test, the appeals court ruled
that the prison’s HIV testing policy does not constitute
deliberate indifference because it reflects the likelihood of
infection.  The defendants did not deliberately decide to
reduce the plaintiff’s life expectancy; although their actions
were deliberate, they did not know their actions would have
that effect.  The court also found that the testing policy does
not violate prisoners’ right to equal protection because
testing “rationally furthers” a legitimate State interest and
no cases have suggested that persons who do not have a
“presumptive history of exposure” to HIV are a “suspect
class.”10
Finally, the appeals court ruled that the disclosure to the
officer of the plaintiff’s HIV status does not violate the
plaintiff’s right to privacy.  In its decision, the Court of
Appeals relied on a 1981 Sixth Circuit case holding that the
disclosure of juveniles’ “social histories” does not violate
the right of privacy and that the Constitution “does not
encompass a general right to nondisclosure of private
information.”11
In Lile v. Tippecanoe County Jail, 844 F. Supp. 1301 (N.D.
Ind. 1992), a case brought pro se (by an inmate without
assistance of counsel), a Federal district court in Indiana
found that inmate plaintiffs’ rights were not violated by a
jail’s failure to provide inmates with HIV antibody tests
after they were splattered with the blood of a fellow inmate
who tried to commit suicide.
Litigation over whether a State court can order the HIV
antibody testing of a prisoner who bites a guard continues
to be a matter of lively debate before the State courts.  On
August 5, 1994, the Illinois Appellate Court for the Fourth
District upheld a ruling of the Circuit Court of Livingston
County ordering that a prisoner be tested for HIV despite the
opposition of the Illinois Department of Corrections to the
test.  In a 2-1 decision, the court stated that while it is not the
duty of the courts to supervise the day-to-day operations of
prisons, the issue at hand is not a case where a court attempts
to direct what meals should be served or what hours should
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be kept.  And, in a concurrence to the majority, a justice
wrote, “This case has nothing to do with the operation of a
place of incarceration; it involves proper information to a
victim of a wrongdoing.”12  Jane Doe, a corrections officer
at the Dwight (Ill.) Correctional Center, was bitten twice by
an inmate.  Doe had alleged that a first test of the inmate was
inadequate and had asked the trial court to direct the
Department of Corrections to conduct a second test.
Anderson v. Murdough, No. 1:92-2694-17BD (D.C.S.C.),
a Federal district court case from South Carolina, consid-
ered the HIV antibody testing of those convicted of criminal
sexual conduct.  In Anderson, a pro se plaintiff who had
been convicted of the kidnapping and rape of a convenience
store operator contended that his Fourth Amendment con-
stitutional rights were violated when he was forced to
undergo a blood test ordered by a State circuit judge.
Citing a similar decision in State v. Farmer, 805 P. 2d 200,
208 (Wa. 1991), in an order dated October 23, 1993, the
Anderson court noted that testing under this statute applies
only when a person has been convicted of a crime involving
sexual battery that exposed the victim to the convicted
person’s bodily fluids and, “where there is a legitimate
compelling State interest.”13  The court’s order further
stated:
The obvious purpose for the statute is to protect
victims of criminal sexual conduct from becoming
unknowing carriers of the HIV virus.  The statu-
tory scheme addresses the problem of awareness of
HIV for the protection of those to whom the virus
may have been transmitted.  If, therefore, a defen-
dant is convicted of such criminal sexual conduct,
a quick determination of whether he or she is
infected with the HIV virus is important so the
victim may be then tested and may take appropri-
ate action.  Thus, the statute’s testing requirement
serves an obvious and compelling “special need.”
Public safety and the magnitude of danger justifies
the minimal invasion of Anderson’s rights.14
Confidentiality
The confidentiality of HIV antibody test results has also
been the subject of litigation within and outside the prison
context.  In Doe v. City of New York, 825 F. Supp. 36
(S.D.N.Y. 1993) (Doe I), a Federal district court in New
York held that “the constitutional right to privacy does not
extend to matters of public record.”15  The case considered
the disclosure at a press conference of the plaintiff’s HIV-
positive status by officials of the New York City Commis-
sion on Human Rights.  The district court held that while the
disclosure may have violated a contract (i.e., a conciliation
agreement), there was no violation of the Constitution.  The
only Federal issue before the district court in Doe I involved
the constitutional right of privacy.
In Doe v. City of New York, 15 F. 3d 264 (2d Cir. 1994) (Doe
II ), the Federal Appeals Court for the Second Circuit
reversed the district court opinion in Doe I holding that
“individuals who are infected with the HIV virus clearly
possess a constitutional right to privacy regarding their
condition.”16  The Doe II court wrote that “this was a right
to ‘confidentiality,’ rather than autonomy and indepen-
dence in decision-making.” “. . . The right to confidentiality
includes the right to protection regarding information about
the state of one’s health.”17  The plaintiff’s entry into a
conciliation agreement on his discrimination claim filed
with the City Commission on Human Rights did not consti-
tute a waiver of his privacy rights.  While this case did not
involve an inmate or correctional setting, it raises important
issues regarding disclosure of HIV status.
In another recent case, the Court of Appeals for the Tenth
Circuit ruled that disclosure that a person is HIV positive is
a breach of confidentiality even if subsequently it is deter-
mined that the test result was incorrect.  In reversing and
remanding a decision of the Federal district court for the
District of Utah, the court of appeals in A.L.A. v. West
Valley City, No. 92-4210 (10th Cir. 1994), ruled that
disclosure by a police officer who arrested the plaintiff for
passing a bad check “severely damaged the plaintiff’s
personal life.”18  During the arrest of the plaintiff at a mall
for passing a bad check, the arresting officer found a piece
of paper in the plaintiff’s wallet indicating that he had tested
positive for HIV.  Later, at the police station, the arresting
officer told the plaintiff’s sister, two housemates, and at
least one other witness that the plaintiff was HIV positive.
As a result, according to the plaintiff, his friends and family
shunned him and refused to visit him in jail.  His fellow
prisoners and the prison guard subjected him to harassment
and discriminatory treatment, and he had to undergo treat-
ment for depression while in jail because of the damage done
to his familial relationships.  The plaintiff was particularly
distraught because his relationship with his mother had
suffered irreparable damage.  In its decision, the court wrote
that an HIV test later conducted in jail showing the plaintiff
free from infection was “simply immaterial to the question
of whether the plaintiff sustained a personal injury as a
result of the broadcasts.”
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The needs of corrections staff to protect themselves from
HIV-positive prisoners may, however, permit the release of
a prisoner’s HIV-positive status by prison officials.  For
example, in Selby v. Rapping, 1992 WL 400739 (S.D.N.Y.
1993), a Federal district court in New York State rejected a
prisoner’s claim that his rights had been violated by the
disclosure to a guard and a doctor that he had AIDS.  The
inmate, a Westchester County Jail prisoner, had been sent
to Westchester County Medical Center for care.  His medi-
cal records included the language “body fluid precaution,”
and when he arrived at the hospital, a prison guard told the
treating physician that the inmate had AIDS.
In its decision, the court rejected the inmate’s argument that
only the medical unit at the jail was allowed to know he was
HIV positive.  The district court judge also ruled that the
State’s confidentiality law allows prison staff and doctors
treating prisoners to know a prisoner’s HIV status if there
is a need.19
Segregation and Housing Assignments
Prisoner petitions and lawsuits concerning the segregation
of HIV-positive inmates continue to be quite common, with
the courts generally, but not universally, issuing rulings
upholding correctional policies.  The trend in prisons
appears to be to desegregate, or mainstream, HIV-positive
prisoners.  To date, however, there has been no definitive
case upholding this policy.
HIV-positive inmates may seek to challenge their segrega-
tion, confinement, and limits on their right to prison jobs
and activities as a violation of a State’s human rights act.
Citing a lack of evidence, in Todd Balow v. Minnesota
Department of Corrections, No. PS00916 (1992), the Min-
nesota Department of Human Rights dismissed an HIV-
positive inmate’s complaint alleging that he was subjected
to differential treatment on the basis of his HIV status.
While the case presented evidence to indicate that a prison
work supervisor had made a remark about the inmate’s
HIV-positive status and that as a result other inmates
avoided the inmate, the department found insufficient evi-
dence to make a determination as to who was responsible
and how information on the inmate’s HIV status was
leaked.  In its decision, the department further stated that
even if the supervisor breached the confidentiality of the
inmate’s medical condition, this breach alone may not be
actionable under the Minnesota Human Rights Act, unless
accompanied by the intent to discriminate.20  Finally, the
department’s ruling notes that the evidence shows the
supervisor was “lenient” with the inmate with respect to
disciplinary action (segregation).21
Derby v. Allison, Civil No. 4-93-CV-10160 (S.D. Iowa), a
Federal district court case from Iowa, involves an HIV-
infected inmate’s civil rights action alleging that Iowa
prison officials violated his constitutional right to privacy,
equal protection, free exercise of religion, and access to the
courts when they ordered the inmate medically segregated
from the general population.  The inmate, Arthur Derby,
was diagnosed as HIV positive in 1987.  By June 6, 1991,
when he reported to the Iowa Medical Classification Center
(IMCC), Derby had AIDS.
In accordance with the communicable disease policy of the
Iowa Department of Corrections, Derby was not initially
segregated from the general population.  Under the policy,
inmates with communicable diseases such as AIDS are
housed in the general population unless they act in such a
way as to heighten the risk of transmission to other inmates.
Initially, Derby, a minimum-security inmate, was sent to a
medium-custody prison so that he could complete the drug
and alcohol program available there.
In December 1992, Derby received a report for having
sexual contact with another inmate and for soliciting sex
from others.  In response to the health risk posed by this
behavior, the Department of Corrections’ nursing director
began an investigation of the matter which involved an
interview with the inmate and a group interview with twelve
inmates who may have had sex with Derby.  Based upon a
determination that Derby had engaged in sex with another
inmate and the fact that Derby had two infectious diseases—
AIDS and hepatitis B—Derby was placed in medical segre-
gation.  Having determined that this was the best method of
reducing the risk of the spread of HIV by Derby, the inmate
was transferred to the Iowa State Penitentiary (ISP) for the
remainder of his term.
At ISP, Derby was not allowed to attend chapel services,
visit the law library, and eat or exercise with other inmates.22
Derby also alleged that ISP guards violated his constitu-
tional right to privacy by telling fellow inmates that he had
AIDS.  He further alleged that a red medical segregation tag
and infectious disease protocol posted on his cell violated
his right to privacy and led inmates to threaten him out of
fear of his illness.
Instructed to make recommendations to the district court
hearing the case, a Federal magistrate issued a ruling
generally supportive of the actions of prison officials.  The
magistrate’s report recommended the following findings:
• Defendants did not violate Derby’s rights by
transferring him because an inmate has no
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constitutional right to a particular prison clas-
sification or status.
• Concerning Derby’s challenge to defendants’
decision to place him in medical segregation,
the administrative segregation in this instance
was not a pretext for punitive segregation and
Derby received sufficient due process.23
• Since the Supreme Court has held that in-
mates do not have an absolute right to partici-
pate in rehabilitation programs,24 Derby’s
rights were not violated by his transfer out of
a facility with an alcohol and drug treatment
program.
• Concerning Derby’s allegation that he was
segregated because he is homosexual and
afflicted with AIDS, there is no merit to
Derby’s equal protection challenge.  Derby
posed a health risk because of the danger of
transmission of HIV through solicited sexual
contact.  He was not similarly situated to the
inmate population to which he compares him-
self.
• Derby has not proven that unnamed guards
told inmates about his AIDS status.
The magistrate also rejected Derby’s claim that section 504
of the Rehabilitation Act was violated, finding that the
defendants transferred him not solely because he had AIDS,
but also because of his sexual behavior.  As to Derby’s
claims that his right to freedom of religion and access to the
courts were violated, the magistrate found no evidence that
his rights were substantially burdened or actually infringed.
Finally, the magistrate recommended that the district court
reject most of Derby’s claims with respect to a consent
decree covering inmates’ rights in Iowa prisons.25
Following the release of the magistrate’s recommendations
in October 1994, the plaintiff sought additional time to
respond and object to the report.
Goss v. Sullivan, 839 F. Supp. 1532 (D. Wyo. 1993), a
Federal district court case from Wyoming, involved a
plaintiff inmate assaulted by another inmate who, he al-
leged, was HIV positive and who deliberately sought to
make blood-to-blood contact.  In his pleadings, the plaintiff
conceded that the failure to segregate an HIV-infected
prisoner from the general population or to disclose the
results of HIV antibody tests to the general population does
not violate the Constitution.  The district court ruled that
since the plaintiff failed to show any evidence that any
defendant was or is aware of any risk of spreading HIV by
his assailant or any other prisoner, he failed to establish
deliberate indifference.  The court noted:
Allegations of a generalized fear of contracting
AIDS from allegedly aggressive HIV-positive in-
mates and conclusory allegations that prison offi-
cials were or are aware of such intentions but have
done nothing to intervene, are insufficient to state
a constitutionally inhumane condition of confine-
ment or a culpable state of mind.26
In Johnson v. United States, 816 F. Supp. 1519 (N.D. Ala.
1993), a Federal district court in Alabama ruled that placing
the plaintiff in a cell with an HIV-infected inmate did not
violate the Eighth Amendment prohibition against cruel
and unusual punishment. Johnson involved an inmate’s
action against the Federal Bureau of Prisons and prison
officials alleging a violation of his Eighth Amendment
rights against cruel and unusual punishment in that his
former cellmate tampered with his toothbrush, toothpaste,
and razor blade.  In addition, the plaintiff claimed that on
several occasions, he observed his cellmate’s blood on their
sink, toilet, and towels.  Although the plaintiff did not allege
that he contracted HIV from sharing facilities with his HIV-
infected cellmate, he fears he may have contracted HIV from
him.  In addition, Johnson complained that he was subjected
to witnessing his cellmate’s deteriorating condition and
that during the two days prior to his cellmate’s death, he was
forced to feed and “sanitize” him.  At the time of the court’s
decision, the plaintiff had tested negative for HIV three
times since the cellmate’s death.
In its decision, the Johnson court wrote that “to establish an
Eighth Amendment claim, the evidence must show that the
measure taken inflicted unnecessary and wanton pain and
suffering . . . or was totally without penological justifica-
tion” and that prison officials were deliberately indifferent
to a condition of confinement which constitutes cruel and
unusual punishment and further requires a showing of a
culpable state of mind on the part of prison officials.  The
court also stated that the plaintiff is further required to show,
first, that the conditions to which he is subjected constituted
a deprivation of minimal civilized measures of life’s neces-
sities or basic human needs, and second, that the prison
official’s state of mind was one of deliberate indifference to
the needs of the plaintiff.27
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In its decision, the court cited the declaration of Dr. Kenneth
Moritsugu, the medical director of the Federal Bureau of
Prisons:
The Bureau of Prisons does not segregate HIV-
positive inmates.  HIV-positive inmates remain in
an institution’s general population as long as they
do not require hospitalization.  The Bureau’s
emphasis on education, universal precautions, and
professional management of HIV-positive inmates
has rendered isolation unnecessary. . . .  Inmates
who are HIV-positive and who are believed to put
other inmates or employees at risk (e.g., those who
display intentional behavior that can result in the
spread of the virus) are administratively separated
from those whom they place at risk.
All Bureau of Prison inmates are informed of ways
to avoid contracting AIDS. . . .  Policy and train-
ing stress that individuals must respond to the
presence of blood, semen, vaginal fluids, or any
body fluids containing visible blood under the
presumption that these fluids are contaminated.
Inmates are informed that casual contact will not
result in exposure to the virus. . . .
An inmate can have an HIV-positive roommate
and not be at any risk of contracting the virus
unless the inmates engage in high-risk behav-
ior. . . .28
The Johnson court reasoned that as the prison rules prohibit
the types of behavior that result in the transmission of the
HIV virus, those prisoners who follow the rules are not in
significant danger of contracting HIV infection.  Therefore,
prison officials’ policy decisions not to segregate the HIV-
infected inmates cannot be said to constitute deliberate
indifference.  The plaintiff had not been deprived of any
basic need by the prison officials’ actions.  The plaintiff
alleged neither that his former cellmate had engaged in
high-risk conduct that would expose him to HIV nor any
facts from which it might be inferred that the decision to
house an HIV-infected inmate with the plaintiff evidenced
a deliberate indifference to his serious medical needs or a
culpable state of mind on the part of the defendants.
Marcussen v. Brandstat, 836 F. Supp. 624 (N.D. Iowa
1993), a Federal district court case from Iowa, involved an
inmate’s complaint that he was double-celled with an HIV-
positive prisoner who used his toiletries, including his
razor, cigarette roller, and drinking cup.  In its ruling, the
court held that the plaintiff would have to show a “pervasive
risk of harm to inmates” to prevail.29  The plaintiff did not
show sufficient risk of contracting HIV through the kinds of
everyday contact he alleged, and prior case law rejects any
requirement that HIV-positive inmates be segregated.  The
court went on to say that prison rules prohibiting inmates
from acting so as to expose others to infection provide
sufficient protection to uninfected inmates.  In addition,
noted the court, qualified immunity generally shields “gov-
ernment officials performing discretionary functions from
liability for civil damages so long as their conduct does not
violate clearly established statutory or constitutional rights
of which a reasonable person would have known.”30  In any
case, the defendants would be entitled to qualified immu-
nity.
Similarly, in Camarillo v. McCarthy, 998 F. 2d 638 (9th
Circuit 1993), the Federal Court of Appeals for the Ninth
Circuit ruled that the defendants were entitled to qualified
immunity from the plaintiff’s claim that he was denied
freedom of association by virtue of being transferred to a
unit for HIV-positive inmates.  While it was established that
prisoners have First Amendment association rights, the
“relevant, properly particularized question” before the court
was whether it was clearly established that “inmates are
entitled to be free from prison regulations that restrict their
association with members of the general prison popula-
tion.”
Zaczek v. Murray, No. 91-6098, 1992 U.S. App. LEXIS
33993 (4th Cir. 1992), involved a Federal prisoner’s appeal
of a district court’s dismissal with prejudice of his complaint
alleging he was falsely arrested, falsely imprisoned, and
maliciously prosecuted.31  The prisoner filed numerous
successive and repetitive motions in spite of admonitions
from the court, arguing in part in his lengthy pleadings that
corrections officials violated his rights by not conducting
mandatory HIV antibody testing of prisoners and segregat-
ing infected inmates.
In his district court pleadings, the plaintiff, Zaczek, con-
tended that the defendants failed to protect him from a
known risk of infection with HIV because they failed to
conduct mandatory HIV antibody testing and failed to
segregate inmates infected with the virus.  The plaintiff
further claimed that the defendants had violated both statu-
tory and constitutional protections through their actions.  In
support of the statutory claim, Zaczek cited Virginia Code
Section 53.1-34 (Michie 1991), but the court rejected that
argument noting that the State code section cited pertains
only to local jails and Zaczek was incarcerated in a State
prison.
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Zaczek also claimed that failure to segregate inmates in-
fected with HIV constituted deliberate indifference to his
health and safety.  While acknowledging that it had not
addressed the issue of  the segregation of prisoners infected
with the virus, the district court noted that several other
courts had already taken up this issue.
After distinguishing a line of cases that, in light of chal-
lenges to prison decisions to segregate inmates with the
AIDS virus, authorized segregation or other precautionary
treatment of infected inmates as a permissible exercise of
the discretion accorded to prison officials, the court went on
to reject the plaintiff’s claim,32 comparing the facts in
Zaczek to other cases in which courts have denied requests
for the mandatory segregation of inmates with AIDS.  One
of these cases, Glick v. Henderson, 855 F. 2d 536 (8th Cir.
1988), involved claims similar to those brought by Zaczek.
In Glick, a prisoner contended that prison administrators’
failure to segregate inmates infected with HIV from the
general prisoner population constituted a failure to protect
the health and safety of noninfected inmates.  The Glick
court held that the complaint did not state a claim of
deliberate indifference, because the plaintiff did not show a
pervasive risk of contracting the virus, and that his claims
were based on “unsubstantiated fears and ignorance.”33  The
Zaczek decision reads as follows:
Although some courts have upheld prison offi-
cials’ decisions to undertake mandatory testing
and segregation, . . . cases dealing with this issue
all have one basic premise in common: each of the
courts relied heavily on prison administrators’
exercise of discretion.  We hold that under this
reasoning, the district court’s rejection of Zaczek’s
claims regarding inmates infected with the AIDS
virus was correct.  Therefore, we affirm the . . .
judgment in favor of the Defendants.34
Access to Programs
In Gates v. Rowland, No. 93-15363, 93-16136, D.C. No.
CV-87-01636-LKK (9th Cir. 1994), the Federal Court of
Appeals for the Ninth Circuit ruled that a district court had
improperly ordered prison officials to allow HIV-positive
inmates to work in prison food service.35  The ruling comes
in a case that considered a class action lawsuit by prison
inmates challenging conditions of confinement at the Cali-
fornia Medical Facility at Vacaville, California.  In the
district court case, the inmates claimed that staffing short-
ages and overcrowding at Vacaville had exposed them to an
unconstitutional risk of harm.  The inmates further alleged
that the denial of access to medical and mental health care
and to attorneys, and the segregation of HIV-positive in-
mates violated their constitutional rights.  A subclass of
HIV-positive inmates also alleged violation of section 504
of the Federal Rehabilitation Act of 1973.  Section 504
provides that
“[n]o otherwise qualified individual with a disabil-
ity . . . shall, solely by reason of her or his disability,
be excluded from the participation in, be denied
the benefits of, or be subjected to discrimination
under any program or activity receiving Federal
financial assistance.36
Following settlement negotiations, which began after two
months of trial in the district court, the parties approved a
consent decree that stated that the defendants must review
the staffing levels at Vacaville to determine whether they
were adequate to providing proper supervision, escorts, and
other services to inmates.  The consent decree also provided
that the defendants would develop a pilot program to
determine the feasibility of desegregating HIV-positive
inmates.  When the defendants submitted their report, the
plaintiffs disputed its findings and a mediator was brought
in to resolve differences between the parties.
With respect to the prison’s policy regarding HIV-positive
inmates, after reviewing the policy and after an evidentiary
hearing on the matter, the mediator recommended that the
court prohibit the defendants from denying food service
employment to HIV-positive inmates, absent a written
determination that an individual inmate was not otherwise
qualified to perform the job and that the defendant could not
reasonably accommodate the inmate so that he would be
able to perform the essential function of the job.  The district
court adopted these findings and held that the policy of
excluding HIV-positive inmates from food service violated
the Rehabilitation Act.
In Gates, the relevant issue before the appeals court was how
the Rehabilitation Act was to be applied in a prison setting.
Reasoning that there is no reason to believe Congress
intended the Rehabilitation Act to apply to prison facilities
without regard to the reasonable requirements of effective
prison administration, the appeals court deemed the appli-
cable standard for the review of the act (statutory rights) in
a prison setting to be equivalent to the review of constitu-
tional rights in a prison setting.  That standard, set forth in
Turner v. Safley, 482 U.S. 78 (1987), reads as follows:
[W]hen a prison regulation impinges on inmates’
constitutional rights, the regulation is valid if it is
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reasonably related to legitimate penological inter-
ests.37
In reversing the district court on the issue of exclusion of
HIV-positive inmates from work in food service, the appeals
court stressed the particular sensitivity of prisoners to food
service, which had often been the source of violence or riots.
The court noted:
The prisoners have no choice of where to eat.  The
prison authorities testified that if HIV-seropositive
inmates are placed in food service jobs, the other
inmates will perceive a threat regardless of scien-
tific research or medical pronouncements.  When
the transmission is by bodily fluids, such percep-
tions are particularly likely.  Inmates fear that
other inmates may do things to food that might be
objectionable.  If HIV-seropositive inmates are
placed in food service jobs, other inmates will
think the worst—that they will bleed into the food,
spit into the food, or even worse.  If the inmate
population perceives a risk from the food they must
eat, they will want the infected inmates removed
from the food service jobs.  If they have no assur-
ance that the infected inmates are removed, there
may be violent actions against the inmates with the
virus, inmates they perceive to have the virus, or
the staff that permits the perceived risk.38
In response to the plaintiffs’ response that proper education
concerning HIV transmission will remove the perceived
risk, the court added that the prison authorities point out
that many members of the general prison population are not
motivated by rational thought and have irrational suspi-
cions or phobias that education will not modify.  In light of
these findings, the appeals court ruled that Vacaville prison
officials had provided a reasonable basis for the exclusion of
HIV-positive inmates from food service positions.
In Casey v. Lewis, 4 F. 3d 1516 (9th Cir. 1993), an earlier
decision by the Ninth Circuit Court of Appeals that effec-
tively skirted the issue, the court ruled that a district court
in Arizona should not have enjoined a prison’s policy
prohibiting HIV-positive prisoners from working in food
service.  In relevant part, in Casey, the appeals court
considered an Arizona Department of Corrections appeal of
an order enjoining the department from denying food
service jobs to HIV-positive inmates.  In ruling for the
department, the court found that there was no evidence that
any named plaintiff was HIV positive or that any named
plaintiff had ever stated he or she was interested in a food
service job or had applied for one.  Inmates had brought the
original lawsuit under 42 U.S.C. § 1983 (1988) and section
504 of the Rehabilitation Act of 1973, 29 U.S.C. § 794
(1988).
At issue in Casey was a policy adopted by the Arizona
Department of Corrections prohibiting HIV-positive indi-
viduals from obtaining employment in its food service
department.  The inmates argued  that they had standing
(the right to sue) to challenge the validity of this policy
because a named inmate was then HIV positive and because
this inmate would have been denied had she applied for such
employment.
The Casey court rejected this argument, writing that the
HIV-positive inmate did not demonstrate any injury in fact
as she was not identified as HIV positive until three months
after the issuance of the district court’s injunctive order, and
she neither applied for a food service position nor demon-
strated that she intended to do so.  Nor did the record in the
case establish that any named plaintiff was seropositive.
Therefore, found the court, the class of inmates lacked
standing and the district court lacked the power to enter the
injunction.  Even if a named inmate had been identified as
HIV positive as early as the pleading stage, the inmates still
failed to demonstrate an actual injury.  No named plaintiff
has ever stated that he or she was interested in a food service
job.  None applied for one, and there was reason to believe
that an HIV-positive inmate would never seek such a
position.  The unrebutted affidavit of the chief of security at
the Central Unit in the Florence, Arizona, facility, indicated
that whenever inmates discovered that another inmate was
HIV positive, which according to the official occurs despite
stringent confidentiality efforts by Arizona Department of
Corrections’ staff members, threats were made against that
inmate’s life.  According to the official’s affidavit, an HIV-
positive inmate whose seropositive status was discovered by
the general inmate population would be in a life-threatening
situation.  Declaring that no named plaintiff had been
personally subject to the alleged unlawful policy, the ap-
peals court ruled that the district court lacked jurisdiction to
enter the injunction prohibiting the application of the
policy.
In Williams v. Hill , No. 94-2399 (E.D. Pa. 1994), a 1994
Federal district court case from the Western District of
Pennsylvania, the court threw out the case of an HIV-
positive inmate who alleged that his constitutional rights
were violated when he was denied a job as a “block worker”
doing general duties at the prison.  In granting the defendant’s
motion for dismissal, the court found that neither the U.S.
Constitution nor any Federal statute guarantees an inmate
the right to a prison job because he is HIV positive.
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Onishea v. Herring, a Federal case from Alabama, consid-
ers the question of whether HIV-positive prisoners are
“otherwise qualified” under section 504 of the Rehabilita-
tion Act of 1973 or could become so through reasonable
accommodation, and thus be able to participate in more
prison activities.39  Section 504 of the Rehabilitation Act
applies to persons with contagious diseases, and using these
guidelines, courts have held that persons who are HIV
positive are handicapped persons to whom section 504
applies.40  These issues were left unresolved by the ruling in
Harris v. Thigpen, 941 F. 2d 1495 (11th Cir. 1991), an
Eleventh Circuit Federal Appeals Court case that upheld the
Alabama Corrections Department’s regulations requiring
the HIV-antibody testing of inmates and the segregation of
those found to be HIV positive.  Onishea considers the issues
remanded to the district court by the appeals court’s deci-
sion in Harris v. Thigpen.  The court in Harris v. Thigpen
also directed the district court to reconsider whether the lack
of adequate access to the prison law library by HIV-infected
prisoners denies them their right of access to the courts, thus
violating the First or Fourteenth Amendment.
Adequacy of Medical Care
Prison litigation continues to focus on the adequacy of
medical care and associated services for prisoners with HIV
and AIDS.  In Jose Otero v. Larry Dubois, C.A. No. 93-
6712 (Suffolk Superior Court), an HIV-infected Massachu-
setts inmate incarcerated in New Hampshire alleged that he
was not provided the same level of care and treatment
provided to other HIV-infected Massachusetts inmates in-
carcerated in-State.  Defendants in the case have filed a
motion to have the case thrown out as lacking merit.  A
decision on the motion is pending.
Criminal Indictment
and Sentencing of
Persons With HIV Infection
Sentencing of Persons with HIV/AIDS
Whether and how the judicial system should consider HIV
infection in its processing of persons accused and/or con-
victed of crimes remains a challenging question for the
Nation’s criminal and appellate courts.  Conflicting rulings
appear largely related to the nature of the crime committed
and to the nature of the defendant’s illness.  For example,
while in recent years several courts have considered not
prosecuting, or commuting the sentences of, defendants
with HIV or AIDS who have been charged with or convicted
of nonviolent crimes, other crimes like having unprotected
sex with teenagers are treated quite severely.  In one such
nonviolent offender case, New York v. Larson (App. Div.,
1st Dept. 1993), a majority of the Appellate Division of the
New York Supreme Court, First Department, affirmed a
lower court’s dismissal of indictments against a man in-
dicted for drug dealing.  In its decision, the Appellate
Division noted that at the time the trial court announced the
dismissal, the court had noted that “the defendant’s physi-
cal condition had progressively deteriorated during the
pendency of the prosecution to the point that the defendant
had become as thin as a rail and could hardly stand.”41  The
Appellate Division went on to note that the alleged crimi-
nality had been motivated by the suspect’s need to feed his
addiction, and since that addiction was now being ad-
dressed in treatment, there was little risk of recidivism and
no danger posed to the community.
In contrast, many courts are quite harsh in dealing with
HIV-positive individuals who engage in unprotected sex.
For example, in May 1994, in the case of Virginia v. Webb,
No. F-796-93 (Petersburg Cir. Ct. 1994), a Petersburg,
Virginia, court sentenced a 28-year-old HIV-positive man
to 10 years in prison for knowingly having unprotected sex
with three teenage girls.  Two of the girls had been infected
with HIV and one of the two was pregnant.  Although
Virginia has no legal precedent for the charges against
Webb, the State looked to legal theories from other States
where such persons have been convicted of attempted
murder or assault with a deadly weapon.42  According to the
charging attorney, Webb had known since 1988 that he was
HIV positive and “knew the importance of protected sex and
disclosure to his sexual partners.”  In spite of this knowl-
edge, the defendant continued to have unprotected sex with
multiple partners without disclosing that he was HIV posi-
tive.43
Proving intent was a concern of prosecutors in Webb
because the defendant made no statement that he intended
to kill anyone or that he intended to spread the HIV virus.
In the end, the prosecution prevailed, relying in part on a
State court of appeals decision holding that specific intent
may be shown by circumstances and facts in a particular
case.
In Arizona v. John Wayne Ellevan, 1 CA-CR 93-0754-PR
(Arizona Ct. of App., Div. One), an Arizona appeals court
ordered the resentencing of a convicted thief who is HIV
positive because his 16-year sentence amounted to life in
prison.  In its decision, the court noted, “Positive HIV status
i  material to informed plea bargaining and sentence be-
76 1994 Update:  HIV/AIDS and STDs in Correctional Facilities
cause it can transform into a life sentence a term of years that
would otherwise end well within the recipient’s probable
life span.”44  The inmate, John W. Ellevan, sought a
resentencing on his conviction after learning while in
prison that he was HIV positive.  A trial court judge had
dismissed the inmate’s petition saying that the inmate had
failed to prove that he became infected before he was
sentenced.
Rejecting the trial court’s reasoning in a unanimous deci-
sion, the Arizona Court of Appeals held that the trial court
had abused its discretion in failing to grant a resentencing.
“Of two possible alternatives,” wrote the court, “—that
petitioner was infected with HIV before or after sentenc-
ing—the evidence introduced at the hearing tended only to
support the first.”  The appeals court also noted that the
State had offered no evidence to support its assertion that the
prisoner could have become infected inside the prison.45
The appeals court decision ordered the trial judge to resen-
tence the prisoner in light of the discovery of his HIV-
positive status.
Spitting and Biting
Despite evidence that HIV has never demonstrably been
transmitted through saliva, over the last several years, at
least two HIV-infected inmates have been prosecuted and
convicted of attempted murder for biting or spitting on a
correctional officer.  New Jersey inmate Gregory Dean
Smith was serving a 5-year term for robbery when he was
sentenced to an additional 25 years in prison for biting a
correctional officer.
Texas inmate Curtis Weeks, serving a 2-year sentence for
robbery, received a sentence of 99 years or life for spitting
in an officer’s face.46  On October 11, 1994, a Federal district
court judge in Texas refused to overturn the life sentence of
Weeks.  In her order in Weeks v. Collins, D.C. S. Texas., S.
Div., No. H-93-3708 (October 11, 1994), the Federal judge
applied the Supreme Court standard that a court “must
determine whether, after reviewing the evidence in the light
most favorable to the prosecution, any rational trier of fact
could have found the essential elements of the crime beyond
a reasonable doubt.”47  That evidence, the judge noted,
included testimony that the inmate had HIV, that some
people infected with HIV have the virus in their saliva, that
blood might be in saliva because the inmate needed dental
work and had just eaten, that the virus is transmitted
through the mucous membranes, and that the inmate’s
saliva got inside the guard’s nose, a mucous membrane.
Attorneys for the inmate have already filed a notice of
appeal to the Federal Court of Appeals for the Fifth Circuit.
In Weeks v. Collins, attorneys for the inmate had urged the
district court to recommend immediate dismissal of his
“illegal, unconstitutional conviction and sentence,” saying
the State had “failed to prove an essential element of the
crime of attempted murder.”  The pleading came in re-
sponse to Texas’s motion for summary judgment in Weeks
v. Morales, D.C. S. Texas, S. Div., CA No. H-93-3708, a
case considering a writ of habeus corpus48 filed by Weeks in
November 1993.  In their brief to the court, attorneys for
Weeks argued that the State failed to prove an essential
element of the crime of attempted murder because there was
no evidence establishing that spitting by an HIV-infected
p rson can cause death.  Attorneys for Weeks further argued
that the State failed to demonstrate that Weeks acted with
the capacity to commit the offense because it failed to offer
any proof that Weeks’s saliva contained HIV.  While some
legal scholars believed that Weeks had a good argument, he
made essentially the same one before a State appeals court,
which rejected it in Weeks v. State, 834 S.W. 2d 559
(1992).49  In her ruling in Weeks v. Collins, the district court
judge also rejected the inmate’s attorneys’ request to take
judicial notice of an advisory published in the T xas Regis-
ter suggesting that biting and being bitten are not consid-
ered exposure to HIV unless blood is present.
Civil Cases Involving
Potential Exposure to HIV
In Esser v. Glens Falls Hospital, No. 26731, Appeal No.
3701 (N.Y. Sup. Ct.), on April 13, 1994, a Glens Falls, New
York, hospital filed an appeal seeking dismissal of a suit
brought against it by a corrections officer who was acci-
dently sprayed with the HIV-infected blood of a prisoner
being treated at the hospital.  The officer was standing next
to the HIV-positive inmate in the hospital’s prison ward
when he was sprayed in the face and chest with the inmate’s
blood from a syringe.  Although the officer continues to test
negative for HIV, his suit sought damages for emotional
distress and psychological injury he alleges were caused by
the accident.  At the trial court level, the judge dismissed the
defendant hospital’s motion, writing that proof is “over-
whelming of breach of duty, traumatic injury, and causal
relation between [the] contact and the resulting injury.”
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Industrial Accident Claims
In 1994, 6 industrial accident claims were filed by Massa-
chusetts Department of Correction employees who alleged
that they were either bitten or otherwise exposed to HIV by
inmates.  All of the claims have been settled, with the
department agreeing to provide temporary leave and/or
payment for HIV screening for the employees.
Cases Involving Hepatitis and
Sexually Transmitted Diseases
In the pending case of James DeFuria, et al. v. Mass. DOC,
et al., C.A. No. 92-1834, Massachusetts inmate plaintiffs
are challenging a State prison’s medical care and treatment
for hepatitis B and C.  The inmates are also seeking access
to the medication alpha interferon and to other medical
procedures and tests for all inmates with hepatitis B.
Ray Wesley Robinson v. Larry DuBois, et al., C.A. No. 93-
5144 (Middlesex Superior Court), another Massachusetts
case, involves a prison inmate’s claim that he contracted
herpes while in prison and has been denied adequate
medical treatment for his condition.  Litigation in the case
is in its early stages.
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Appendix
Biomedical and Epidemiologic Research
Developments
The period between the Ninth International Conference on
AIDS in Berlin in June 1993 and the Tenth International
Conference in Yokohama in August 1994 was marked by
increasing pessimism that dramatic breakthroughs in HIV
treatment were on the horizon.  Several developments
contributed to this shift in perspective:
• An increased appreciation for the limitations
of the drug most widely used to treat HIV
infection—zidovudine (ZDV, previously
called azidothymidine, or AZT).
• Evidence that strains of HIV emerge that are
resistant to antiviral drugs already approved
for use as alternatives to ZDV and to other
drugs earlier in development.
• Discouraging results from early studies of
vaccines to prevent HIV, which led the United
States Government not to proceed with plans
for the first large-scale trials of such vaccines.
On the other hand, an encouraging finding was that use of
ZDV by HIV-infected pregnant women after the fourteenth
week of pregnancy could reduce the likelihood that the virus
would be transmitted to their newborns.
Generally disheartening findings from clinical research led
to recommendations for increased emphasis on laboratory
investigations into the fundamental molecular mechanisms
involved in processes of HIV infection and disease develop-
ment.1  This shift in emphasis was endorsed at the summer
AIDS meeting in Yokohama by the newly appointed direc-
tor of the Office of AIDS Research, which has budgetary
authority over more than $1.3 billion in AIDS research
funding across all the institutes of the National Institutes of
Health.2  Even activist groups, who had previously called for
faster access to drugs in development, shifted to criticisms
of the Food and Drug Administration (FDA) for giving
premature approval to new drugs, coupled with calls for
more thorough clinical evaluation of drugs (both prior to
licensure and marketing and through postmarketing test-
ing).
Against this backdrop of pessimism regarding breakthroughs
in HIV treatment, the expansion and improvement of
prevention programs designed to foster and sustain reduc-
tions in HIV risk behaviors became even more important.
Uncertainties About
“Early Intervention”
In the summer of 1989, the National Institute of Allergy and
Infectious Diseases (NIAID), one of the National Institutes
of Health (NIH), reported the results of a clinical trial testing
the effects of ZDV among HIV-infected persons with rela-
tively intact immune systems—as measured by T-helper
lymphocyte (CD4+ cell) counts between 500 and 200 per
cubic millimeter.  Based on the observation that CD4+ cell
declines were delayed in persons who received ZDV, NIAID
recommended that therapy with ZDV be initiated earlier
than previously recommended:  when CD4+ counts dropped
below 500, rather than 200.  The FDA changed the labeling
indications for ZDV consistent with this recommendation.
Four years later, shortly before the international conference
in Berlin, the joint British-French-Irish “Concorde” study
showed that the initial benefits attributed to dosage with
ZDV relatively early in the course of HIV infection did not
persist.  After a year of follow-up, the drug showed no
measurable benefit in terms of slowed disease progression
among persons who began using it when they were
asymptomatic.  Overall, ZDV was not shown to delay
progression to AIDS or to prolong survival.3
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These new data led the NIH to convene the “State of the Art
Conference on Antiretroviral Therapy for HIV-Infected
Patients” in June 1993, soon after the Berlin conference.
Retreating from an unequivocal recommendation for “early
intervention” when CD4+ counts drop below 500, the
resulting guideline left it to patients and their physicians to
decide whether or not to initiate therapy for asymptomatic
patients with CD4+ counts between 500 and 200 per cubic
millimeter.  Continued monitoring without medication is
now considered an equally defensible option.  In the absence
of evidence of prolonged survival or slowed disease progres-
sion, an alternative rationale for early intervention with
ZDV might be improved quality of life.  In early 1994,
results of a study of the effect of ZDV showed that persons
assigned to receive the drug when initially asymptomatic
and with CD4+ counts above 200 experienced no fewer
clinical symptoms than placebo recipients.4
The difference between the initial clinical findings on early
intervention with ZDV and the more recent studies resulted
from the duration of the trial and the first study’s depen-
dence on “surrogate markers” of clinical improvement
rather than “clinical end points.”  The Concorde study
showed the same early benefit found in the United States
trials:  an association between ZDV and delayed decline in
helper T-cell (CD4+) counts, a laboratory “surrogate” that
was expected to predict improved clinical outcomes (such as
increased overall survival).  However, the Concorde trial
continued long enough to make direct measurements of
clinical end points, including survival, and it showed that
the initial benefit as measured by CD4+ lymphocyte counts
did not translate into prolonged survival.  Although FDA
licensure of other anti-HIV drugs has continued to be based
on the surrogate of improved CD4+ lymphocyte counts,
analysis of 16 clinical trials of ZDV and other drugs of the
same type showed that improvements in CD4+ counts do
not necessarily predict slowed disease progression or im-
proved survival rates.5
Resistance to Anti-HIV Drugs
and Therapeutic Choices
The emergence of strains of HIV resistant to ZDV had been
observed as early as 1992 and associated with clinical
observations suggesting a limited benefit for the drug when
administered over long periods of time.  Although it elicited
little comment when first published, a 1993 report described
the apparent transmission of a ZDV-resistant strain of HIV
which was associated with more rapidly progressing clini-
cal disease shortly after infection than is ordinarily ob-
served.  The promotion of early intervention in HIV infec-
tion with ZDV had meant that increasing numbers of
healthier HIV-infected persons were being encouraged to
take the antiviral drug between 1989 and mid-1993.  A
possible link between the spread of ZDV-resistant HIV
strains and more severe clinical illness associated with such
strains has important public health significance:  in effect it
could mean that a recommendation designed to reduce the
burden of disease might, over time, have had the opposite
effect by selectively favoring those strains of HIV that cause
more severe or more rapidly progressing illness.  Because
this potential concern rested on only a single case history,
it remained largely speculative.  Recently, however, a larger
series of such cases from the United States, Switzerland, and
Australia has been assembled:  among 111 newly infected
persons in the United States, 13 percent were found to
harbor an HIV strain containing a genetic marker for ZDV
resistance.  From 1988–1990 to 1993–1994, the proportion
of persons shown to harbor such strains rose from 3 percent
to 19 percent.6
In the meantime, anti-HIV treatment relies on the principle
that HIV strains resistant to one antiviral compound may be
susceptible to other drugs.  Laboratory studies and clinical
research have supported this principle.  For example,
patients whose disease progresses or who develop sustained
adverse effects after a period of six months or more of ZDV
therapy seem to benefit from switching to another drug such
as Didanosine (ddI)7 or Zalcitabine (ddC).8  In 1994,
another drug using the same basic strategy as ZDV, ddI, and
ddC, called Zerit (stavudine, or d4T), received FDA ap-
proval for use when other anti-HIV drugs prove ineffective
or toxic.9
Also during the period 1993–1994, additional data ap-
peared that supported previous analyses suggesting that
adding the antiherpes drug acyclovir to ZDV might prolong
survival.  Approximately 500 users of the two-drug regimen
survived longer than an otherwise similar group of 300
persons who used only ZDV.10  These findings from a
retrospective analysis of observational data cannot be con-
sidered definitive until a randomized, controlled, double-
blinded clinical trial is conducted.  However, acyclovir has
minimal side effects and is licensed and thus available by
prescription, so some patients and physicians are already
using it even without meeting the labeled indication for use
to treat herpes virus infection and in the absence of a
definitive trial.
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Zidovudine and Vertical (Mother-
to-Infant) Transmission of HIV
In February 1994, preliminary findings were released from
a United States/French trial designed to test whether
zidovudine (ZDV) treatment of HIV-infected pregnant
women and their newborns would reduce the rate of trans-
mission to their newborns.  While the rate of transmission
in untreated women and infants was 26 percent, in women
and infants who received ZDV it was 8 percent.11  Women
enrolled in the study were in the 14th or later week of
pregnancy and had CD4+ counts above 200, no symptoms
considered to warrant ZDV treatment, and no previous
ZDV exposure.  They received a standard dose of ZDV until
delivery and high-dose ZDV administered intravenously
during delivery; newborn infants received ZDV for the first
six weeks of life.
In August 1994, the United States Public Health Service
(PHS) released formal guidelines recommending the use of
ZDV to prevent vertical transmission of HIV.  These
guidelines extended the recommendations for ZDV use
beyond women who met the enrollment criteria specified in
the original clinical trial to those with more advanced HIV
disease and to later stages of pregnancy, at delivery, and
postpartum to the newborn infant.12  In September 1994, the
FDA changed the labeling indications of ZDV to include
administration to pregnant women for the purpose of reduc-
ing the likelihood of transmission during pregnancy or at
delivery.  Two areas of uncertainty remain regarding these
findings.
First, the long-term effects of exposure to ZDV during fetal
development will not be known for years.  In laboratory
studies, newborn rats exposed to 50 times the relative ZDV
dose administered to humans showed developmental and
skeletal abnormalities.  No toxic effects specifically associ-
ated with the ZDV dosages in the human studies have been
documented thus far in ZDV-exposed infants.  The infec-
tion rate in the placebo group in this trial and other studies
of pregnancy outcomes associated with HIV infection sug-
gest that most infants born to HIV-infected pregnant women
(in this case almost three-fourths) will not become infected
anyway:  routine use of ZDV during pregnancy therefore
would expose a majority of infants to a drug of uncertain
toxicity, so as to rescue a minority who would otherwise be
infected (in this case between 10 and 20 percent) from
perinatal exposure to HIV.  The PHS recommendations note
that long-term follow-up of all ZDV-exposed infants is
important.13
A second limitation of this study relates to the specific
circumstances of the clinical trial and its generalizability.
The group of women enrolled in the study were in the second
trimester of pregnancy, and the results therefore do not
establish a firm treatment regimen.  Given that the develop-
ing fetus may be more susceptible to drug-related adverse
effects at an earlier stage of development, the PHS recom-
mendations do not advise ZDV use earlier in pregnancy.  It
is not known whether initiation of ZDV closer to the
expected date of delivery, at delivery, or postpartum in the
newborn will reduce transmission.  The recommendations
encourage pregnant women and their physicians to consider
such uses based on the principle that a two-thirds reduction
in the rate of HIV transmission from mother to infant would
outweigh any harm less severe than malignancy or profound




The group of anti-HIV drugs that have moved from clinical
trials to marketing approval by the FDA all belong to a class
of compound called nucleoside analogs, which intervene at
the same stage in the life cycle of HIV:  the molecular
“reverse transcription” process during which the genetic
information in HIV is coded into the DNA of infected cells.
Nucleoside analogs all have limitations that restrict their
long-term usefulness, including the emergence of strains of
HIV that are drug resistant, the limited duration of benefits
as measured during clinical trials, and significant toxicity.
As a result, considerable interest has focused on non-
nucleoside drugs that inhibit the process of reverse tran-
scription, and on drugs that intervene at other stages in the
life cycle of HIV.
Among the former group, nevirapine was found to elicit the
development of resistant strains of HIV even more quickly
than the nucleoside analogs.  Clinical trials are now under-
way evaluating the efficacy of combining nevirapine with
approved nucleoside analogs such as ZDV.  Another drug
designed to slow down the process of reverse transcription
by acting on a regulatory mechanism (a “tat inhibitor”) has
shown no clinical benefit in initial trials.
Among the latter group, drugs known as protease inhibitors
are in development by a number of pharmaceutical manu-
facturers (e.g., Abbott, Hoffman-LaRoche, and Merck).14
Protease inhibitors act at the point in the life cycle of HIV
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when new viral particles are beginning to be formed.  The
deputy director of the Division of AIDS in the National
Institute of Allergy and Infectious Diseases has commented
that “after the protease inhibitors I don’t see much in drug
development.”15  Early indications are that it is difficult to
achieve high levels of these drugs in the body without
dosages so large that recipients may suffer toxic side effects,
but that in lower doses they are as effective as the approved
reverse transcriptase inhibitors.  Clinical trials of the effi-
cacy of a number of protease inhibitors will not be completed
until 1996.16
It is known already that strains of HIV can emerge that are
resistant to these drugs.  Researchers speculate that a better
understanding of the nature of “escape” mutants of HIV that
resist these compounds may provide enough information
for them to design compounds that prevent the development
of resistance.17  It is also possible that resistance to a mixture
of anti-HIV drugs would require a combination of mutations
that together would be lethal to HIV or would render it
clinically innocuous.  This possibility will be evaluated in a
planned clinical trial comparing various combinations of
drugs that, individually, elicit HIV-resistant strains.  A
novel feature of this trial is its sponsorship by a newly
formed Inter-Company Collaborative for AIDS Drug De-
velopment, a consortium of 16 major pharmaceutical manu-
facturers involved in AIDS research.18
Preventive Vaccines
In June 1994, the director of the National Institute of
Allergy and Infectious Diseases accepted a recommenda-
tion of a multidisciplinary review panel, the AIDS Research
Advisory Committee and its Subcommittee on Vaccine
Development, that the government delay large-scale do-
mestic efficacy trials of the only two candidate vaccines
currently available.19  The panel explicitly noted that its
recommendation was intended to pertain only to United
States trials and not to other regions of the world where the
intensity of the epidemic and other factors might suggest a
different weighting of the costs and benefits of conducting
an efficacy trial.  The subtype of HIV prevalent in the United
States, for which these products were developed, is also
found in the Caribbean basin and among some injection
drug users in Southeast Asia.
A subsequent meeting of scientific consultants convened by
the World Health Organization (WHO) in October 1994
reached a different conclusion, that large-scale trials of
candidate preventive vaccines “could go ahead to establish
if they can protect people from HIV infection.”20  This
recommendation represented a departure from previous
positions regarding HIV vaccine clinical trials in non–
United States settings:  implementation of large-scale United
States efficacy trials of products similar to those proposed
for non–United States populations had been considered a
prerequisite for the initiation of such trials in developing
nations.  Instead, WHO indicated that if a member nation or
nations wanted to initiate such large-scale trials, WHO
would actively support of the decision.
The decision to delay domestic vaccine trials had been based
on the failure of the candidate products to meet a key
guideline that had been established earlier in the develop-
ment process.  Antibodies collected from volunteer vaccine
recipients participating in early clinical trials had been
shown, in test tube studies, to control the growth of HIV
strains widely used for laboratory studies.  These antibodies
were then tested against HIV isolates collected in the field
from patients who had recently become infected and were
found not to “neutralize” or inactivate these “primary
isolates.”  Those findings cast doubt on the likelihood that
such vaccines would prove highly effective in field trials.21
Shortly before the June meeting, media reports called
attention to a handful of volunteers in preliminary trials of
these products who had become infected through sexual
exposure even though they had been partly or fully immu-
nized.22  Although a few such “breakthroughs” were antici-
pated, they cast further doubt on the viability of these
candidate products.  Counterevidence—in the form of ani-
mal studies in which these vaccines appeared to protect
chimpanzees from infection when inoculated with HIV—
was considered equivocal because HIV is considered only a
weakly effective virus in chimpanzees.
The panel suggested that large-scale trials in the United
States would be warranted either (a) when other products
that use an alternative theoretical approach to immuniza-
tion reach an appropriate stage of clinical testing, or (b)
when additional data become available on the current
products that provide more convincing evidence that they
are likely to be effective at preventing HIV infection.
Vaccines using alternative approaches are not likely to be
ready for consideration for large-scale trials until 1996 at
the earliest.23  The WHO recommendations supportive of
international trials of gp120 and other products did not
reflect a different scientific evaluation of the likely efficacy
or potential risks of such vaccine candidates, but instead
emphasized that 90 percent of all new infections are occur-
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ring in developing countries where the “devastating effects
of HIV and AIDS on individuals, families and societies
lends a special urgency to the search for an effective vaccine
to prevent infection.”24
Unusual Modes of Transmission
During the period 1993–1994, the Centers for Disease
Control and Prevention issued a full report of the results of
an investigation of possible transmission of HIV to patients
in the practice of a dentist who died of AIDS, and also
reported two cases of HIV transmission in household set-
tings, apparently through the direct exposure of the skin
lesions of an uninfected person to the blood of an infected
household member.
In 1990, the CDC reported a possible transmission of HIV
infection from an infected Florida dentist to a patient.
Subsequently, a total of six patients of this dentist were
reported to have acquired HIV infection while receiving
care from this dentist.  Investigators have been unable to
determine the exact means of transmission in these cases,
but the most likely are contamination and improper steril-
ization of dental instruments and blood-to-blood exposure
following an injury to the dentist.25  This remains the only
health care practice in the United States in which HIV
transmission to patients has occurred, but it has occasioned
substantial controversy about the likelihood of further trans-
mission to patients in health care settings in the future.26
In July 1991, the name of another dentist with AIDS was
published in Miami newspapers.  To assess the likelihood
that HIV is transmitted to patients in the practice of HIV-
infected dentists, CDC and the State of Florida carried out
an extensive investigation of the HIV status of this second
dentist’s patients.  Twenty-eight of the patients were found
to be HIV infected, but all but four of these had independent
behavioral risk factors.  An analysis of the genetic se-
quences of the viruses in blood from the dentist and 24 of the
28 HIV-infected patients suggested that the strains were not
linked.  This, in turn, led the investigators to conclude that
there was no evidence of dentist-to-patient or patient-to-
patient transmission in this practice.  (Notably, the investi-
gation also discovered breaches of proper infection-control
procedures in the dentist’s practice.)  Investigations of
12,499 patients of 32 other dentists and dental students
infected with HIV have documented no dentist-to-patient
transmission of HIV in the practice setting.  Similarly, no
transmissions from surgeons or obstetrician-gynecologists
to patients have been reported.27
The cases of apparent transmission via blood exposure in
households involved direct personal care without routine
use of universal precautions.28  In one case, an HIV-infected
woman with open, draining, and bleeding skin lesions had
direct contact with her previously uninfected pre-school-
aged child (including hugging and sleeping in the same
bed); the child at times also suffered from open, bleeding
skin lesions.  In the second case, a woman with no other risk
factors for exposure to HIV had direct contact with the feces
and possibly blood on cotton swabs used by her HIV-
infected son, although direct blood-to-blood contact was
not documented.  CDC reaffirmed in its report that house-
hold members coming into contact with blood or other body
fluids or excretions should wear protective gloves and wash
their hands after any such potential exposures.
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